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SUMMARY 
Risk management strategy is a broad discipline aimed at 
identifYing, evaluating and handling risks by both physical and 
financial means. The medical aid industry in South Africa has 
experienced a disproportionate increase in expenditure relative to 
the overall economic growth. These cost pressures have placed 
restraints on their ability to obtain new members, which is vital 
when subsidizing higher risks with younger healthier members, 
and has resulted in losses for many schemes. Compounding the 
problem has been political and regulatory health care reforms as 
well as technological advances, which have initiated a complete 
restructure of the industry. This dissertation reviews the risk 
management strategies implemented by medical insurers in South 
Africa. An analysis of alternate risk management strategies is taken 
with the view of recommending a tentative means of making 
medical aids more efficient in an increasingly difficult market. 
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GLOSSARY 
Administrators 
Medical scheme administrators are responsible for the day-to-day 
running of the scheme, for monitoring its financial viability, and for 
executing policy. 
Capitation 
A set price paid to a health care service provider for having a medical 
aid member on their books irrespective of the services rendered or to be 
rendered to such patients. 
Case Management 
The management of the delivery of health care. The aim is to contain the 
costs while allowing for the provision of the best possible care for the 
given ailment. 
Co-insurance 
The portion of covered health care costs for which the member has 
financial responsibility, usually according to a fixed percentage. Often 
co-insurance applies after first meeting a deductible requirement. 
Community Rating 
When a medical scheme prices risk premiums according to the risk of a 
sample population and not the risk of any particular individual. 
Co-Payment 
8 
A cost sharing arrangement in which a plan member pays a specified 
charge for a specified service (e.g. R5 for a consultation). The member 
is usually responsible for payment at the time the service is rendered. 
The amount paid is nominal in order to avoid becoming a barrier to care. 
It does not vary with the cost of the service, unlike co-insurance, which 
is based on some percentage of cost. 
Exclusive Provider Organisation 
The medical aid member is obliged to use the medical schemes set 
network. If the member chooses otherwise he/she is responsible to settle 
the account. 
Fee- For- Service (FFS) 
Medical schemes pay according to the number of services provided. 
Gatekeeper 
General practitioners are often referred to as gatekeepers as they are 
responsible for channelling patients to specialists or specific hospitals 
and feeding information back to the medical schemes. 
Generic Drug 
A chemically equivalent copy of a brand-name drug. A genenc 1s 
typically less expensive. 
Health Maintenance Organisation (HMO) 
9 
An arrangement between health fund administrator and provider of 
health care for the purpose of delivering health services to an enrolled 
population for a prepaid fee. The basic HMO models include: staff 
model, group model, individual practice association and network model. 
Independent Practitioner Association (IPA) 
A forum representing doctors with intention to negotiate on their behalf 
with medical schemes and managed care organisations to provide 
comprehensive health care. 
Managed Healthcare (MHC) 
MHC can best be described as a management process made between 
health care consumers (or their agents) and health care providers. 
Medical Scheme 
Any arrangement whose purpose is to finance and pay health care 
expenses. Also referred to as a medical aid. 
Peer Review 
The mechanism used by medical staff to evaluate the quality of total 
health care provided by medical staff with equivalent training. 
Per Case Reimbursement 
Fixed-fee hospital reimbursement, per hospital case regardless of 
duration of stay. 
Per Diem Reimbursement 
10 
Reimbursement of a hospital bill based on a set rate per day rather than 
on charges. 
Preventative Care 
Comprehensive care emphasising prevention, early detection and early 
treatment of conditions. 
Preferred Provider Network 
A number of providers who have become a managed care organisation's 
pool of providers to whom the organisation directs patients in return for 
reduced health care costs. The relationship is contractually supported. 
Preferred Provider Organisation (PPO) 
A plan in which contracts are established with providers of medical care. 
Providers under such contracts are referred to as preferred providers. 
Medical scheme members have incentives to use preferred providers but 
are generally also allowed benefits from non-participating providers. 
Quality Assurance 
A formal set of activities to review and affect the quality of services 
provided. Quality assurance includes quality assessment and corrective 
action to remedy any deficiencies identified in the quality of direct 
patient, administrative and support services. 
Representative Association of Medical Schemes (RAMS) 
ll 
RAMS, a statutory body created in terms of the Medical Schemes Act to 
represent the interest of schemes and to determine scale of benefits for various 
services. 
Registrar of Medical Schemes 
The official appointed in terms of the Medical Schemes Act, responsible 
for the registration of medical schemes and their rules and the 
application of the Acts and these rules. 
Risk Pool 
A defined account (e.g. defined by size, geographical location, etc) to 
which revenue and expenses are posted. It is a method of sharing and 
managing the risk between the providers and funders of health care in a 
capitation payment system. 
Risk Rating 
The process of setting member contribution rates based partially, or 
wholly on previous claims experience for a specific member group. 
Third-party Payment 
An organisation that pays for health services rendered on behalf of the 
patient. These sources of funds are usually based on a system of 
contributions. Typical third-party payers in South Africa are medical 
schemes and health insurance companies. 
Utilization Review 
12 
The process of evaluating the necessity, appropriateness and efficiency 
of health care services. Information gathered from patients and health 
care providers is reviewed on a prospective, concurrent or retrospective 
basis to determine whether it meets established guidelines and criteria. 
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CHAPTER 1: NATURE OF THE RESEARCH 
1.1 BACKGROUND OF THE RESEARCH 
Over the last decade, health care expenditure in South Africa has 
increased faster than overall economic growth. In the five years to 1995 
medical costs rose by an average of 20% a year. The cumulative 
inflation rate for specialists, private hospitals and medication rose in this 
period by 201%, 270% and 185%, respectively. In contrast, the 
cumulative increase in the overall national inflation rate was 71% (F & T 
weekly, 6 March 1998: 1 0). If this is compared with the relatively minor 
annual increases of between 8% and 11% in salaries and wages, it is 
clear why employers are concerned about the future affordability of 
health care -not to mention retired people whose benefits have not been 
properly funded for in advance. 
Much of the growth in this sector has been a consequence of certain 
unique structural characteristics as well as market failure in the 
production and consumption of health care (Magennis 1991:1). 
Although health care costs have been escalating in both the public and 
the private sector it has been more pronounced in the private sector 
(Magennis 1991: 1 ). The rapidly rising costs make private health care 
increasingly unaffordable. The success of any medical scheme is largely 
determined by the measure to which the increasing number of high risk 
categories (aged and infirmed) are subsidised by an increasing number of 
young and healthy people. For medical schemes, the same cost pressures 
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as referred to above place restraints on their ability to obtain new 
membership, and has led to losses for many schemes. 
Calculations done at the University of Pretoria five years ago indicate 
that the obligations of medical aids to pensioners are equivalent to 10 
times the funds' current reserves (F&TW 19 February, 1993). It is these 
reserves which lead to the realisation that medical-aid funds do not apply 
healthy underwriting and risk-management principles. 
As a consequence of the problems outlined above, the medical aid 
system, which constitutes the largest portion of the private health sector, 
is in danger of collapsing. 
Studies such as that of Duncan, Ginter and Swayne (1995:1) cite a lack 
of strategic thinking and generally poor management as the most 
important problems facing the health care industry. Duncan et al 
(1995:1) went on to say that health care has difficulty in dealing with a 
dynamic environment, holding down costs, providing universal access, 
defining quality, and balancing capacity and demand. Not coincidentally, 
the health care sector has been slow to adopt modern management 
methods, particularly strategic and risk management. 
Compounding the problems associated with rapid growth, the health 
care industry has experienced significant environmental change. 
Political and regulatory "health care reform" changes have initiated a 
complete restructure of the industry. Technological advances have 
continually and rapidly evolved the "state of the art". The economy and 
15 
competition have forever altered the vision and mission of many of the 
industry's institutions. In some areas health care professionals are in 
short supply, especially in state employment and many of those have 
become disenchanted. 
Today, no decision-making environment is more difficult or complex 
than that of health care given its social, political and economic role 
which often contradict or whose ends are juxtaposed. The industry 
presents a truly unfamiliar, unexpected, ambiguous, and uncertain 
environment. Dramatic change will continue to take place within the 
technological, social, political, regulatory, competitive and economic 
context of health care delivery. Today health care organisations that do 
not have a clear strategy are doomed to mediocrity as best - and failure 
at worst. 
Through the disciplines of risk management it is assumed that an 
organisation is able to predict and control the effect of future events on 
its operations. Risk management is concerned with identifying, 
evaluating and controlling risks (Bannister 1989:1 ). Risk management 
is seen as a means of identifying and handling unforeseen events, which 
could impinge on the ability of an organisation to achieve its 
objectives. A health provider's future fiscal strength will be greatly 
enhanced if it can minimise its financial risks and liabilities. The factors 
that mandate risk management programmes in medical schemes today 
will have an even greater impact in the future. 
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Risk management is aimed at evaluating and handling risk by both 
physical and financial means. As a management function, risk 
management should form part of the formulation of the strategy of the 
organisation, strategy being a means of setting direction in the long 
term. Once formulated, the strategy must be implemented. 
This dissertation reviews the concept of risk management and tools of 
implementation with the view to determining to what extent risk 
management has been implemented in the South African medical aid 
industry. This dissertation will explore new generation risk 
management tools to determine the better alternative. 
1.2 PROBLEM FORMATION 
Medical inflation has consistently outpaced general inflation: in the 5 
years to 1995 the cumulative inflation for private hospitals for example 
was 270%, this compares with 71% of overall national inflation (F&T 
Weekly March 1998: 10). Although health care costs have escalated in 
both the public as well as private sector it has been more pronounced 
in the latter. Cost pressures have restrained medical schemes from 
obtaining new membership and have led to large losses for many 
schemes, even resulting in insolvency'. This statement is better 
illustrated by looking at the annual income of medical schemes for the 
period 1983-1995, which increased twelve-fold yet, membership in the 
same period only increased by 30%. Hence the increase in income was 
1 In 1980 there were a total of 289 schemes while in the latest report from the Registrar of 
Medical Schemes (1996:1) there were 176 schemes. 
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rather a factor of rising costs than that of rising membership (Registrar 
of medical Schemes 1995: Annexure A). 
The extent of risk management application historically in the medical 
aid industry is however questionable. As a generalisation, with a few 
exceptions, the full extent of risk management application has been 
limited to its most simplistic form i.e. risk pooling. 
This research will explore the medical funder industry in South Africa, 
within the legislative background, to identifY problems plaguing the 
industry in the context of risk management. It will explore possible risk 
management applications to derive solutions to the industry's problems 
with specific reference to co-insurance plans, deductibles, bonus and 
rebate options, claims management, and new generation tools such as 
medical savings accounts and/or managed health care. 
1.3 OBJECTIVE 
The primary objective of this research is to determine to what extent 
risk management has been implemented in the South African Medical 
Aid industry, from risk identificatiorl through to risk financing. 
The secondary objective is to evaluate alternative strategies from a risk 
management perspective and to select the most appropriate strategy. 
1.4 METHODOLOGY 
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To achieve the above objectives literature relating to risk management 
and the formulation and implementation of a managed health care 
strategy will be reviewed. This theory will be translated into a semi-
structured interview framework with the aim of assessing the extent of 
risk management implementation in the medical aid industry in South 
Africa. The questionnaire will also be a fielding ground for exploring 
alternative tools to managing risk in health care funding. 
1.4.1 SAMPLE 
In order to get an unbiased image of the whole population a random 
sample of the medical aid population was taken. 
The members of the sample were interviewed and the Delphi technique 
applied. The Delphi technique, in its simplest form, eliminates 
committee activity among the experts altogether and replaces it with a 
carefully designed program of sequential individual interrogations 
(usually best conducted by questionnaires) interspersed with 
information and opinion feedback. 
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The principles involved in the Delphi Technique include: 
(1) Sending out a comprehensive questionnaire which can also be 
asked in an interview, 
(2) A follow-up questionnaire is fed back to the respondents, with a 
summary of the distribution of these responses by stating the 
average answer. The respondent is then asked to reconsider his 
previous answer and revise it if he/she so desires. If his/her 
response is extremely contrary to the first answer, he/she is to be 
asked to state his/her reason. Placing the onus of justifying 
relatively extreme answers on the respondents has the effect of 
causing those without strong convictions to move their estimates 
closer to the median, while those who feel that their argument for a 
"deviationist" opinion tended to retain their original estimate and 
defend it. The median of these final responses could then be taken 
as representing the nearest thing to a group consensus 
On completion of all interviews, notes taken are reviewed. These are 
compared with the concepts referred to in the literature to see if they 
apply or whether there are other considerations. The risk management 
alternatives are examined. 
Over and above the empirical work done on the sample population 
insight was also drawn from a brief analysis of existing managed 
healthcare players falling outside the sample population. The purpose of 
which was to provide a relative basis of comparison, of tradition 
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medical schemes versus managed health care, on how far down the 
road both models are on the topic of risk management. One can then 
extrapolate how advanced the South African medical aid industry is 
with respect to managing health care and its risks. 
1.5 LIMITATIONS OF THE STUDY 
For the purpose of this report principle number (2) in the Delphi 
technique i.e. follow-up contact with the respondents, will not be 
strictly adhered to given that the contact person in each organisation is 
either the Chief Executive Officer or the Managing Director, both of 
which run on busy schedules. It is difficult to get appointments with 
such individuals. It is thus vital to get the most out of the one session 
with the individual. Further communications were conducted 
telephonically. 
Given that the industry is still exploring many of the issues touched on 
in this research, it was clear that many of the people interviewed had 
broad and varying definitions of certain topics explored such as risk 
management, managed care and case management. 
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1.6 PLAN OF THE STUDY 
Chapter 1: Nature ofthe research 
An analysis of the current South African health care environment, more 
specifically funding of health care, in an effort to extrapolate problems 
plaguing the industry. This chapter sets out the objectives of the 
research study as well as the planned methodology to achieve this end. 
Chapter 2: Risk Management Process 
Risk can be analysed and effectively dealt with by using methods 
advocated by the discipline of risk management. In this section the 
nature of risk management and its place in the overall strategy for 
medical funders is explored. 
Chapter 3: Medical Insurance in South Africa 
Health funding works on the basic principles of insurance, which is a 
mechanism permitting the shifting of a potentially unbearable loss cost 
from individuals to a pool composed of many individuals. The 
foundation of insurance is risk management. 
Chapter 4: Risk Management Strategy in Health Care Funding 
This chapter reviews various risk management alternatives including: 
co-insurance plans, bonus and rebate options, claims management, 
medical savings accounts and managed health care, to see which 
alternatives best address the principles of risk management. 
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Chapter 5: Managed Healthcare 
This chapter defines and outlines the components of a managed 
healthcare strategy. It takes a closer look at the role of utilization 
management. A synopsis of managed health care in the United States is 
also given. 
Chapter 6: Draft policy on Health Funding in South Africa 
The objective of the proposals is, by and large, to improve the 
affordability of and access to private health care through medical 
schemes (Draft Policy Document 1997:1). An important element of 
these reforms would be to reinforce the requirement of community 
rating within medical schemes. The core of a community rated system 
is such that people should not be discriminated against in obtaining 
medical schemes cover on the basis of their health risks. This goal in 
itself flies in the face of risk management principles and goals. There 
has been an outcry from the health insurance industry and this chapter 
will deluge more on the proposals set by government as well as 
industry views. 
Chapter 7: Methodology 
This chapter explores the methodology behind the research design. It 
delves into the sample population and elaborates on how the 
explorative research will be conducted with particular reference to the 
qualitative framework and the Delphi technique. 
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A brief company overview of each company in the sample population is 
given. For the purpose of comparison existing managed healthcare 
players are also briefly covered. 
Chapter 8: Results 
This chapter comprises the questionnaire, company research and the 
results of the empirical study. 
Chapter 9: Conclusion and Recommendations 
A conclusion to the study is drawn. 
Bibliography. 
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CHAPTER 2: THE RISK MANAGEMENT PROCESS 
2.0 INTRODUCTION 
Strategic management and its application to medical insurers could be 
hampered through the manifestation of uncertain events, preventing them 
from achieving their aims. This risk can be analysed and effectively dealt 
with by using methods advocated by the disciplines of risk management. 
This chapter considers the nature of risk management and its place in the 
overall strategy for medical funders. 
Risk is a normal part of the operations of an organisation (Baird & 
Thomas 1990:35). Risk is potential variation in outcome. When risk is 
present, the outcome cannot be forecast precisely. 'fhe presence of risk 
gives rise to uncertainty. The level of uncertainty depends on the amount 
and type of information available to identify possible outcomes. The 
reduction of uncertainty has economic value, and information can reduce 
uncertainty (Williams, Smith and Young 1995:12). 
Johnson & Scholes (1993 :289) argue that risk should be assessed as part 
of an evaluation of specific strategic options. Thus for example, financial 
risks of a particular strategic option should be considered as part of the 
evaluation of a strategy, as there is a clear link between risk and strategy 
when considering the financing of a particular project. Johnson & 
Scholes (1993:292) recommend the analysis of the risks involved in the 
assumptions made, in considering future markets or other uncertain 
variables, and as part of the process of evaluating strategic options. 
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The outcome of a strategy is uncertain in that the assumptions made in 
the formulation of the strategy may be incorrect or the expected results 
not forthcoming. This may be caused by various events including, in the 
case of medical funders, an irrational inflation in the costs of health care 
claims. Thus strategy and risk are interwoven which leads to the 
conclusion that risk needs to be managed as part of the strategy of an 
organisation. 
When a strategy is formulated by medical aids they run the risk that the 
overall goal is not achieved, that they may not be able to meet the 
expectation of their stakeholders or match their resources to the 
changing environment. In order to reduce this possibility a strategy 
should be developed which takes into consideration these concerns. Risk 
management is a process, which allows management to identify, evaluate 
and control the events, which could possibly adversely affect the 
achievement of their objectives. 
There are many :fuctors, which may detract from an organisation 
achieving its goals. One such factor is the possibility of legal action being 
pursued by an employee. This leads to unforeseen costs being incurred 
by way of compensation. Further expenses such as legal fees and other 
costs in both financial and human terms, some of which are difficult to 
quantify, will also be experienced. These would contribute towards a 
reduction in organisational achievements and also, possibly, loss of 
reputation. In some cases the cost could be large enough to affect the 
survival of the organisation or lead to a failure in the overall strategy. 
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Resources are needed to achieve the objectives of an organisation and if 
some of these have to be diverted to meet the cost of increased 
reinsurance premiums for example, this could lead to failure in the 
strategy through lack of resources. 
Unusually high claims in the medical aid industry, as a result of either 
unexpected chronic illnesses or moral hazard in claiming, can have the 
affect of: increasing the cost of insuring; impact the possibility of 
obtaining reinsurance as well as the overall functioning of the firm, if 
care is not taken to carry out an investigation following one such claim. 
Principles of risk management i.e. identifYing, evaluating and handling 
risks, which will be further defined within the context of this chapter, are 
by the very nature of the business of insuring medical costs already 
applicable to the medical aid industry. This research will however 
analyse to what extent the South African medical aid industry 
implements all these principles and to what extent it has explored 
alternative risk management strategies. 
27 
2.1 DEFINffiON OF RISK 
Vaughan (1989:17) considers risk to be: 
" a condition in which there is a possibility of an adverse 
deviation from a desired outcome that is expected or hoped 
for" 
This would seem to include risk as: vanance, disaster, lack of 
information and loss probability and also involves the concepts of 
uncertainty and the possibility of the occurrence of an untoward event, 
which is an inherent part of risk when discussing risk management. 
2.1.1 PROBABILITY 
In order to proceed further, it is necessary to review the notion of 
probability. The concept of probability is used in understanding the law 
of large numbers. The concept is that in the long run, probability will . 
determine the likelihood that a particular event will occur. It must be 
realised that this may not necessarily be true for a single event but if 
these events are repeated a sufficient number of times, there is a 
likelihood that it will reach the number expected (Troyer et al 1986: 165). 
The formula for determining the probability of a particular event is equal 
to the results of the event under study divided by the total number of 
different results that have an equal chance of occurring. For example, if 
the event under study is the number of uncomplicated deliveries in the 
obstetrical unit of a particular hospital during one year, and there were 
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500 deliveries in the hospital during the period, of which 20 were 
considered complicated, then the probability of having a complicated 
delivery in that particular hospital would be 4 percent i.e. (20/500). 
Quantitative techniques can be extremely useful in risk management 
because probability theory serves as the basis for insurers' pricing 
decisions. It is only logical that risk managers would use the same 
techniques in evaluating insurance as a risk management alternative. 
One of the more useful applications of probability theory in risk 
management is its use in simulation models (Vaughan 1997:7). Such 
models use mathematical equations to represent the various scenarios 
within the risk environment and indicate the likely outcomes of the 
various choices. Simulation models vary from simple to very complex. 
The models permit risk managers to test various scenarios and determine 
the most likely outcomes for various decisions. 
There are two general categories of computer models: deterministic 
models and probabilistic models. 
• Deterministic models are characterised by consistent results. 
They do not explicitly recognise random variation in the 
environment being modelled. If a deterministic model is run many 
times with exactly the same values for all of the input factors, it 1 
will produce exactly the same output each time. 
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• Probabilistic models, also called stochastic models, explicitly 
recognise randomness or uncertainty. The range of chance 
variation may be quite large in some models. 
2.1.2 VARIATION 
Variation 1s the estimated probability distribution. A person 
contemplating hip replacement surgery might be said to have a 
theoretical 5 percent chance of contracting an infection. The danger of 
using such statistical probability is that it does not consider the unique 
facts and circumstances under which those particular infections arose but 
rather only provide a statistical ballpark guide to predicting outcomes. 
The variations might be very different. The concept of variation thus 
becomes an important consideration in understanding the concept of 
risk. 
2.1.3 UNCERTAINTY 
Another concept associated with risk is uncertainty. A person who 
cannot predict an outcome is uncertain or is consciously aware of the 
risk of an unpredictable outcome. Uncertainty is a subjective concept, so 
it can be measured directly (Williams, Smith and Young 1995: I 0). The 
degree of uncertainty depends on that person's estimation of the risk 
involved with the activity and confidence in those beliefs or estimations. 
The reduction of uncertainty has economic value, and information can 
reduce uncertainty. Risk and uncertainty have an important impact on an 
organisation in that they exact a cost mainly referred to as the cost of 
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risk i.e. cost of loss, or cost of uncertainty itself e.g. cost of insurance 
(Williams et al 1995: 15). 
2.1. 4 DEGREE OF RISK 
The most commonly accepted meaning of "degree of risk" is related to 
the likelihood of occurrence (Vaughan 1997:10). We intuitively consider 
those risks with a high probability of loss to be "riskier" than those with 
a lower probability. When risk is defined as the possibility of an adverse 
deviation from a desired outcome that is expected or hoped for, the 
degree of risk is measured by the probability of the adverse deviation. 
When dealing with a large number of exposure units, estimates can be 
made about the likelihood that a given number of losses will occur, and 
predictions can be made on the basis of these estimates. Here the 
expectation is that the predicted number of losses will occur. In the case 
of aggregate exposures, the degree of risk is not the probability of a 
single occurrence or loss; it is the probability of some outcome different 
from that predicted or expected. For an insurance company, then, the 
risk is that its prediction will not be accurate. The actual experience will 
undoubtedly deviate from the expectation, and insofar as this deviation is 
unfavourable, the insurance company faces risk. Therefore the insurance 
company makes predictions not only on the outcome but also estimates 
the range of error (Vaughan 1997: 11). 
At times we make use of terms "more risk" and "less risk" to indicate a 
measure of the possible size of the loss, even though the probability of 
loss is the same. It seems, therefore, that a measure of risk should 
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recognise the magnitude of the potential loss. Therefore the expected 
value of a loss is the probability of that loss multiplied by the amount of 
the potential loss. 
Richards and Rathbun (1983:25) identify a set ofup to five risk classes, 
based on the economic consequences of the occurrence of specific 
individual risks: 
1. Preventative risks: risks whose cost of occurrence is higher than 
their cost of management and whose occurrence may invoke 
additional legal sanctions. This class would include injuries 
caused by gross negligence. 
2. Normally prevented risks: risks whose cost of occurrence is 
greater than the cost of their management but whose occurrence 
will be considered only as negligent. This class includes most 
negligent injuries and most types of product liability actions. 
3. Management risks: risks whose cost of occurrence 1s only 
slightly greater than their cost of management. The plaintiff 
usually has the burden of showing that the defendant owed the 
plaintiff a special duty to recover for one of these risks. 
4. Unprevented risks: risks whose cost of occurrence is less than 
their cost of management. The classic example of this class is the 
cost of railroad crossing barriers compared to the cost of people 
being hit by trains. 
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5. Unpreventable risks: risks whose occurrence is manageable. 
The assignment of risk to one of these classes is a major problem in 
quality control, because the class of risk determines how much effort 
must be expended to prevent the risk. The misclassification of a 
preventative or normally prevented risk as a managed or unpreventable 
risk can result in large financial losses. For example, a hospital that does 
not update obsolete equipment, such a.s inaccurate oxygen monitors in 
the premature nursery, would be liable for any inquiries attributable to 
the obsolete equipment. The classifications of risk must be reviewed 
periodically to determine if the cost of the risk-taking behaviour has 
changed, thereby altering the classification. 
Managers should be able to distinguish between the concepts of risk,· 
probability, and uncertainty as well as understand factors that affect risk 
attitudes so that they can evaluate risks in accordance with the various 
researchers' classification schemes. 
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2.2 CLASSIFICATION OF RISK 
Businesses may fail or suffer as a result of a variety of causes. The 
differences in these causes and their effects constitute the basis of 
different classifications of risk. The sources of risk may be classified as 
dynamic or static, pure or speculative, and fundamental and particular 
(Vaughan 1997: 13). 
2.2.1 DYNAMIC OR STATIC RISK 
Dynamic risks are those resulting from changes in the economy, arising 
from two sets of factors (Willett 1951:14). The first sets are factors in 
the external environment: the economy, the industry, competitors and 
consumers. Changes in these factors are uncontrollable, but all have the 
potential to produce financial loss to the firm. The other factor that can 
produce the losses that constitute the basis of speculative risk are 
management decisions within the firm. 
Dynamic risks normally benefit society in the longer term, since they are 
the result of adjustments to misallocation of resources. 
Static risks involve those losses that would result even if no changes in 
the economy. occurred. Static losses tend to occur with degree of 
regularity over time and, as a result, are generally predictable. Because 
they are predictable, static risks are more suited to treatment by 
insurance than are dynamic risks. 
) 
' 
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2.2.2 PURE VERSUS SPECULATIVE RISK 
Perhaps the most used classification is one developed by A. Mowbary, 
R.H. Blanchard, and C.A Williams, Jr. (1969:6). Their system divides 
economic risks into pure and speculative. Essentially, pure risks are 
those in which the only chance is that of loss. When a former patient 
sues a hospital, the nature of the risk giving rise to the suit is pure in 
form because the hospital stands to suffer a loss if the plaintiff is 
successful. In contrast speculative risk presents chances of gain as well 
as loss. A hospital that attempts to develop a new health care service 
may show a financial gain from utilization of that service or it may suffer 
a loss if the service is not used. The risk is deliberately created in the 
hope of gain. 
2.2.3 FUNDAMENTAL AND PARTICULAR RISKS 
Fundamental risks involve losses that are impersonal m ongm and 
consequence. They are group risks, caused for the most part by 
economic, social and political phenomena, although they may also result 
from physical occurrences. They affect large segments, or even, all the 
population. 
Particular risks involve losses that arise out of individual events and are 
felt by individuals rather than by the entire group. They may be static or 
dynamic. The individual would deal with these risks through insurance, 
loss prevention or some other technique. 
2.3 GENERAL PRINCIPLES OF RISK MANAGEMENT 
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11 Risk management is a scientific approach to dealing 
with pure risks by anticipating possible accidental 
losses and designing and implementing procedures 
that minimise the occurrence of loss or the financial 
impact of the losses that do occur. 11 (Vaughan 
1997:30) 
A fundamental part of the risk management function is designing and 
implementing procedures that minimise the occurrence of loss or the 
financial impact of the losses that do occur. 
Risk management may be considered a process involving a number of 
steps aimed at identifying, evaluating and handling risks. Claes & 
Meerman (1991); Dickson (1991); Grose (1989); Head & Horn (1991), 
among others, have all considered the constituent tasks of risk 
management and these will be discussed below. 
2. 3.1 DETERMINING OBJECTIVES 
The first step in the risk management process is to decide precisely what 
the organisation would like its risk management programme to do. 
There are a variety of possible objectives for the risk management 
function. They include maintaining the organisation's survival, 
minimising the costs associated with pure risk, and protecting employees 
from accidents that might cause serious injury. The first objective of risk 
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management, however, is to guarantee the continuing existence of the 
organization as an operating entity in the economy (Vaughan 1997:35). 
Risk management programme objectives can be categorised as pre-loss 
and post-loss. Pre-loss objectives concern how much effort the medical 
aid will expend on the risk management programme to reduce or prevent 
losses. Post-loss objectives deal with how the institutions can recover 
from a loss, given the fact that the primary aim is survival of the medical 
aid. If the loss would produce certain effects that could injure the 
corporation's reputation, the pre-loss objective may be changed to put 
more emphasis on loss reduction and loss prevention efforts. 
The requirements for survival according to Monagle (1985:12) include: 
( 1) The ability to meet legal obligations; 
(2) A sufficient pool of usable assets and organisational talent to 
regain post-loss stature, and 
(3) Public acceptance of the institution after the loss. 
Efforts beyond essential legal obligations are often required to convince 
key supporters that underlying conditions remain favourable despite the 
immediate misfortune. 
Mere survival is not enough, however. Efficiency and growth are critical 
objectives as well. Growth generally requires: 
( 1) The prevention of interruption in earnings; 
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(2) Preservation of earnings growth, and 
(3) Sufficient liquidity to remain acquisitive and expansive. 
Finally, risk aversion is very real. Freedom from anxiety about possible 
losses is a valid risk management goal. 
Although the actual practice of risk management would be likely to vary 
among organisations, certain elements would be common to all risk 
management programmes. Together these elements comprise the risk 
management function. They are: 
1. Risk Identification 
2. Risk Evaluation 
3. Risk Treatment, i.e. risk control and risk financing. 
2.3.2 RISK IDENTIFICATION2 
This task is an integral part of a risk management programme. It is only 
by identifying risks that action can be taken to control them. Risk 
identification is a continual process as new risks are arising constantly. 
The process of identifying risks depends on a wide-reaching 
communication network generating a constant flow of information. 
Systems should be established, aimed at determining the nature of the 
risks being faced by the organization so that action can be taken to 
provide for their occurrence and lessen their impact on the organization. 
2 Tools used in risk identification in the South African medical aid environment are explored 
in question 2.1 of the interview framework in the Appendix to Chapter 7. 
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Until recently the primary methodology of risk identification was the 
observation of losses that had already occurred (Vaughan 1997:108). As 
a rule, risk identification did not occur until a loss had taken place. Once 
a loss occurred, people sought measures that would prevent the 
reccurrence of loss from the same source. 
2.3.2.1 Tools in risk identification 
The more important tools used in risk identification include internal 
records of the organisation, insurance policy checks, risk analysis 
questionnaires, flow process charts, analysis of financial statements, 
inspections of the firm's operations and management interviews. These, 
combined with a vivid imagination and a thorough understanding of the 
organisation's operations can help to guarantee that important exposures 
are not overlooked (Vaughan 1997:36). 
Monagle (1985:15) identifies four common methods by which a medical 
organisation systematically and continuously identifies property, liability, 
and personnel exposures as soon as or before they emerge: 
1. Risk Analysis Questionnaires: A key tool in risk identification 
sometimes also called a fact finder. These questionnaires are 
designed to lead the risk manager to the discovery of risks through 
a series of detailed and penetrating questions, and in some instances, 
this instrument is designed to include both insurable and uninsurable 
risks. The risk analysis questionnaire is designed to serve as a 
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repository for the information that is gained from documents, 
interviews, and inspections. The information in the completed 
questionnaire is gained from an analysis of documents, inspections, 
records, and interviews. Its purpose is to lead the person attempting 
to identifY exposures through the identification process in a logical 
and consistent fashion. 
2. Exposure Checklist: There are a number of pre·printed surveys 
available to determine loss potentials within the organisation. They 
are useful in jogging the memory before and after inspections, but 
generally should not be used during an inspection. 
3. Expert Systems: In a sense, an expert system used m risk 
identification incorporates the features of risk analysis 
questionnaires, exposure checklists, and insurance policy checklists 
in a single tool. 
2.3.2.2 Risk Identification Techniques 
The risk identification tools described earlier provide a framework within 
which one can interpret information derived from four risk identification 
techniques: orientation, analysis of documents, management interviews 
and inspections (Vaughan 1997: 113 )3• 
3 We expand on the first two points, the last two points are self explanatory 
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1. Orientation: The first step in risk identification is to gam as 
thorough a knowledge as possible of the organisation and its 
operations. If the organisation is a public corporation, the best 
place to start is with the latest annual report. 
2. Analysis of Documents: The history of the organisation and its 
current operations are recorded in a variety of records. These 
records represent a basic source of information required for risk 
analysis and exposure identification. As a starting point in the risk 
identification process, the auditor should obtain certain internal and 
external documents that summarize the activities and history of the 
organisation. These documents include the following: Copy of the 
annual report; latest balance sheet; latest income statement; 
flowchart of operations etc. 
• Financial statement analysis: Since all business transactions 
eventually involve either money or property, the risk manager can 
identifY all existing property, liability, and personnel exposure by 
analysing the balance sheet, operating statement, and supporting 
records. Examinations of budget and forecasts will identifY future 
risks. 
• Flow chart method: Flow charts show all operations of the medical 
aid to delivery of the final products or service. A checklist of 
potential losses is supplied to each operational stage in the flow. 
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Claims history also plays an important role in risk identification. Once 
managers know the services it is vital to be fully aware of past claims 
information and each health provider's claims experience. Managers must 
also be aware of the national claims experience as a basis of comparison. 
It is however important for the risk manager to understand that claims 
statistics do vary from province to province. 
The preferred approach to risk identification consists of a combination 
approach, in which all risk identification tools are brought to bear on the 
problem. In a sense, each tool can solve a piece of the puzzle, and 
combined they can be of considerable assistance to the risk manager. But 
no individual approach or combination of these tools can replace the 
diligence and imagination of the risk manager in discovering the firm's 
risks. 
The risk identification tools and methods discussed are not sufficient to 
identifY new risks as they emerge (Vaughan 1997:122). To identifY new 
risks, the risk manager needs a fur-reaching information system. Because 
risks may arise from many sources, the risk manager needs information 
systems designed to provide a continual flow of information about 
changes in operations, acquisition of new assets, new construction, and 
changing relationships with outside entities. Records and statistics are 
essential tools of the risk management profession, and without adequate 
records, it is difficult to analyse the risks facing the organisation and to 
determine the advisability of retaining certain risks. In addition, records 
relating to property valuations, past losses and other critical pieces of 
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information should be readily available to the persons responsible for 
administering the programme. 
Much of the information required for this risk management information 
system already exists within most organisations in an unstructured form. 
The information becomes more useful when it is combined into a useful 
database that facilitates analysis. 
2.3.3 RISK EVALUATION 4 
Once the risks have been identified, the risk manager must evaluate 
them. This involves measuring the potential size of the loss and the 
probability that the loss is likely to occur and then providing some 
ranking in order of priorities. Whether a particular exposure is 
ultimately classed as critical, important, or unimportant depends on the 
potential severity of the loss. In addition the magnitude of the potential 
loss must also be measured to determine the amount of insurance that 
should be purchased when the decision is made to transfer risks. 
The analysis process can be approached from many different angles. A 
typical example might be a statistical or mathematical process in which 
the manager attempts to identity the exposures and analyse them in an 
effort to manage particular risks, i.e. the concept of probability. 
4 The risk analysis undertaken by medical aids in South Africa is studied under question 2.2 
of the interview framework in the Appendix to Chapter 7. 
5 Probabilities are explored further in paragraph 2. I. l. 
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The recorded occurrences should be looked at in several ways (Troyer et 
all986:165): 
• The probable frequency of the occurrence of the loss; 
• the probable severity of the loss; 
• the possible severity of the loss; 
• the effect the potential loss would have on the organisation 
financially. 
The first step is to look at the maximum probable and possible losses. 
The maximum probable loss means the worst loss that would be 
anticipated under average conditions. The maximum possible loss 
assumes the worst possible conditions and looks at the worst loss that 
can arise. Typically one would look at the maximum possible loss in 
dealing with a single structure, or a limited number of "properties" in a 
risk portfolio. Since the facility might not have an experience base la~ge 
enough to spread the loss and therefore would lack the spread among a 
large number of events to determine the maximum probable loss 
(Vaughan 1997: 17). This, however, would not be the case with a 
medical funder. The insurer/underwriter would rather attempt to 
determine the magnitude of the most likely loss. Given the underwriters' 
spread of risk and the numerous "properties" in his/her portfolio, this is a 
reasonable strategy. 
Once the probable and possible outcomes have been determined, the 
next step is to determine the effects of those potential losses on an 
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organisation, both from a clinical and financial standpoint. In today's 
environment, what effect will it have on: 
(l) the assets of the organisation; 
(2) on its future creditworthiness; 
(3) the goodwill of the medical aid m the community, once the 
medical aid learns of the losses. 
In order to analyse the risks in a holistic manner a risk management 
committee should be created which is multidisciplinarl i.e. composed of 
physicians, nurses, a pharmacist, and the risk manager. This committee 
once organised can do several things. 
• It can look at individual cases and serious incidents - for example, a 
potential or actual claim. There can be a multidisciplinary review 
process for the risk manager to review the medical records and help 
obtain advice as to what indeed has happened. Was the care ideal? 
• It can analyse occurrence data to find systems and patterns so that 
procedures can be evaluated, medical disposables or drugs used, 
staffing patterns altered, educational programmes undertaken, or 
whatever may be necessary to correct problems with the care that 
may be identified. 
It can be a good source for pooling information from different 
departments or people involved in a problem, such as the nursing 
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members or the physicians. The goal of this committee would be to 
reduce the exposure and the frequency of claims while increasing the 
quality of care. 
2.3.4 RISK TREATMENT 
As stated in the definition of risk management, a fundamental part of the 
risk management function is designing and implementing procedures that 
minimise the occurrence of loss or the financial impact of the losses that 
do occur. This indicates the two broad techniques used in risk 
management for dealing with risks: risk control techniques and risk 
financing techniques. 
The risk manager should apply at least one risk control and one risk 
financing tool to each significant exposure: good risk management 
requires a combination of several techniques, each used in proper 
balance with others. If only risk control techniques are used, there 
remains some possibility of serious loss that could require risk financing 
to restore. If, on the other hand, only risk financing techniques were 
used - with no efforts to control losses - the costs of financing would be 
unnecessarily high. 
Historically, risk management focused on preserving the financial 
resources of the institution. Today, however, particularly in a high 
6 Risk committees are covered in question 1.2 of the interview framework. 
7 The issue of risk treatment, both with respect to risk control and risk finance in the South 
African medical aid industry is explored in the Appendix Chapter 7, question 2.4 of the 
interview framework. 
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technology industry such as health care, human resources are a valuable 
asset (Troyer & Salman 1986: 151 ). The medical aids' relationship with 
its health care providers and customer groups, and ability to develop and 
maintain a good rapport with it, constitutes an important resource. If the 
medical aid is unable to maintain that rapport, the employer groups will 
be in a position to either threaten to or actually take their business to 
another medical aid. Therefore medical aids must protect that resource. 
This constitutes a risk that a medical aid would need to control through 
improved efficiency of service. 
2.3.4.1 Risk Control Techniques 
Once the risks have been identified and evaluated decisions are made as 
to how these risks are to be controlled. 
Broadly defined, risk control techniques are designed to minimize, at the 
least possible cost, those risks to which the organization is exposed. Risk 
control methods include risk avoidance and the various approaches to 
reducing the risk through loss prevention and control efforts. 
The two major techniques of risk control are risk avoidance and risk 
reduction: 
• Risk avoidance: Technically, avoidance takes place when 
decisions are made that prevent a risk from even coming into 
existence. This would include abandoning or not engaging in an 
asset or activity rather than accepting the associated pure risk. 
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An example would arise as a result of the high incidence of 
medical malpractice claims in some fields that has resulted in a 
shortage of practitioners in these areas. The line between risk 
avoidance, risk reduction or risk transfer is sometimes a hazy 
one. Once the risk exists, it is more appropriate to classify the 
measures used to eliminate it or minimise it as loss prevention 
rather than avoidance. The distinction, however, is merely 
semantic. In either case, the efforts to minimize risk constituted 
risk control efforts. 
If avoidance is used extensively the firm may not be able to 
achieve its primary objectives. For this reason avoidance is the 
last resort in dealing with risk. It is used when there is no other 
alternative (Vaughan 1997: 180). 
• Risk reduction: This term is used to define a broader set of 
efforts aimed at minimizing risk. Risk reduction consists of all 
techniques designed to reduce the frequency of loss, or the 
potential severity of those losses that do occur. It is common to 
distinguish between loss prevention- those efforts aimed at 
preventing losses from occurring - and loss control- those efforts 
aimed at minimizing the severity of loss if it should occur. One 
can reduce or eliminate the chance of loss by, for example, good 
housekeeping, quality control, and safety programmes, in the 
case of medical aids strong case management to ensure the 
validity of claims. 
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2.3.4.1.1 Specialized loss control techniques 
It is possible to describe broad control techniques into which the 
virtually endless array of specific approaches can be classed. Vaughan 
( 1997: 190) outlines several specialized loss control techniques. 
• Separation of exposure units: Dispersed assets and activities to 
reduce the risk of loss in a single event. 
• Combination of exposure units: Combining widespread exposures to 
make losses more predictable by use of the law of large numbers. 
• Salvage: When efforts aimed at preventing the occurrence of a loss 
fail and the loss occurs, the amount of the loss can be reduced by 
immediate '~ction to protect the remaining value that has not been 
damaged. 
• Rehabilitation: The salvage function applied to human beings. 
• Non-insurance transfer: Some risk transfers - most notably 
insurance-are a form of risk financing. Other types of transfers are 
more appropriately classified as risk control measures (Vaughan 
1997). These risk-control transfers include a variety of business 
activities, such as leasing, subcontracting and contractual 
arrangements that alter the incidence of loss. Another type of risk 
transfer that falls within the ambit of risk control consists of 
contractual transfers of risk that are auxiliary to another contract or 
agreement. Such agreements are referred to as holdharmless 
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agreements and indemnity agreements. An example of such an 
agreement would be concluding a contractual arrangement in which 
medical insurers transfer an element of risk into the hands of the 
provider. One method of achieving this would be by introducing a 
fixed fee instead of a fee-for-service system. 
The classification of these types of transfers as risk control measures can 
be debated. Generally, risk control reduces risk. When a risk is 
transferred to another party, it has not been eliminated, but merely 
shifted to another party. From this perspective, contractual transfers of 
risk do not reduce risk, at least not in the aggregate. From the 
perspective of the transferor, however, the risk is reduced, so we will 
consider these as risk control measures. 
2.3.4.2 Risk Financing Techniques 
Risk control techniques will not eliminate all risks facing the 
organisation. Although risk may be reduced, some risks will remain. 
These remaining risks are addressed by the second broad approach to 
risk management, risk financing. The techniques of risk financing, 
retention and transfer are mutually exclusive and collectively exhaustive. 
Financing risk is a means of providing funds to meet the costs incurred 
following the operation of a risk. The classification of risk financing 
techniques is based on the source of funds (i.e. whether it is inside or 
outside the organisation). Risks that are not transferred are retained. 
There are essentially two types of financing techniques: Insurance and 
Retention. 
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2.3.4.2.1 Insurance 
Risk transfer, involves the use of external funds. It can be categorized as 
(1) non-insurance transfer, or making someone else responsible for the 
loss obligation, or (2) insurance transfer, or selling the risk to a 
professional risk bearer for a premium. 
Insurance is a contractual relationship by which risk is transferred to 
another party. Insurance in its simplest aspect has two fundamental 
characteristics: 
• Transferring or shifting risk from one individual to a group. 
• Sharing losses, on some equitable basis, by all members of the 
group. 
In addition to eliminating risk at the level of the individual through 
transfer, the insurance mechanism reduces risk (and the uncertainty 
related to risk) for society as a whole. The risk the insurance company 
faces is merely a summation of the risk transferred to it by individuals. 
The insurance company is able to do something that the individual 
cannot, and that is to predict within narrow limits, the amount of losses 
that will actually occur. The accuracy of the insurer's predictions is based 
on the law of large numbers. By combining a sufficiently large number of 
homogenous exposure units, the insurer is able to make predictions for 
the group as a whole. This is accomplished through the theory of 
probability. 
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If the medical insurance company's actuaries or statisticians could predict 
future losses with absolute precision, the insurer would have no 
possibility of loss. It would collect each individual's share of the total 
losses and expenses of operation and use these funds to pay the losses 
and expenses as they occurred. Premium income would always be 
sufficient. To the extent that the accuracy in prediction is attained, and 
risk is reduced. 
Although probability plays an important role on the operation of the 
insurance mechanism, insurance does not always depend on probabilities 
and predictions. Insurance arrangements can exist in which the 
participants agree to share losses and to determine each party's share of 
the costs on a post-loss basis. It is only when insurance is to be operated 
on an advance premium basis, with the participants paying for their share 
of losses in advance, that probability theory and predictions are 
important. 
Reinsurance 
Reinsurance is a device whereby an insurance company may avoid 
catastrophe hazard in the operation of the insurance mechanism. As the 
term indicates, reinsurance is insurance for the insurer. It is based on the 
same principles of sharing and transfer as insurance itself There are two 
types of reinsurance treaties: Facultative and automatic (Vaughan 1997). 
Under facultative treaty, each risk is submitted by the direct writer to the 
reinsurer for acceptance or rejection. Although the terms under which 
reinsurance will take place are spelled out, the direct writer is not 
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obliged to submit a risk to the reinsurer and the reinsurer may accept or 
reject risks that are submitted. Until risk has been submitted and 
accepted or rejected the writer carries the entire risk. Under the terms of 
an automatic treaty, the reinsurer agrees in advance to accept a portion 
of the gross line of the direct writing company or a portion of certain 
risks that meet the reinsurance underwriting rules of the reinsurer. 
2.3.4.2.2 Risk retention 
Risk retention, the most common method of handling risk, may be 
passive or active (unplanned or planned). Retention is passive when the 
existence of the exposure is unknown and, thus, there is no attempt to 
address it. Retention is active when the exposure is considered and 
consciously retained. Organizations may consider active risk retention 
when (1) it is impossible to transfer or prevent the loss, risk avoidance is 
desirable; (2) the maximum possible loss is so small that the organisation 
can safely absorb it; (3) the chance of loss is so low that it can be 
ignored or so high that transfer would be too costly; or (4) when losses 
are highly predictable. 
The organisation that is retaining risk may: 
(1) Treat losses as current expenses on a pay-as-you-go basis; 
(2) Create reserves for loss liabilities, either funded or unfunded. In a 
funded retention programme, the firm earmarks assets and holds 
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them in some liquid or semi-liquid form against the possible 
losses that are retained; 
(3) Establish a captive insurance company affiliate to underwrite the 
firm's risk; 
( 4) Borrow the funds at the time of a loss. 
2.4 PROGRAMME ADMINISTRATION 
The programme, once implemented, must be evaluated and monitored. 
This is to ensure that the objectives of the programme have been 
attained. If this is not the case the person responsible for risk 
management will need to take action to rectify the situation. 
2.5 CONCLUSION 
The loss exposure that confronts medical aids includes property loss and 
net income losses as a result of a decrease in revenues or an increase in 
expenses. Medical aids, like other organisations, have limited resources 
available for any programme, risk management being no exception. 
Therefore, by measuring and analyzing the identified risks, managers are 
in a better position to allocate resources to areas that will produce the 
best return for the time, efforts and funds invested. 
Whatever the organisational goals are - efficiency, growth, improvement 
of reputation in the community, reduction of anxiety over potential loss 
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exposure - they should guide the specific objectives of the risk 
management programme. Thus, the determination of these objectives 
and organizational values lies at the heart of the risk management 
programme. 
"? 
After setting objectives a company would go about identifying risk. Until 
recently the primary methodology of risk identification was the 
observation of losses that had already occurred. To identifY new risks, 
the risk manager needs reaching information systems designed to provide 
a continual flow of information. Records and statistics are essential tools 
of risk management, especially when combined into useful databases that 
facilitate analysis. 
Once risks have been identified, the risk manager must evaluate them in 
terms of potential size and probability of loss, which will empower the 
manager with the knowledge on how to treat the relevant risks. 
Formulation is the initial part of managing strategically but once strategy 
has been developed, implementation is vital. The following chapter refers 
more specifically to the medical aid industry and to the implementation 
of risk management in health care organisations. 
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CHAPTER 3: MEDICAL INSURANCE IN SOUTH AFRICA 
3.1 INTRODUCTION 
Medical schemes are non-profit organizations and their main objective 
is to assist members with their medical expenses (Darrington 
1985: 1 07). They work on basic principles of insurance. Adam Smith 
offered a definition more than 200 years ago: 
" The trade of insurance gives great security to the fortunes of 
private people, and by dividing among a great many that loss 
which may ruin an individual, makes it fall light and easy upon 
the whole society. " (Smith 19 3 7: 715) 
Although the economic nature of today is very different from that of 
Smith's, little change is needed in his definition to make it fit the 
current situation. Insurance may function in various circumstances, it 
remains a mechanism permitting the shifting of a potentially 
unbearable loss cost.from the individual to a pool composed of many 
individuals, when averaging the total cost of loss paid by the pool 
across all its members. 
Worldwide, health care systems have been facing financial difficulties 
and South Africa has been no exception. In the private health care 
sector costs have risen 33 percent faster than employee remuneration 
and, partly as a result of this, medical scheme membership has been 
declining since 1990 (De Clerk 1993:1). 
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Medical aids have priced themselves into the public eye. There is 
substantial evidence to indicate that when a large proportion of 
medical costs are offset by insurance, doctors will recommend more 
services, the consumers in return will demand more and better 
servtces. Thus as insurance increases a higher quality of care is 
demanded. Hospitals, as they work to fill the demand for increased 
services, raise prices in order to raise revenue, which can be used to 
provide more expensive form of care demanded. Since most 
consumers in the private sector do not pay out of pocket for hospital 
care because they are heavily insured, they are shielded from the 
resulting increase in prices and do not respond in the normal way by 
curtailing demand. On the contrary as consumers observe the higher 
prices, or cost, of medical care, their desire for insurance increases 
and likewise their demand for medical care increases, so the 
inflationary cycle continues. 
This is just one of the problems facing the medical aid industry and 
contributing towards its demise. The purpose of this chapter is to draw 
on the background and structure of the medical aid industry in South 
Africa in order to gain a clearer understanding of the causes of some 
of the inefficiencies in the system. 
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3.1 THE SOUTH AFRICAN HEALTH CARE ENVIRONMENT 
South Africa has a population of over 40 million, 73 percent of who 
are women and children. The World Bank (Private Health Care1998: 
25) classifies South Africa as a middle-income country. South Africans 
spend 8,5 percent of Gross Domestic Product (GDP) on health care, 
of which as much as 60 percent is spent in the private sector, which in 
turn only services 23 percent of the population (Government Gazette 
1997: 12). 
Our health-care expenditure may even be more than 8,5 percent of 
GDP because public sector expenditure excludes indirect costs, such 
as maintenance ofbuildings and equipment. Nor does the figure reflect 
expenditure on health care at local authority level, e.g. immunization 
clinics, expenditure on hygiene and environmental health, and more. 
Compared with other countries this is very high, as can be seen from 
the figures in table 3 .1. on page 60. 
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Table 3.1: Health statistics for reporting OECD countries 1993 
Country Acute beds per Total health spend 
I 000 population percent ofGDP (1994) 
Australia 4.3 8.5 
Austria 5.4 9.7 
Belgium 4.8 8.2 
Denmark 4.1 6.6 
Finland 4.6 8.3 
France 5.0 9.7 
Germany 7.2 9.5 
Greece 3.9 5.2 
Ireland 3.2 7.9 
Netherlands 4.1 8.8 
New Zealand Na 7.5 
South Africa 4.0 8.5 
Turkey 1.9 4.2 
United 2.1 6.9 
Kingdom 
United States 3.5 14.3 
Source: The seventh annual pubhcatton of the Hospttal Assoctatton of South Africa 
South Africa exhibits major disparities and inequalities in health care 
distribution. This is the result of former apartheid policies, which 
ensured racial, gender and provincial disparities. The majority of South 
Africa has inadequate access to basic services including health, clean 
water and basic sanitation. Statistics for 1994 suggest that between 35 
and 55 percent of the population live in poverty. 53% percent of the 
population live in rural areas the vast majority of whom are poor 
(Government Gazette, April 1997: 11 ). 
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The 199711998 Health Budget allocation was R20,2 billion, this was 
up 9,5 percent to the 1996/1997 budget. This figure equates to the 
health expenditure in the private sector: The difference lies in the 
volume of people being serviced by the private versus the public 
sector, with the private sector servicing 23 percent of the population. 
Although the increase in the budget in the last financial year once 
again comes in below medical inflation, there has undoubtedly been an 
increase in the fraction of the budget allocated to health in the past few 
years. Health consumes 10,7 percent ofthe 1997/98 budget, compared 
to 10,3 percent in 1996/97 and 10,2 percent in 1995/96, a 41 percent 
increase in monetary terms from 1995. This allocation is comparable 
to high-income countries that average about 12,5 percent compared to 
middle - income countries at 5,1 percent and low income countries at 
3,4 percent (Government Gazette, Aprill997: 11). 
In spite of South Africa's high expenditure on health care, it ranks as 
the unhealthiest country in the world as reflected in table 3.2 on the 
following page. 
Table 3.2: The world's healthiest and unhealthiest countries 
Country Rank Country Rank 
Israel 1 UK 14 
Sweden 2 USA 15 
Canada 3 Poland 16 
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Australia 4 Mexico 17 
Switzerland 5 Taiwan 18 
Japan 6 China 19 
Netherlands 7 Hungary 20 
Singapore 8 Malaysia 21 
Italy 9 Argentina 22 
France 10 Turkey 23 
South Korea 11 Russia 24 
Spain 12 Brazil 25 
Germany 13 India 26 
South Africa 27 
Source: The seventh annual publicatiOn ofthe Hospital Assoc1at10n of South Africa 
Though health expenditure compares fairly well to developed 
countries the resulting health care level is no better than middle 
income countries which spend far less. 
It is estimated that the infant mortality rate, being the mortality rate 
for infants under the age of five, happens to be greater than 49 for 
every 1000 and is much higher than expected of a country with 
South Africa's level of income (Government Gazette, April 
1997:11 ). This figure compares with middle-income countries at 38 
for every lOOO(Government Gazette, Aprill997:11). 
3.1.1 PROBLEMS IN HEALTH CARE DELIVERY 
The health system in South Africa is a combination of a voluntary 
private sector and a national public health service that is tax funded. 
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In the region of 7, 7 percent of the population (of approximately 31 
million) are provided for by the public sector and 23 percent (9 
million) by the private sector (Government Gazette 1997: 12). 
The maJor problems facing this system may be summarized as 
follows: 
• There is a gap in the provision of primary health care services and 
related infrastructure; 
• There is inadequate physical distribution of resources on a 
geographic basis; 
• There are maJOr inconsistencies in the determination of the 
distribution of the state budget for the public health system generally. 
These inconsistencies exist at both the macro and micro levels. Both 
systems of accounting and basic information to determine new 
resource priorities are inadequate; 
• Both the private and public sectors are administered rather than 
managed with poor utilization of information; 
• The private sector cost increases are resulting in a fragmentation of 
the risk pool with more and more people choosing not to take 
indemnity coverage, risk rating of high medical risks, product 
proliferation with respect to medical cover, free-riding on the state 
services, and benefit stripping to cut costs. The result is that many 
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people who could afford to pay for their own health care now rely on 
the state services where there is an under-recovery of costs; 
• The continuation of fee-for-service remuneration on a large scale has 
resulted in the uncontrolled increases in expenditure on private 
medical services. 
3.1.2 PRIVATE HEALTH CARE SECTOR 
Healthcare is one of South Africa's fastest growing industries, with 
employers spending 10-15 percent of total payroll on this sector. 
Twenty years ago, the average expenditure was closer to 1 percent 
of payroll, says Conradie of Hollandia Reinsurance Group (Sunday 
Times Business Times 1998: 1 ). Given that salary increases of 8w 11 
percent per annum has not kept up with the larger 25 percent 
medical inflation, the cost of medical aid cover is becoming 
prohibitively expensive. Young, low risk members are opting out of 
the medical aid schemes, and the risk profile of the medical aids is 
deteriorating further. Already the number of registered medical 
schemes has dropped from 220 to 174 over the past four years 
(Registrar ofMedical Schemes 1996:1). 
The size of the South African private health care sector has 
increased markedly during the 1980's. Much of the growth in this 
sector has been a consequence of certain unique structural changes, 
such as the migration of patients and high skilled staff from the 
public sector to the private sector, as well as market failure in the 
production and consumption of health care (Magennis 1991:1). By 
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the end of 1991, medical schemes financed medical care for an 
estimated 18,7 percent of the South African population (Mcintyre 
1993:2). The number of doctors in the private sector had increased 
by 112 percent between 1979 and 1990 as opposed to 31 ,5 percent 
in the public sector (Masobe 1992:2). The private sector accounts 
for an estimated 50 percent of the total South African health care 
expenditure. More than 59 percent of registered medical 
practitioners, 84 percent of pharmacies and 93 percent of dentists 
are active in the private sector (Masobe 1992:2). 
Although health care costs have been escalating in both the public 
and the private sectors it has been more pronounced in the private 
sector. Between 1975 and 1990, medical aid contributions increased 
at an average of 24,5 percent per annum while the consumer price 
index increased at 13,7 percent (Registrar of Medical Schemes 
1994) (Appendix 1 ). Furthermore, benefit payouts have increased 
more rapidly than subscriptions since the late 1980's, leaving 
medical aid schemes with declining reserves 
and increasingly financially insecure despite raising contribution 
scales (Mcintyre 1993: 1 ). 
In 1994 industry figures indicate that the growth in cost per member 
were largest for private hospitals where costs increased over 30 
percent and indications are that 1995 evidenced a similar escalation 
in costs (King, Nel, Eden and Young 1995:3). In the same breath, 
however, it is common belief, and this research study will confirm, 
that the majority of South African medical fund administrators have 
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never seriously employed case management tactics in evaluating the 
medical bill. Nor have they applied utilization management tools in 
order to determine where the source of the problem of rising costs 
lie. 
In the face of these adversities, there has been increasing support for 
the restructuring of private sector medical finance mechanisms to 
help contain risks and its concomitant costs. Since the early 1980's 
there has been a large scale move, most notably in the United States, 
to introduce managed healthcare, a means of controlling private 
sector health care expenditure. Encouraged by indications that 
managed healthcare has had some success in controlling costs, there 
has been significant private and government support for the 
introduction of managed healthcare in South Africa. 
Amendments to the Medical Schemes Act in 1989 and 1993 have 
removed many legal obstacles to the development of managed 
healthcare in the private sector. In particular they have removed the 
guarantee of payments to providers for services rendered, allowing 
schemes to refuse to pay for treatment that they considered 
unnecessary. In addition, the amended Act gives freedom to medical 
schemes and insurers to create "limited" m:dical cover packages, 
replacing legislation which specified which benefits must be 
included. In short, the new law will bring managed healthcare to the 
fore. At the same time the South African Medical and Dental 
Council has removed previous prohibitions on collaboration between 
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providers (hospitals, doctors etc.) and insurers, thereby allowing 
them to start managed healthcare schemes. 
3.1.2.1 Summary 
As a consequence of the problems outlined above, the medical aid 
system, which constitutes the largest portion of the private health 
sector, is in danger of collapsing. The urgency to resolve the crisis is 
compounded by the fact that the private health care sector is likely 
to expand considerably in the near future. The current medical aid 
market only covers 12 percent of the black population and with the 
government promulgating legislation requiring that all formally 
employed individuals in South Africa be under some form of medical 
cover, the medical aid industry could see an increase in demand. -
There are currently 6,5 million people on some form of medical 
cover. This compares with a potential further 7,5 million formally 
employed individuals who currently have no cover (Da Costa 
1996:7). This indicates a large untapped market for the medical aid 
industry. 
3.2 THE MEDICAL AID INDUSTRY, BACKGROUND, 
PROGRESSION AND PROBLEMS 
3.2.1 THE MEDICAL AID INDUSTRY 
The first medical scheme was started in 1889 by the diamond 
conglomerate De Beers, for its employees. Since then there has been a 
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proliferation of medical schemes in South Africa and in 1967 the 
Medical Schemes Act was introduced to control the structure and 
functioning of these schemes. 
At present three types of medical schemes exist. They are medical aid 
schemes, medical benefit schemes arid exempted schemes. 
Medical aid schemes and medical benefit schemes are registered in 
accordance with the Medical Schemes Act (No. 72 of 1967) while 
exempted schemes are excluded from this act. The Medical Schemes 
Act defines certain base requirements with which registered medical 
schemes must comply. 
The number of schemes has however progressively decreased in the 
last decade. In 1980 there were a total of289 schemes, of which 214 
were registered medical aid schemes while at the end of 1989, there 
were a total of250 schemes, of which 189 were registered medical aid 
schemes, 18 medical benefit, and 43 exempted schemes (Registrar of 
Medical Schemes 1990). According to the latest report of the 
Registrar of Medical Schemes (1996: 1) there were 176 medical 
schemes. 
3.2.1.1 Medical Aid Schemes 
A medical aid scheme is defined as (Medical Schemes Act No. 72 of 
1967:2): 
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" A medical scheme of which the rnles provide for rendering of 
medical and dental services to the members thereof and to the 
dependants of such members by medical practitioners and 
dentists of their own choice. " 
A medical aid scheme is a form of health insurance that pays for the 
services received by members and dependants from practitioners of 
their choice. 
The scheme pays for the cost of medical care, within the limits of a 
specific package of benefits. Providers are paid on a fee-for-service 
basis and medical schemes effectively guarantee payment to health 
care practitioners if they charge according to the scale of benefit. 
(Medical Schemes Act No. 72, 1967). 
Employers usually establish medical aid schemes, or negotiate medical 
coverage on behalf of employees with individual schemes, and require 
their employees to join these schemes. Employers usually contribute 
50 percent of the monthly fee (Reitz 1984:217). 
Open and closed schemes merely refer to the membership boundaries 
of schemes. A closed scheme comprises members belonging 
exclusively to a particular organisation whilst open schemes are not 
restricted to members of one organisation only. 
3.2.1.2 Medical Benefit Schemes 
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The Medical Schemes Act (No. 72 of 1967:2) defines a medical 
benefit scheme as: 
" A medical scheme of which the rules provide for the conclusion 
of an agreement between such scheme and any medical 
practitioner or group of medical practitioners or any dentist or 
any members of such group of dentists, as the case may be, by 
way of a salary or by way of an amount calculated on the basis of 
the number of members of such scheme and dependants of such 
members for whose treatment such medical practitioners or such 
dentists or such members of such group of dentists, as the case 
may be, is under such agreement responsible". 
Medical benefit schemes contract with specific providers of health 
services who are usually paid a capitation fee to provide services to its 
members (Broomberg and Price 1989:2). 
The curative benefits offered by benefit schemes are generally less 
comprehensive than those provided by medical aid schemes. Many of 
these schemes operate their own hospitals and members do not have a 
free choice of practitioners. The benefits offered by medical aid 
schemes are usually more comprehensive from a curative perspective 
and hence the contributions paid are higher than is the case with 
medical benefit schemes. Medical aid schemes generally operate for 
the higher income, more skilled group, whilst medical benefit schemes 
cater for the lower paid, usually semi-skilled or unskilled 
worker(Dorrington 1985: 1 08). 
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In fact in South Africa the old medical benefit society were, in 
principle very similar to managed health care organisations. In these 
schemes members and employers contributed monthly or weekly but 
they received medical care provided by the scheme itself The scheme 
provided services through the employment of it's own general 
practitioners and medical specialists. However, these benefit societies 
developed a poor reputation because they were attempting to provide 
health care on such low budgets that it was impossible to provide a 
reasonable quality of care. 
3.2.1.3 Exempted Schemes 
Section 2(1) of the Medical Schemes Act allows schemes to apply for 
exemption from complying with certain requirements. Although many 
of these schemes operate on a fee-for-service basis, they are free to 
draw up their own tariff of fees and are not compelled to guarantee 
payment to providers (Veliotis, Magennis and Brown 1993:18). These 
are known as exempted medical schemes. The following schemes are 
exempted: 
1. PLOYMED The medical scheme for the South African Police 
2. MEDCORR The medical scheme for the employee's of the 
South African Prison Service 
3. TRANSMED The medical scheme for the employee's of the 
South African Transport Services 
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The above schemes were founded in 1982 and although they are not 
bound by the Act, they operate on a fee-for-service basis and generally 
abide to the scale of benefits as determined by Representative 
Association of Medical Schemes (RAMS). These schemes are not 
compelled to guarantee payment to providers. The above schemes· 
receive large subsidies from the various public sectors, which they 
serve, and they generally provide generous benefits to their members 
(Reitz 1984: 219). 
4. SCHEMES CREATED BY INDUSTRIAL LEGISLATION 
Certain schemes were established in terms of Industrial Council 
agreements. There are two categories: 
=> Industrial Council Medical Aid Schemes 
=> Industrial Council Medical Benefit Schemes 
Industrial Council Medical Aid Schemes exist mainly in industries in 
which the trade unions are organised on a craft union basis and hence 
cover mostly skilled workers. Their benefits range between those 
offered by commercial medical aid schemes and those offered by 
medical benefit schemes. They are controlled by local industrial 
councils and are responsible to the Minister of Manpower. The fees in 
The Scale of Benefits do not bind practitioners, and there is no fixed 
regulation and central control of these schemes. (Prinsloo 1985a:2). 
Industrial Council Medical Benefit Schemes on the other hand occur 
predominantly in industries where industrial unions operate. Generally 
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the benefits offered are more restricted and do not cover dependants 
(Dorrington 1985:107: 109). 
3.2.2 THE MEDICAL SCHEMES ACT 
Following recommendations ofthe Coertze Commission (1965) which 
investigated medical schemes in South Africa, schemes were regulated 
in terms of the Medical Schemes Act (No. 72 of 1967). There have 
been several amendments to this Act since its introduction. This 
section will highlight the main features of the present legislation. 
3.2.2.1 Benefits Covered 
Regulation 4(1) of the Act prescribes that a registered medical scheme 
must provide benefits for services provided by: 
• Medical and surgical services rendered by a medical practitioner 
• Dental services rendered by a dentist 
• Physiotherapy services rendered by a physiotherapist 
• Supply of medicines obtained on prescription 
• Accommodation in a Provincial or Government hospital. 
The specifics on benefits paid out vary from scheme to scheme and 
depend largely on the funds available. Regulation 4(2) includes 
conditions that are not covered by the Act and medical schemes can 
exclude them, if they want to e.g. treatment of obesity or cosmetic 
surgery. 
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Minimum and maximum benefits and exclusions 
The Act specifies the minimum and maximum benefits to which a 
member is entitled in respect of services covered in section 4(1) of the 
regulation. 
Dependants are entitled to all benefits allowed to members. The 
minimum benefits to which a member is entitled to are: 
• Where a scale of benefits tariff exists for services covered, the 
scheme must pay at least 70 percent of this tariff. 
• Where no scale of benefit tariff exists, the scheme must pay at 
least 50 percent of the difference between the cost of the service 
and the levy (up to a maximum of Rl 0) that the scheme may 
Impose. 
• The total annual limit for the scheme must be at least Rl 000 for a 
single member, R2000 for a member with one dependant and R2 
500 for a member with more than one dependant. 
• The minimum benefit for a service as mentioned in regulation 4( 1) 
may not be less than Rl 00 per member per financial year. 
Regulation 5(3) specifies the maximum benefits payable by a scheme 
for a service provided. Where a scale of benefits has been drawn up, 
the benefit paid shall not be more than 100 percent of the stipulated 
tariff. Where no scale of benefit has been determined, the benefit paid 
may not exceed the cost of such a service. More recently the Registrar 
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of medical schemes has exempted certain schemes from this provision, 
thus allowing them to pay out in excess of the scale of benefits 
(Broomberg 1991:415). 
With effect from September 1990, the Registrar of Medical Schemes 
allows schemes to request permission to pay more than The Scale of 
Benefits, should they choose to (Broom berg 1991 :416). 
3.2.2.2 Tariff Legislation 
Private fees for medical and dental services are set out in The Guide to 
Fees for Medical and Dental Services. The Scale of Benefits is 
published in the Government Gazette and it covers fees paid for the 
supply and services of doctors, dentists, physiotherapists and private 
hospitals (Prinsloo 1985b:7). 
The price of medicines is not stipulated in The Scale of Benefits. It is 
printed in The Monthly Index of Medical Specialities (MIMS) which is 
a monthly publication providing both the wholesale and retail prices of 
ethical medicines. 
The setting of a tariff acceptable to both providers and financiers of 
health care represents a long-standing issue of much disagreement and 
conflict (Mandel] 1986:2). The option that a doctor had to be 
contracted in or out was abolished during the 1984 amendments and 
since then practitioners have been free to charge according to The 
Scale of Benefits published by RAMS, or the recommended tariffs 
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determined by the various professional Associations (Medical 
Association of South Africa and Dental Association of South Africa). 
Tariff calculations comprise two stages: the use of units and the rand 
value. Units are drawn up independently by the professional 
Associations and are determined according to the complexity of the 
procedure and in recognition of academic training (Prinsloo 
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1985a:2). Once the relative unit structure has been determined, RAMS 
and the professional associations (Veliotis et al 1993: 18) link rand 
values to these units. 
Table 3.3 illustrates an example of the interaction of the two 
components in the setting of the general practitioner's fees for a first 
consultation (MASA Pamphlet 1991b). 
Table 3.3: Units versus Rand values further broken down to show 
the normally applied Scale of Benefits versus the recommended 
MASA tariff 
Year Unit i Scale of Benefits ff 1980 6 - R6,60 , 
1981 6 R7,20 - R7,20 
9,90 
1982 6 R8,40 - R7,70 
11,40 
1983 6 R9,30 
-
R8,80 
12,60 
1984 6 RI0,50 - R9,50 
14,10 
1985 6 R12,60 R9,50 
1986 9 R22,50 Rl3,60 
1987 9 R27,00 R13,60 
1988 9 R27,00 R15,00 
1989 10 R33,00 R17,50 
1990 12 R48,00 R2l,l0 
1991 12 R55,20 R24,80 
Source: MASA Pamphlet 1991 b 
As illustrated in Table 3.3 RAMS and the representative associations 
(MASA and DASA) allocate their own Rand value to units. The effect 
of this dual system of tariff determination of medical and dental 
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services, has resulted in a widening disparity between the Scale of 
Benefits and the recommended tariff. 
3.2.2.3 The Browne Commission 
In late 1986, the Browne Commission of Inquiry into Health Services 
was released. The general recommendations were: 
• Additional cover should be insured by a voluntary msurance 
system; 
• The medical scheme movement should consider Health 
Maintenance Organizations8 and Preferred Provider Organisations, 
as developed in the United States; 
• Alternative methods of providing health care should be seriously 
looked at; 
• Greater flexibility in contribution rate determination should be 
allowed, thus enabling schemes to underwrite and charge different 
contribution rates for different classes of risk 
3.2.2.4 The 1989 Amendments 
8 Health Maintenance Organisations are medical funder's that apply principles of managed 
health care. 
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Prior to September 1989 medical schemes were allowed to determine 
contributions only on the basis offamily size and income. Risk sharing, 
cross-subsidisation and equal access to health services, were therefore 
allowed by the provisions of the Medical Schemes Act. 
3.2.2.4.1 Payment of Accounts 
Section 32 of the Act effectively guarantees direct payment to the 
practitioner within 4,5 months. In order to qualifY providers must 
charge according to The Scale of Benefits. If a provider does not 
charge according to The Scale of Benefits, he/she forfeits the right to 
guaranteed payment and the medical scheme may choose to reimburse 
the member, who is in turn responsible for settling the provider's 
account. 
The "guarantee of payments" tied the hands of medical aids when 
attempting to exert control on the abuse of the system as they were 
unable to deny payment when unsatisfied with the information 
presented. 
3.2.2.4.2 Cross-subsidisation versus risk rating 
There are essentially two basic methods used m calculating the 
monthly premium for member contributions. They are cross-
subsidisation and risk rating (Broomberg 1991 :415). 
Cross-subsidisation (community rating) 
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Cross-subsidisation refers to a system where membership fees are 
pooled to meet the costs of medical care for all members regardless of 
age, income and previous medical history. The benefits are that ageing 
members are guaranteed medical cover in their old age without 
additional costs. 
Risk rating (experience rating) 
Risk rating refers to a process of setting member contribution rates 
based partially, or wholly, on previous claims experience for a specific 
member group. 
Up until 1989, the Medical Schemes. Act allowed member · 
contributions to be calculated only according to income and family 
size (Veliotis 1993:21). In order to meet the needs of the younger 
members the 1989 amendments to this Act permit stratified 
contributions and therefore effectively allowed experience rating. 
These amendments have also allowed medical schemes to introduce 
low-claim and no-claim bonuses as an incentive for members to utilize 
services prudently. 
3.2.2.4.3 The role of insurer in health care 
The Medical Schemes Act precluded insurance companies from 
underwriting health care cover. The difference between health costs to 
the patient, and those paid by the medical aid, has resulted in the 
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introduction of insurance products which include hospital plans, major 
medical and dreaded disease policies, and plans which fund the 
difference between the scale of benefits and the private tariff. This 
protection is paid as a cash paym~nt directly to patients and therefore 
the constraints of the Act are bypassed (Veliotis et al 1993: 20). 
These plans make payment based on events and generally do not 
provide comprehensive medical cover. They are popular among people 
who self-insure against minor and frequency ailments, but who also 
require medical insurance for serious illnesses necessitating 
hospitalisation. Recently some packages have been linked to other 
financial instruments such as endowment policies. 
The Medical Schemes Amendment Bill has introduced increased 
flexibility and it is likely that there will be a closer association between 
insurers and medical schemes in the future. 
3.3 PROBLEMS THAT HAVE PLAGUED THE INDUSTRY 
Veliotis (1991:76) is of the opinion that the combination of fee for 
service system, the guaranteed payment, the statutory scale of benefit, 
and the minimum and maximum benefit levels as being prominent 
reasons resulting in the cost crisis facing the medical aid industry. 
In a survey conducted by Veliotis (1991:79) respondents accused 
RAMS of setting the scale of benefits too low. They claim that the low 
scale of benefits is the primary reason forcing health care providers to 
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increase the supply of services in an attempt to increase economies of 
scale. It also came to the fore that minimum benefit levels afford 
members first Rand cover and provided no incentive for members to 
be cost conscious. As a result there is an inappropriate over-demand 
for services. 
3. 3.1 RISING COSTS OF HEALTH CARE 
There are many reasons why the cost of health care both in the private 
and public sectors have increased. Advances in medical technology, 
the development of new more expensive drugs, and the fall in the 
Rand exchange rate (which increased the cost of imported goods in 
the health sector) have all contributed to the increases. 
However the increase in the private sector has been substantially more 
than the increase in the public sector. The real, per capita, 
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increase in medical schemes has been running at a compound 9,64 
percent a year since the early 1980's. Cumulative inflation rates for 
specialists, private hospitals and medicine over the five years to 1995 
were 201 percent, 270 percent and 185 percent respectively. The 
cumulative total inflation for all health care sectors over the same 
period was 152 percent (Financial Mail 1997:9). Empirical evidence 
supports the above observations. 
• Enthoven (1980:28) attributes the tremendous growth, complexity 
and cost of medical technology as a major factor contributing to 
the increased spending on medical costs. The system may be more 
responsive to beneficial medical breakthroughs and new 
technology as providers are free to buy and use them. How 
beneficial some new technology may be relative to its cost, is 
however often not clear. 
Since most sophisticated medical equipment needs to be imported 
to South Africa, the problem is compounded by the devaluating 
currency against most major international currencies. 
• More use of higher cost specialists rather than primary care (e.g. 
general practitioner) services i.e. more emphasis on curative as 
opposed to preventative measures. 
• A similar case can be made for the cost of pharmaceuticals. Where 
providers have merely been using an ethical9 drug 
9 An ethical drug is the original research based patented drug. 
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without considering the efficacy of the cheaper generic10 
equivalent. 
• Inefficiencies through duplication of services and facilities. 
The Department of Health contends that member contributions to 
medical schemes are inflated by up to 25 percent due to abuse and 
fraud, relating to health care benefits (Southern Health Care, Autumn, 
1998:6). 
The ultimate reason for this is that there are no cost containment 
mechanisms - no incentives to be efficient and reduce expenditure - in 
the private sector. The cause of this lies in the structure of the private 
sector around "fee-for-service" payments and "third party payment 
systems". 
3.3.1.1 Third party payment and the fee-for-service system 
The financing and provision of health care in the private sector prior to 
managed healthcare (MHC) has generally been characterized by: 
1. "third party'' payment and 
2. fee-for-service system. 
Under the "third party" payment system consumers bought health 
insurance from medical aid schemes. When patients required health 
10 A generic drug is an imitation of the original drug, but contains the same active ingredients 
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services, they consulted doctors or other health professionals 
(providers). Medical aid schemes then paid the providers for any 
services rendered according to a schedule of tariffs set yearly by the 
RAMS. Under the fee-for-service system, medical schemes paid 
according to the particular services provided. 
These arrangements have predisposed to escalation of health care 
costs in the private sector in two main ways. Firstly, because doctors 
will be paid for any services they provide, and paid more for more 
expensive procedures, providers have an incentive to "over treat" and 
"over investigate" patients (provider moral hazard). Secondly, 
consumers do not have to face the direct cost of any services rendered 
(although in the long run they will have to pay higher medical scheme 
contributions). They may thus be more likely to consult doctors 
unnecessarily and less likely to lead healthy lifestyles (consumer moral 
hazard). Consumers may also be less likely to exert pressure on 
providers to ensure that unnecessary expensive treatment, 
consultations, tests or procedures are not prescribed. In short, medical 
schemes have been able to exert little influence over either providers 
or patients to control escalating costs. These consequences are better 
reflected by the following conclusions: 
• Broomberg and Price (1990) found that caesarean section rates in 
the private fee-for-service medical aid sector was 50 percent 
greater than at the Johannesburg Hospital (a public referral 
centre), strongly suggestive that fee-for-services payment of 
in the same dosages. 
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doctors in the medical aid sector led to increased intervention in 
delivery. 
• Research by Milliman and Robinson in the United States shows 
why the market is moving from fee-for-service remuneration to 
managed care programmes encapsulating utilization reviews. 
Unnecessary costs generated under this system were reckoned to 
be 53 percent: 
• hospital admissions generated unnecessary costs totalling 24 
percent, 
• in-patient services 62 percent, 
• day hospital surgery 58 percent and 
• visits to doctors 49 percent. 
Certain possible advantages of the FFS/medical aid system should be 
noted, however. These are: 
• Patients are free to choose their own doctors and medical aids 
according to the quality of service and value for money that they 
feel they provide. Unfortunately for consumers of health care, 
while they may have some information on outcomes of care, they 
seldom have the medical expertise to assess the quality of care 
which they receive and have to rely on doctors to act as their 
"agents" in deciding what services they need. 
• Providers are rewarded for greater effort and quality of service. 
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3.3.1.2 Provider reimbursement 
The two largest costs to medical aids, accounting for over 50 percent 
of medical aid expenditure, are pharmaceuticals and private hospitals. 
Table 3.4 reflects growth in annual costs under each category. It 
reflects that the compounded growth, in both categories, considerably 
outpace that of other health disciplines, especially the price increases 
at provincial hospital level. 
Table 3.4: Contribution to total health care expenditure 
1990 1991 1992 1993 1994 Average 
percent percent percent percent percent percent 
General Practitioners 14,6 14,0 11,5 10,5 10,4 12,4 
Specialists 16,4 17,0 17,0 18,0 18,5 17,4 
Dentists 10,1 10,0 9,7 9,0 8,4 9,4 
Provincial Hospital 5,2 5,0 4,3 3,7 2,9 4,3 
Private Hospitals 18,5 17,3 17,5 18,7 22,1 18,8 
Hospital (total) 23,7 22,4 21,9 22,4 25,0 23,1 
Medicine 27,4 29,0 31,8 32,9 30,5 30,3 
Ex gratia 0,3 0,3 0,3 0,3 0,3 0,3 
Other 7,6 6,9 7,0 6,8 7,0 7,1 
Source: Sunday Times. Busmess times, May 4 1997 
Table 3.5: Growth in annual medical costs per member 
1990 1992 1993 1994 1995 Average 
Percent percent percent percent percent percent 
General 24,0 8,0 5,0 11,0 14,0 12,4 
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Practitioners 
Specialists 27,0 35,0 16,0 18,0 19,0 23,0 
Dentists 28,0 28,0 6,0 5,0 17,0 16,8 
Private 22,0 33,0 33,0 32,0 30,0 30,0 
Hospitals 
Provincial 24,0 14,0 -2,0 -10,0 -25,0 0,2 
Hospitals 
Medicine 37,0 45,0 19,0 6,0 14,0 24,2 
Other 19,0 33,0 12,0 9,0 27,0 20,0 
Total 29,0 31,0 15,0 11,0 18,0 20,8 
Source: Sunday Ttmes. Busmess times, May 4 1997 
3.3.2 OTHER PROBLEMS THAT HAVE PLAGUED THIS 
INDUSTRY, INCLUDING LEGISLATIVE CONSTRAINTS 
• Section 22 of the Pharmacy Act, which protected retail 
pharmacies, prevented free market forces from operating in the 
retail pharmacy industry. It restricted the ownership of pharmacies 
to pharmacists. Section 22 is currently being amended to extend 
ownership of pharmacies to other parties, e.g. retail stores. This 
should allow for a more competitive environment, which should in 
turn benefit the consumer. 
• Generic substitution of medicines was prohibited. In 1997 the 
Health Ministry began making a case in favour of mandatory 
generic substitution in both the private and public sectors. 
• The advertising of prices of ethical medicines are prohibited. 
• The ethical codes of the South African Medical and Dental 
Council (SAMDC) promote and protect doctors' interests. 
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• Legislation prevented managed care models from being actively 
introduced. 
• The Medical Schemes Act provided protection to the member in 
respect of the member's relationship to the funder (medical 
scheme). The focus of the Act was to protect the interests of the 
provider of the service, the consumer, (members and their families) 
who paid contributions to sustain the providers were of secondary 
importance. Protective measures built into the Act included 
statutory tariffs, obligation on the funder to pay direct to the 
provider of service with no knowledge of and regardless of 
whether the service provided was adequate, inadequate or 
provided at all. The only requirement for payment was an account, 
which the provider would submit direct to the funder. Major 
amendments to the Act were implemented on 1 January 1994 that 
had the effect of changing the relationship between provider of 
service and the funder but which continued to ignore protection of 
the member in respect of quality and appropriateness of care. 
(Southern Healthcare Vol. 2, No. l :6). 
• Day clinic licenses were frozen whilst hospital licenses were still 
granted. 
Barriers to entry were created as a result of legislation: Section 2 of 
the Medical Schemes Act (No. 72 of 1967} prevents the direct entry of 
insurance companies into the health insurance market. Yet many 
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insurance companies do provide hospital and dreaded disease policies 
(Medicine Today 1990:2). They also provide benefits for the 
differences in the fees charged by health care providers and what 
medical schemes pay. Since the protection is paid as a cash payment 
directly to patients, the constraints of the Act are bypassed (Business 
Day 1991:12). 
• No grip/control on soaring costs because of the arms length 
transaction with the providers of health care and the lack of 
influence on care given. 
• Increased bargaining power of suppliers of medical aid funds. 
• Employers have played a passive role in the whole health care 
process. However, since the escalating medical aid costs require an 
increasing amount of money from the companies, many employers 
are taking active steps to control the process. Some are 
introducing cash payments at the point of service whilst others are 
placing limits on the amount of consultations a member can have 
per year. 
• The introduction of the 1989 amendment effectively allowed 
medical aid schemes to risk rate members. This has resulted in the 
fragmentation of members, which could therefore reduce their 
bargaining power. 
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• No restriction on provider choice (e.g. unethical practices when 
relatives get involved). 
• Under the current legislation, because of the combination of fee-
for-service remuneration coupled with guarantee of payment, 
medical schemes have had little control over the health care 
process. The bargaining power therefore lies with the health care 
providers (Veliotis 1991:33). 
• Poor case management. 
The above concerns reflect problems that are unique to specific 
sectors in the private health system. The common thread that runs 
through the above issues was that many legislative and ethical codes 
deterred the efficient operation of free market forces. Slowly these are 
being relaxed e.g. allowing for the formation of Health Maintenance 
Organisations that implement full managed health care programmes. 
The more specific issues that need to be addressed now sit in the 
hands of inefficiently run medical aid companies. 
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3.4 CONCLUSION 
It is obvious from the above discussion that much is left to be desired 
in the application of risk management in the South African medical aid 
industry. The inefficiency in the system can be attributed to various 
factors, but the more pivotal issues would be: 
• The inequalities in health distribution in the country. 
• Both the private as well as public sectors are administered rather 
than managed with poor utilization of information. 
• Prohibitive legislation has handcuffed medical funders m their 
attempts at managing risks. 
The following chapter will explore the topic of risk management in 
health care funding in more detail. 
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CHAPTER 4: RISK MANAGEMENT STRATEGY IN HEALTH 
CARE FUNDING 
4.0 INTRODUCTION 
The growing interest in alternative risk management strategies such as 
managed healthcare in South Africa arises principally out of the crises 
experienced by the private health sector. The current health care 
environment is characterised by declining coverage, increasing costs 
and displacement of unwanted costs onto the public sector. 
The annual income of medical schemes during 1982 amounted to 
R883 million, of which R875 million was paid in benefits and expenses 
during that year (Dorrington 1985:107). In 1995, the medical schemes 
had a total income in of Rl5,9 billion of which a total expenditure of 
Rl6,1 billion was deducted (Registrar of Medical Schemes 1995: 
Annexure A). 
Graph 4.1: Medical aid members in the years 1984 -1995 
1 0 11 1 2 
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Source: Registrar of Medical Schemes 1994 and 1995 
This 12 fold increase was not proportionately matched with an 
increase in membership, as reflected in Table 4.1, which only 
appreciated by 30% in the stated period, but was rather as a result of 
spiralling costs in the health care industry. 
Medical schemes have tried to mmtmtze cost increases simply by 
resisting demands for fee increases by providers, rationing benefits and 
risk rating members. On the other hand they have continued to 
increase medical scheme contributions. In terms of risk management 
principles this is arguably insufficient. 
Little has been done to analyse future risks and control current risks. 
Much over-servicing and abuse has gone undetected. This argument 
becomes clear when one looks at the cost of a standard procedure 
such as tonsillectomy where the variation in extent of treatment is 
minimal yet on analysing statistics on cost variations claims received 
by Fedhealth in 1997, it was apparent that costs paid by the medical 
aid bandied around two standard deviations, with no plausible 
explanation, risk evaluation and/or treatment. 
There is also a concentration on curative rather than preventative 
intervention. In this environment the health care of patients is unlikely 
to be handled in a consistent and holistic fashion. They may become 
more likely to consult doctors unnecessarily and less likely to lead 
healthy lifestyles in order to avoid incurring cost in the longer term 
(consumer moral hazard). Thus neither patients nor providers have an 
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incentive to limit services used. These actions indicate that medical 
aids have played a minimal role in handling risks, neither by exerting 
an element of control on providers nor by treating a member's health in 
a holistic manner in order to better control future health risks. 
In summary, medical schemes have been able to exert very little 
influence over either providers or patients to control escalating costs. 
Because of the lack of incentives to control costs, fee-for-service and 
third party payment have led to: 
• Emphasis on expensive new technologies and procedures; 
• More use ofhigher costs specialists ; 
• Inefficiencies through duplication of services and facilities; 
• Questionably high hospital admissions. 
The FFS and third party payment modes have also lead to fragmented 
provision through many independent practices that has resulted in little 
co-ordination and rationalisation of services. It has been difficult to 
research the efficiency and quality of service provision as provider 
practice styles has been very varied and patients' utilization of services 
have been difficult to track. Thus crucial elements about basic health 
priorities and cost effectiveness has not been available. 
4.1 RISK MANAGEMENT PRINCIPLES IN THE MEDICAL AID 
INDUSTRY 
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The risk management process has three basic components, as explored 
in the previous chapter. They are: 
1. Risk Identification 
2. Risk Evaluation 
3. Risk Treatment i.e. risk control and risk financing. 
Historically risk management in the medical aid industry has been most 
closely connected with the finance evolving from insurance 
management. This is still an important aspect of the function of health 
insurance but should not be considered in isolation. The other tasks of 
risk management should not be ignored and management should set 
objectives, which will take these into account. 
In formulating a strategy for the medical aid industry in South Africa 
this report will explore a combination ofhealth funding options: 
• A first generation product relates to the traditional medical cover 
i.e. comprehensive coverage. In this case the insurer reimburses 
the full cost of medical care to the insured. 
• Second generation products introduce disincentives such as Co-
Insurance Schemes, Deductibles and Bonus and Rebates. These 
options represent deviations from comprehensive coverage. These 
deviations could relate to (1) the type of health goods included in 
the plan, (2) the type of providers allowed to deliver certain 
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services, and (3) the extent of compensation paid by the insurer. 
Limitations in terms of expenditure present the most general case 
(Zweifel 1996:158). Caps on expenditure are usually meant when 
people refer to "cost sharing by the insureds". 
• Third generation products or "new generation products" explore 
options of medical savings accounts and claims management. 
• Fourth generation products encapsulate managed health care. 
The final - fifth generation, which falls outside the scope of this 
study, offer capitated products and closed networks1 1• 
4.1.1 FIRST GENERATION PRODUCT 
4.1.1.1 Tradition Medical Schemes 
Under the traditional scheme the comprehensive funding of benefits 
was characterised by a pay-as-you-go, non-profit structure based on 
fee-for-service and predetermined negotiated agreements on 
11 Patients must visit certain designated health care providers which are contracted 
with the scheme and who are remunerated on a set fee per member under books per 
month. 
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remuneration structures. Contributions were based on a number of 
criteria, including income, number of dependants, group experience 
rating and age of principle members. Members are generally afforded 
flexibility of care by means of multiple benefit options (Registrar of 
Medical Schemes 1996:5). 
A general problem with most conventional forms of insurance is that 
low utilization by consumers goes unrewarded. In partial or full 
coverage plans, low utilizers may be reas'sured by the fact that if the 
need arises, a portion or even the full cost of care will be paid by the 
insurer. But invariably there may be a strong feeling that benefits of 
the insurance are "lost" if no medical services are consumed. There is 
typically no way to convert this foregone insurance benefit to some 
other form of reward. Apart from the physical security of knowing he 
or she is insured there is no way for the insured person to benefit from 
conventional forms of coverage unless services are utilized. This lack 
of reward for low utilization encourages unnecessary use of the 
system. 
A second related problem in conventional insurance plans is the lack of 
direct incentives for consumers to adopt healthier lifestyles. Although 
some private plans offer lower premiums to non-smokers, non-obese, 
or other groups who exhibit lower health risks, once an individual is 
enrolled in such plans there is little, if any, reward for maintaining or 
further improving personal health habits. The significance of this 
second flaw in the structure of conventional insurance grows as we 
acquire additional empirical evidence that lifestyle strongly influence 
97 
the incidence of major disease and the cost of health care (Manning, 
Keeler, Newhouse, Sloss, Wasserman 1991: 1 ). 
Given that the traditional method of providing cover has been covered 
extensively in previous chapters we will now deal with alternative 
methods. 
4.1.2 SECOND GENERATION PRODUCTS 
Conventional insurance does little to exert a recognisable influence on 
the demand for and outlay of medical care. Second generation 
products explore options of cost sharing as a means to influencing 
demand. Conventional cost-sharing arrangements do limit the demand 
for medical services, even among members of private insurance 
(Zweifell992:12). 
4.1.2.1 Co-payment schemes11 and Deductibles 
4.1.2.1.1. Co-payment 
Consumers derive protection from health insurance by knowing that 
when expenses are incurred they will not have to pay the full amount 
out-of-pocket. Indeed, under full insurance (zero co-insurance), out-
of-pocket expense is zero regardless of the full expense. 
12 Question 3 .1. of the Interview Framework addresses the issue of co-payment by South 
African medical aids. 
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Thus conventional insurance, particularly full coverage, reduces the 
financial risk associated with illness, but also diminishes the 
consumer's sensitivity to the true cost of care, this in turn may lead to 
excessive utilization (i.e. moral hazard). One way to discourage 
unnecessary utilization in conventional insurance plans is to impose a 
proportional cost sharing. Cost sharing relies on the negative cost 
sanction of cost sharing at the time of consumption of care as the sole 
means for limiting moral hazard. 
4.1.2.1.2 Deductibles 
In this case the insured person pays the first x monetary units of his 
total health expenditure out of his own pocket. The effective price 
therefore amounts to the supply price as long as total expenditure is 
relatively low (up to x). Above this threshold it drops to zero. If the 
insured expects to exceed this level in the course of the period 
anyway, then the incentive for cost effectiveness in consumption 
vanishes from the beginning. Nevertheless this form of co-payment is 
widespread as it relives the insurer from the processing of petty claims, 
as claims with a total value of below x will never be submitted 
(Zweifel 1996: 160). 
Insureds covered by a policy without deductibles basically have an 
incentive to submit all of their medical aid bills. Zweifel (1992:5) 
found that for minor illnesses, giving rise to annual bills up to the 
neighbourhood of the value of the deductibles, the deductible should 
have a stronger impact on the intensity of treatment than does co-
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insurance. For bills sufficiently beyond the limit, the deductibles should 
have no effect, while co-insurance should loose its effect more and 
more. 
The co-payment plans and deductibles are a slight improvement on 
conventional insurance in that it adds weight to risk control where the 
incentive to abuse is reduced by the members having to co-pay. 
4.1.2.2 Bonus and Rebate Options13 
4.1.2.2.1 The dynamic bonus system 
Under the " dynamic bonus" system the insureds' merit rating depends 
on claims submitted in a number of previous years. In the Zweifel 
(1992:70) study, the insurer offered two monthly premiums worth of 
rebates for no claims at the end of the first year without claims, three 
monthly premiums at the end of the second year and a maximum of 
four starting in the third consecutive year without claims. Given the 
number of years, compared to the yearly bonus system, the dynamic 
system requires a longer planning horizon. Zweifel concluded that the 
subsequent year might induce a member to refrain from treatment at 
the ambulatory level even if their billed value exceeds the value of the 
bonus at stake. This could be detrimental to the management of health 
risk in the longer term. 
4.1.2.2.2 Fixed rebates for no claims 
100 
In this case the insurer has a tradition of paying back a rebate for no 
claims at the end of a year. This rebate to members, who did not claim 
for medical services, amounts to three monthly premiums. In order to 
obtain it, the insured must be without claims under all three titles of 
the plan (ambulatory, hospital and dental). This is an added difficulty 
for the risk manager when analysing and treating risks as the insured 
must then decide whether or not he/she wants to submit the bill for the 
lower end costs. Zweifel ( 1992: 42) says that the decision to submit a 
medical bill rather than paying it out-of-pocket gains importance. The 
insured will then weigh up the benefits of submitting the bill versus the 
benefits of receiving a rebate for no claims at the end ofthe year. The 
premium rebate at stake determines a threshold value that must be 
exceeded by a bill to making it financially advantageous to submit it to 
the insurer. However, such a system is quite demanding in terms of the 
optimisation calculus required on the part of the insured: He/she must 
gauge the probability of being able to save his bonus during the 
following year, which requires an assessment of the likelihood of 
future loss of health and their severity (Zweifel 1992: 13). Moreover, 
he/she must also predict his future financial wealth to determine 
his/her ability to pay for health care out-of-pocket. Furthermore, the 
decisions to consume ambulatory1\ hospital and dental care became 
interdependent in view of the rebate for no claims. For example, the 
dental bill would still have to be paid out-of-pocket if the insured 
managed to save his/her rebate by consuming no ambulatory and 
hospital care. Thus, by using up a part of the rebate at stake, a dental 
13 Question 3.2. of the Interview Framework deals with the issue of bonus options in the South 
African Medical funding industry. 
1
' Termed day care in South Africa 
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bill will undermine the insured's incentive to refrain from ambulatory 
medical care in his/her attempts to save his/her rebate. 
Zweifel (1992:52) concludes that the incentive in a rebate contributed 
to the choice of a reduced intensity of treatment, at least as long as the 
expenditure associated with the alternative courses available do not 
exceed the point of financial equivalence in all cases. 
4.1.2.2.3 Relative success of new scheme options 
A study conducted by Peter Zweifel of the University of Zurich, 
Department of Economics, Switzerland (Zweifel, 1992) analysed the 
relative success of co-insurance versus deductibles, and co-insurance 
versus rebate and bonus options as a means of curtailing overuse of 
the health services (more specifically looking at ambulatory care). 
Fixed rebates in the study amounted to three monthly premiums for no 
claims during the year. The experience- rated bonus system had a 
rebate amounting to a minimum of two and a maximum of four 
monthly premiums. The main findings of the study can be summarised 
in the following statements: 
• Since the insured has no financial interest in submitting a bill the 
value of which is less than the deductible, the billings/cost 
distribution will, in general, be thinned out at its lower end for 
reasons that have nothing to do with the demand for medical care. 
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• High values of annual medical bills will, to some extent, reflect 
especially severe illness episodes during which the urgency of 
demand overrides considerations of cost. In all, the effect of co-
insurance, while still discernible at values of billings where a 
deductible has lost its impact, should fade towards the upper end 
of the cost distribution as well i.e. cost sharing provisions generally 
tend to lose their impact farther up in the distribution of annual 
billings. 
• Under rebate and bonus options, the insured finances the rebate in 
advance, which entails a loss of interest payments, compared to the 
lower premium of a policy with conventional cost sharing. 
Frequently however, this drawback will be outweighed by the 
advantages of temporal separation of the occurrence of two risks, 
" loss of health" and "net financial outlay for medical care", as 
under rebate and bonus options immediate cost sharing by the 
insured can almost always be waived. 
• Fixed rebates for no claims, while exposmg the insured to no 
greater financial risk than conventional cost-sharing policies 
featuring deductibles and co-insurance, limited moral hazard in 
day-to-day care to the extent that is comparable with conventional 
cost-sharing policies. The dampening effect of an experience-rated, 
variable bonus for no claim tends to even exceed that of a 
financially equivalent fixed rebate. 
4.1.2.2.4 Summary 
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Compared to conventional insurance i.e. featuring comprehensive 
coverage, deductibles and/or co-insurance rates amounting to more 
than 20 percent of the claim, significantly lower the probability ofhigh 
bills of ambulatory medical care (which is generally believed to 
respond more strongly to insured-based incentives than hospital care). 
Zweifel (1992:4) found that the bonus option exerts a stronger 
financial incentive to limit demand than does a fixed rebate. This is so 
because the bonus option promises an even higher future rebate if the 
current period is claim free. 
In comparing all three plans: co-insurance, bonus or rebate, the 
evidence suggests that the experience-rated bonus offer has the 
strongest dampening impact on demand, followed by the fixed rebate 
offer and first dollar coverage plans. Some limited evidence is also 
available supporting the view that such financial incentives, rather than 
jeopardising the health of the insured, may in fact turn marginally bad 
into good health risks. Even anecdotal outlays on hospital care might 
be reduced by such incentives, with rebate and bonus options once 
more taking the lead over conventional cost sharing. 
Advantages of new scheme options: 
• Relative to conventional insurance there is a financial incentive to 
limit demand. 
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• A sizeable portion of hospital admissions can be claimed to react 
to cost-sharing provisions primarily aimed at controlling moral 
hazard in ambulatory medical care (Zweifell992:4). 
• The financial reward to the member, incentivises him to become a 
more educated consumer of health care products. 
Disadvantages of new scheme options: 
• A flaw in the study appears when applying the aforementioned 
alternatives to the age class above 65 years. Fixed rebate and 
experience-rated bonus offers for no claims may lose their impact 
on the demand for ambulatory care among the aged. Even 
traditional co-insurance shows signs of becoming less effective 
among this age group. 
• It assumes the consumer can diagnose minor ailments and treat 
them. It furthermore assumes that the consumer would know when 
circumstances are serious enough to justifY treatment. 
• It only concentrates on abuse by members and does not address 
provider abuse. 
• Health insurance options with strong financial incentives for cost 
control become self-defeating in the longer run if it leads to a 
deleterious effect on health. 
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• Rebates and bonuses amount to a mere shifting of costs from the 
insurer to the individual. From a total systems point of view, no 
resources have been saved at all if the amount of medical services 
consumed remains unchanged. The crucial issue is the adjustment 
of behaviour which results in a reduced consumption of services. 
• Small deductibles and/or co-insurance exert little recognisable 
influence on the demand for and outlay of medical care. 
• Any increase in the co-payment rate or the deductible level will be 
viewed by the consumer as a reduction in insurance benefits. 
• It places the bargaining responsibility in the hands of the 
consumers who have reduced bargaining power as individuals with 
less information and expertise available to them, depending on the 
individuals' level of education in this regard. 
• Second generation products such as co-insurance, bonus and 
rebate options focus on short-term solutions to spiralling health 
care costs. They do not look at risk management in a holistic 
fashion by identifying, evaluating or treating risks any more than 
conventional insurance. 
4.1.3 THIRD GENERATIONPRODUCTS 
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4.1.3.1 Medical Savings Accounts (MSA) 15 
MSA are a form of self-insurance, which can only be debited for 
recognisable medical expenses. A MSA puts the patient back in 
control of medical spending through, for example, a personal savings 
account linked to calamity insurance. Members would then manage 
their own out-of-hospital expenditure with no risk premiums, that is 
to say, with their own funds being paid to the scheme as 
contributions. This assists the medical insurer in controlling member 
and provider abuse of the system by placing the financial risk squarely 
with the member. In terms thereof, the unexpected portion at year-
end accumulates for the exclusive use of the member and his/her 
family in future. 
Critics of the MSA system say there is an in-built disincentive to seek 
appropriate cures, due to fears of over-spending. Members may be 
loath to spend on low priority or preventative medical care. There is 
also little management of the quality or appropriateness of the care 
they receive. However, according to the Friedman model (Financial 
Mail 1998:20), payers spending on themselves will seek the best price 
and quality. As savings may only be transferred to a medical provider 
account and cannot be withdrawn for non-medical purposes, the 
patient is inclined to seek the most cost-effective cure. Yet one could 
argue that the average consumer has limited knowledge of medicine 
to make these decisions independently. 
15 Savings Accounts in the local environment are explored in question 3.3 of the Interview 
Framework. 
107 
Van den Reever of the Centre for Health Policy at the University of 
the Witwatersrand says that MSA's are popular because they can be 
used for tax avoidance, but there are many problems with the MSA 
system. Van den Reever believes that they tend to delay early 
treatment because members want to keep medical expenditure to a 
minimum. They reduce the incentive to manage the treatment and 
costs by providing the wrong incentives to the gatekeeper 16• They do 
not address the real costs at the higher levels of care, such as 
expenditure on hospitals and drugs, and may even worsen them 
(Financial Mail 1998:20). 
The following summaries of advantages and disadvantages, which 
appear to be similar to international experience, of new generation 
plans have been argued by stakeholders since their inception. 
(Excerpt Medscheme: Prescribed R~ading- The pros and cons of 
medical savings accounts October 1996 as quoted in Registrar of 
Medical Schemes 1996:6). 
Advantages: 
• The system arose from the need to develop disincentives for 
16 Refer to Glossary 
abuse and fraud and consequent spiralling cost structures in a 
fee-for-service payment method, which gave rise to runaway 
health inflation. 
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• Behaviour of the member is changed as a result of a sense of 
ownership and personal responsibility to fund certain 
controllable health care expenses. 
• There is consequently no incentive to claim unnecessarily and 
utilization patterns are reduced with a consequent reduction in 
costs. 
• Members, who do not require extensive cover for out-of-
hospital benefits, would benefit by this structure. 
• The financial reward to the member incentivises him to become 
a more educated consumer of health care products. 
• The bargaining power on price and utilization of services is 
placed firmly in the hands of the individual. . 
• Those who contribute more to these funds would benefit from 
large tax breaks, particularly under a system of salary sacrifice 
contribution system. 
• Accumulated funds in the personal account can be utilised for 
future health care expenses and for retirement funding. 
• Accumulated funds could be transferred to another scheme 
upon resignation. 
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Disadvantages: 
• It assumes the consumer can diagnose minor ailments and treat 
them. It furthermore assumes that the consumer would know 
when circumstances are serious enough to justifY treatment. 
• It only concentrates on abuse by members and does not 
address provider abuse. Where savings schemes are coupled 
with reimbursement for actual costs incurred and not the Scale 
of Benefits, there is an incentive for providers to increase their 
prices to make up for the decreased utilization. 
• It places the bargaining responsibility in the hands of the 
consumers who have reduced bargaining power as individuals 
with less information and expertise available to them, 
depending on the individual's level of education in this regard. 
• A portion of the contribution that would otherwise be available 
for cross-subsidisation is no longer available for this purpose. 
In the event that the contribution is disproportionally large in 
comparison to his/her income, the member might deliberately 
withhold necessary treatment in order to obtain the maximum 
savings benefit. 
• Preventative care might be withheld if the incentive not to use 
his/her own funds, becomes too large. 
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• The system would jeopardise integration into managed care 
options and consequent interventions. 
• There is no preferential treatment in the event of a medical 
scheme having to be liquidated. 
• If not properly administered, funds, which are advanced, may 
not be recovered by the scheme at a loss to other members if 
the member who resigns his/her membership of the scheme, 
fails to meet his/her obligation to repay the loan. 
While these "new generation benefit plans" invited much debate 
between proponents and opponents, certain schemes have reported 
substantial reductions in claim patterns on the basis that these 
accounts provide members with a sense of ownership over health care 
spending and they would therefore utilize their own funds sparingly. 
For example in Singapore, where mandatory MSA systems have been 
in operation for 19 years, medical spending accounts for 3,1 percent 
of Gross National Product as opposed to 14 percent in the United 
States (Financial Mail 1998:20). 
It is anticipated that the debate will continue with due regard to the 
draft policy statements from the Department of Health in which 
reservations have been expressed as to the feasibility of such manner 
of funding in terms of national health care policy goals. 
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4.2.3.2 Claims management 
Claims management is a risk control technique. After the delivery of a 
unit of health care, the provider of the service will submit a bill to the 
medical scheme for payment. It is at this stage that claims management 
comes into play i.e. after the event. In a broader managed care offering 
the claim manager would assess the nature of the claim and match it to 
the pre-authorization and concurrent review as drafted by the case 
manager. Yet many medical aids have started claims management in 
isolation as the first step towards managed healthcare. In this case 
claims management is merely a cost control mechanism used mainly to 
ensure validity of claims. 
Claims management would also have under its ambit the management 
of the chosen provider netwo~k and the overall efficiency thereof. It 
would be the department liaising with the service providers, from the 
nurses through to the specialists, pooling all available information with 
a primary goal of reducing the exposure and frequency of claims. 
Claims management is a loss reduction17 process used in risk 
management. While a claims management system is not a solution to 
the causes of problems, it is a positive control mechanism that must be 
established. An effectively run system can reduce the overall cost of 
claims substantially. 
11 Refer to 2.3.4.1 
112 
From a financial viewpoint, proper and timely claims management is a 
separate and distinct entity in the health care arena that can improve 
the medical aids profitability and affect its long-term stability. 
The importance of prompt and efficient investigation of claims cannot 
be over emphasized. An immediate inquiry to determine the facts and 
circumstances of the occurrence and careful check on injuries, 
disability, and potential damages is important. If the risk or Claims 
Management Department has not been informed properly of the facts, 
it is placed at a substantial disadvantage. 
Claims management plays a very important role in risk management, 
addressing risk treatment. Some literature views claims management 
as stand-alone health insurance options, others categorize it under the 
ambit of managed health care. 
4.1.4 FOURTH GENERATION PRODUCTS 
4.2.4.1 Managed healthcare overview18 
Managed healthcare can best be described as a management process 
which is instituted once contractual arrangements have been made 
between health care consumers (or their agents) and health care 
providers. Its most important characteristic is that funders (medical 
schemes) have more influence over provision of health care through 
intensive auditing, management systems, and management utilization 
1g Chapter 5 is dedicated to a discussion on the topic of managed healthcare. 
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unlike the third party/fee-for-service system where financiers and 
providers are separate and have conflicting interests which lead to cost 
escalation. 
In managed healthcare, the financing and delivery of health care are 
effectively integrated in one organisation, creating even more direct 
incentives for cost containment. 
Under most managed contracts, enrolled members (or their employers) 
generally pay a set monthly premium to a plan or fund. The plan or 
fund then contracts with selected providers and facilities (including, 
for example, doctors, nurses and hospitals) who agree to provide a 
comprehensive package of health care services to members for a 
predetermined, relatively low price. Capitation or salary payment 
systems or managed fee-for-service payments often substitute the 
traditional fee-for-service payment which reduce incentives to over-
service and transfer some of the risk to the provider of health care. 
Furthermore, contracting providers agree to have their practice 
monitored regularly for cost effectiveness and quality, either by fellow 
doctors with the scheme (peer review) or an outside management 
team. This is where utilization management becomes vital. 
Utilization management incorporates the aspects of appropriateness of 
admission, duration of stay, levels of care and efficient use of ancillary 
services. Utilization management is the key to maintaining a focus on 
the provision of expedient medical care and not losing this focus by 
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the perception that the medical unit is now a cost centre with cost 
containment absorbing too much attention. 
Overall therefore, managed healthcare is promoted as a means of 
achieving "cost-effective" health care through active management of 
health care resources; reducing unnecessary care and over-servicing; 
controlling provider reimbursement; tailoring services to the needs 
identified through experience for certain groups and emphasising 
prevention as an alternative to expensive cures. 
4.2 CONCLUSION 
The new insurance options might indeed attract particularly good 
risks. Bad risks would gravitate towards more conventional policies, 
especially those offering comprehensive coverage. Hence it could be 
the risk selection rather than the demand of moral hazard that is 
responsible for the favourable performance of these new options. 
Zweifel (1992:13) found that these new options i.e. co-insurance, 
rebates etc. created an incentive for the insured to forgo medical care 
in the advent of illness. "Bonus hunger" could conceivably induce 
insureds to defer or even forgo necessary medical treatment, 
jeopardising their health. The negative consequences of "bonus 
hunger"~ would leave their traces in the patterns of outlay on medical 
care over time .. Specifically, early savings would tend to be wiped out 
in the later periods. 
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The crucial issue is the adjustment of behaviour, which results in a 
reduced consumption of services. This should, however, occur in a 
"managed" manner where medical professionals, as opposed to the 
consumer, drive the process. 
Managed healthcare by definition addresses many of the risk 
management principles as highlighted in this research. It not only deals 
with identifYing and analysing future risks more thoroughly than ever 
before, with actuarial models pricing capitation levels, but it also deals 
with the treatment of risk by looking at health care in a holistic manner 
and exerting control through the full continuum of health care 
services, from the gatekeeper (general practitioner) level to post-
hospital care and claims management. 
By networking and tying in preferred providers managed healthcare 
also co-ordinates and rationalises services, hence controlling risks. In 
this manner it is also easier to research the efficiency and quality of 
services as provider practices will have to conform with predetermined 
protocols and utilization of patients services is easier to track. Claims 
management effectively treats and evaluates the risks. 
Of the options explored in this chapter, managed health care is the only 
option that fully embraces the entire delivery of health channel. 
There has been a significant shift towards a variety of managed care 
programmes and particularly, cost shifting and cost sharing 
arrangements between schemes and health care providers, inspired by 
incentives remuneration structures, utilization review and per diem 
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charges or "capitation fees". Pre-authorisation measures for hospital 
care, preferred provider arrangement with specific suppliers of care 
and the introduction of pharmacy benefit management programmes 
and chronic medication programmes were explored extensively. 
The following chapter will analyse managed healthcare in greater 
detail. 
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CHAPTER 5 MANAGED HEALTHCARE 
5.0 INTRODUCTION 
The term "managed health care" was originally used to describe prepaid 
health care, primarily in the context of Health Maintenance 
Organisations (HMO). Currently it is used to describe a network of 
providers who have been given the responsibility of co-ordinating cost 
effective health care without compromising quality (Managed care 
Information, Definitions and Contract Considerations 1993:274; 
Ceslowitz 1993 :336). 
In order to understand what is meant by co-ordinating health care, one 
must understand who the role players are. In the private sector health 
care scenario there are three players: 
• The provider of health care services, for example, pharmacist or 
doctor; 
• The patients; 
• The third party payer, for example, the medical scheme. 
Historically all of the parties have worked independently. The patient 
sees a doctor, the doctor writes a prescription and the patient goes to the 
pharmacist to get the medicine. The accounts are then forwarded to the 
third party payer who pays according to the schedule of benefits. 
Managed care aims at drawing the three players into a closer, more 
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transparent relationship, in order to maximize the effect of the care 
rendered, and reduce the overall cost of these services. 
Managed care has as its primary objective a reduction in health care 
costs and making private health care accessible to a broader base of the 
population. Despite widespread resistance, managed healthcare offers 
the only viable means of curbing rampant healthcare inflation, says 
Conradi of Hollandia Reinsurance Group (Sunday Business Times 
1998:1). 
The escalating costs of health care in the United States of America 
appear to have been reduced by managed healthcare in the last decade in 
particular. With the advent of managed care, the percentage of Medical 
Care Consumer Price Index for prescription drugs dropped by a third in 
the ten years between 1984 and 1994 (Vincenzino 1994:34). Vincenzino 
(1994:34) also found increased competition between health care 
providers as a result of the increase in the enrolment of new members in 
Health Maintenance Organisations and Preferred Provider Organizations. 
Managed healthcare involves:-
• Claims management; 
• The development of utilization and clinical management 
processes to monitor the appropriateness of medical treatment; 
• The establishment of a network of service providers who 
contractually agree to the clinical management and utilization 
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guidelines in return for increased patient volumes and prompt 
payment; 
• Sophisticated information systems that are able to integrate all 
aspects of healthcare, process a range of commonly used 
industry-coding systems (e.g. RAMS , CTP4 and IDClO) and 
communicate directly with existing medical aid systems. 
5.1 THE NATURE OF MANAGED CARE 
Managed care is a formalised system of managing health care and its 
costs. Managed healthcare is a management process, which is instituted 
once contractual arrangements have been made between health care 
consumers (or their agents i.e. employers) and health care providers. Its 
most important characteristic is that funders (medical schemes) have 
more influence over provision of health care through intensive auditing 
and management systems, unlike the third party/fee-for-service system 
where financiers and providers are separate and have conflicting interests 
which leads to escalation of costs. 
In managed healthcare the financing and delivery of health care are 
effectively integrated in one organisation, creating even more direct 
incentives for cost containment. Until the advent of managed care, health 
services have been rendered in South Africa on a fee-for-service basis. If 
the doctor wanted to increase the profit margin, utilization was increased 
and more diagnostic tests were performed. Managed care addresses this 
problem. Wastage and over-utilization is reduced to a minimum (Korpiel 
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1995: 193). One of the tools used to curb over-servicing is remuneration 
by capitation. 
Under managed health care enrolled members (or their employers) 
generally pay a set monthly premium to a plan or fund. Capitation or 
salary payment systems often substitute fee-for-service payment systems, 
to reduce the incentive to over-service. The plan or fund then contracts 
with selected providers and facilities (including, for example, doctors, 
nurses and hospitals) who agree to provide a comprehensive package of 
health care services to members for a predetermined, relatively low 
price. Furthermore, contracting providers agree to have their practice 
monitored regularly for cost effectiveness and quality, either by fellow 
doctors with the scheme (peer review) or an outside management team. 
With capitation, managed care transfers some of the risk back to the 
service provider. 
General practitioners play an important role in the managed healthcare 
process by acting as "gatekeepers": pa_tients may only be referred to 
specialists by their generalist doctor, according to the policy of the 
managed care operator or health maintenance organisation, thereby 
cutting down on unnecessary and expensive over-use of specialist 
services. In this way the doctor performs the function of the 
"gatekeeper", who allows for access to other health care professionals. 
Review of their practice patterns and appropriateness is generally done 
by other doctors in the group i.e. peer review, not outside managers 
(Price 1992). 
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Managed health are differs from conventional health insurance in that it 
focuses on the longer-term health of any member, therefore cost 
containment is not at the expense of quality. In a managed healthcare 
environment more emphasis is placed on historic data and data capture, 
as it requires in-depth data analysis in order to identify current risks and 
determine potential future risks enabling the funder to better price these 
risks into premium income. As a result, medical aids can, for the first 
time, analyse the underlying risks inherent in the industry. 
Overall therefore, managed healthcare is promoted as a means of 
achieving "cost-effective" health care through active management of 
health care resources; reducing unnecessary care and over-servicing; 
controlling provider reimbursement; tailoring services to the needs 
identified through experience for certain groups and emphasizing 
prevention as an alternative to expensive cures. 
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5.2 INSURANCE PRINCIPLES 
Managed healthcare is about the management of risk, and hence 
insurers such as Fedsure, Sanlam, Liberty, Momentum etc. are 
dedicating much management time and resource to this area of business. 
Insurers are well positioned to compete in the managed health care arena: 
• They have sound actuarial skills; 
• They are familiar with the concepts of risk management; 
• They have typically invested heavily in sophisticated information 
technology systems; 
• They have well-developed broker networks; 
• They are well represented in all the major centres via extensive 
branch networks. 
Most of the top insurance companies in South Africa, with the notable 
exception of Old Mutual (who is expected to enter this market soon), 
have entered the healthcare market in some or other form. Managed 
healthcare in itself is not the draw card for the insurance companies, but 
managed healthcare expertise provides opportunities to sell lucrative 
insurance products to the medical aid society and to individuals. So-
called "new generation" medical insurance products have been launched 
by several insurance companies and are increasingly attracting members 
from the traditional medical aids. 
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5.3 UTILIZATION MANAGEMENT19 
Utilization management, otherwise known as case management, is the 
key to maintaining a focus on. the provision of expedient medical care 
and not losing focus by the perception that the medical unit is now a cost 
centre, with the greatest emphasis on cost containment. 
Utilization management is defined as: "The planning, organising, 
directing, and controlling of the health care product in a cost effective 
manner while maintaining high quality care and contributing to the 
overall goals of the institution. This is accomplished through the 
judicious use of resources to control inappropriate inpatient admissions, ,, 
lengths of stay, and use of ancillary services". (Utilization Management 
Review 1983:7). 
Utilization management is an integral part of managed healthcare. The 
most common form of utilization management would be hospital 
utilization management and pharmaceutical utilization management. In 
response to the current health care challenges each hospital management 
and medical staff must make a greater effort to improve the efficiency of 
their institution while maintaining the level of quality of services 
rendered. 
1
" Utilization Management in the South African medical environment is explored through question 3.4 of the Interview Framework 
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For example quality assurance includes the assessment of all activities 
underway in the hospital, including: 
• Utilization Review; 
• Quality Control; 
• Risk Management; 
• Antibiotic Review; 
• Infection Control; 
• Surgical Case Monitoring; 
• Ancillary Service Review; 
• Blood Utilization Review; 
• Pharmacy and Therapeutic Review. 
5.3.1 UTILIZATION REVIEW 
Utilization review refers to the process of evaluating the necessity, 
appropriateness and efficiency of services provided. Information 
gathered from both the patient and the provider is reviewed for 
appropriateness and to determine whether it meets established guidelines 
and criteria (Kongstvedt 1989). 
The appropriateness of health care services can be reviewed through 
prospective, concurrent and retrospective methods (Abrams 1988:27; 
Kongstvedt 1989). 
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Prospective 
In this method review occurs before the service is rendered. It generally 
applies to speciality and hospital services and not to services rendered by 
general practitioners (primary care services). 
Concurrent 
Concurrent review takes place while the service is being rendered and 
applies only to hospital services. 
Retrospective 
In this system review takes place after the service has been rendered. 
This is the most common method used and may apply to any type of 
service. 
As part of utilization management programmes, significant cost saving 
can be achieved by using facilities and methods of treatment that are 
considerably cheaper, and which do not affect the quality of health care. 
This is particularly important in the control of hospitalisation and drug 
costs in South Africa. Examples may include the use of: 
• Outpatient surgery at day clinic facilities 
• Intermediate nursing facilities 
• Home health care 
• Hospice care 
• Drug formularies 
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• General medicines. 
5.3.1.1 Utilization review in hospital care 
Utilization review in hospitals is usually by means of prospective, 
concurrent, retrospective and large case management (V eli otis et al 
1993: 46). 
Prospective authorisation is commonly referred to as pre-certification. 
The general practitioner and/or specialist contact the plan before an 
elective hospitalisation and the plan reviewed the case against defined 
criteria in order to determine appropriateness. The plan then assigns an 
authorisation number and can stipulate restrictions such as hospital 
choice and length of stay. Certain plans may require a second surgical 
opinion prior to issuing an authorisation number (Kongstvedt 1989; 
Shouldice 1991 ). 
Concurrent review of care takes place in the hospital and is usually 
performed by the plan's nurse and the medical director. The responsible 
nurses will co-ordinate discharge planning and play an active role in 
gathering information and communicating with doctors and the patient's 
family (Abrams 1988:27). 
Retrospective review in hospitals involves analysing hospital bills and 
looking at patterns of treatment. The results may be used to 
preferentially refer cases to hospitals that demonstrate cost-
effectiveness and high quality care. 
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Large case management is a specialist form of utilization review for the 
management of catastrophic cases (e.g. AIDS, severe head injuries) 
(Kongstvedt 1989). It usually takes place in cases where hospitalisation 
has already occurred. Case management focuses on providing necessary 
services in the most cost-effective setting possible and generally extends 
and co-ordinates care in the outpatient setting as well (V eli otis et al 
1993:47). 
5.3.1.2 Practical Implications 
In order to contain costs, utilization review programmes form an 
important part of managed care systems. If performed correctly and 
supported with appropriate information, which is considered by all 
parties to be acceptable and reputable, such measures can promote cost-
effective quality health care for the benefit of patients. This overall 
objective can only be achieved if sophisticated information systems, 
adapted to the unique health care needs in South Africa, are developed 
(Veliotis et al 1993:48). 
5.3.2 CASEMANAGEMENT 
Case management involves the co-ordination of all aspects of health care 
where the final account is potentially higher than the average case of its 
kind (Kongsvedt 1993:501). This activity involves the allocation of a 
case manager by the relevant medical schemes or managed care 
organisation to such a case. 
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The case manager assesses the medical care given to the patient and 
intervenes in various ways if necessary. These include simple telephonic 
discussions with the relevant doctors who are involved in the treatments 
of the patients to ensure that the level of care is appropriate. 
Unnecessary investigations and treatments are avoided (Kongstvedt 
1993: 120). 
The case manager would also interact with the patient to ensure that the 
patient does not allow himself7herself to undergo unnecessary treatment 
and/or investigations. In the case of chronic illness, especially among the 
elderly, this is a valuable exercise particularly with respect to compliance 
with prescriptions. 
The goal of case management is always to reduce the cost of health care 
and maintain quality. 
5.3.3 SUMMARY 
The basis of utilization is to enhance the quality of medical care given to 
patients and helps medical service providers meet the requirement of 
private insurance companies for receiving payment. Regardless of the 
type of review programme, all programmes must assure objective 
considerations of appropriateness of admission, length of stay, and 
timeliness of professional and ancillary services. 
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5.4 COST CONTAINMENT 
The greatest risk faced by a medical aid is that the utilization or cost of 
treatment will be greater than expected. 
Various cost-containment tools are employed by managed care systems 
to avoid such situations arising. These include: 
• Hospital cost containment, such as pre-authorisation of hospital 
treatment and pre-admission screening (carrying out pre-
admission tests such as blood iron level and allergenic tests on an 
outpatients basis to avoid unnecessary stays in hospital). Re-
authorisation is often required where patients are required to stay 
in hospital for longer than anticipated. 
• Case management. The managed care company often becomes 
actively involved in co-ordinating the requisite services. 
• Discharge planning. One of the areas of greatest waste is in the 
continuing costs of hospital care during recovery. Patients are 
often kept in intensive-care wards, or hospital for longer than 
necessary. Discharge planning is an attempt to manage this 
process. 
• Retrospective review. This involves reviewing case treatments to 
ensure services and medicines billed were actually delivered in 
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their entirety by following up on cases weeks or even months 
afterwards. 
• Pharmacy Benefit Management (PBM). PBM is an attempt to 
encourage members and providers to prescribe and use the most 
cost-effective treatments and medication. This may involve bulk 
buying and distribution to gain discounted prices. 
• Formularies. In some cases managed care companies will only 
cover for a specified list of medicines - known as a formulary -
comprising one or more drugs for each ailment. Criteria for 
inclusion in formulary are the effectiveness of the drug and the 
discount negotiated with the manufacturer. 
• Drug utilization review. This involves a review by the managed 
care company of medication scripts for the appropriateness 
given the ailment of the patient. 
• Single exit fees. This is being implemented in South Africa and is 
an attempt to remove the profit motive for retail pharmacies that 
earn a dispensing fee rather than profiting on the sale of 
medicine. 
• Member education. This involves preventative care and 
education in better dietary habits, exercise and lifestyle 
management with a view to prevent the onset of serious illness 
later in life. 
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• Other factors which might contribute somewhat to controlling 
cost inflation when combined with managed health care are: 
greater use of appropriate, lower cost personnel; more rational 
planning to fit each population's health needs (e.g. more 
outpatient services); limiting malpractice litigation to decrease 
defensive medical practice. 
5.4.1 SHORTCOMINGS OF MANAGED HEALTHCARE IN ACHIEVING 
COST CONTAINMENT 
There is mixed evidence as to whether managed healthcare plans have 
led to overall savings in the United States. One recent study suggests 
that HMO costs to employers contributing on behalf of employees were 
14,7 percent less than traditional health insurance, as opposed to 6,1 
percent for PPO's and 7,9 percent for POS plans (Erb 1992). Other 
studies have also suggested that HMO contributions are lower relative to 
other schemes, although it should be noted that HMO premiums have 
still risen substantially over time (Gold 1991 ). There are also indications 
that traditional insurance plans tended to cater for larger numbers of 
higher risk, which would artificially inflate costs relative to other 
options. On the other hand, savings may be underestimated as HMO 
coverage is usually more comprehensive than traditional insurance and 
out-of-pocket expenses are generally a lot lower (Ingelhart 1992). 
There is evidence that these savings may generally reflect a once-off cost 
saving due to reduction in hospitalisation rates and length of stay. There 
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has been no reduction in the longer-term rate of growth of health costs 
under managed healthcare. 
The key factor fuelling health care cost inflation has been identified as 
technological advance (Newhouse 1993; Goldberg and Greenberg 1988) 
and managed health care per se has done little to control the proliferation 
and use of expensive new technology. Only when managed healthcare 
can develop and implement a socially acceptable method for evaluating 
and controlling use of new clinical technologies can it conquer cost 
escalation, as other savings are much less significant. The alternative 
would seem to be government regulation of cost-ineffective technology 
or imposition of caps on spending (Ingelhart 1992; Robinson 1991; 
Aaron Schwartz 1990). 
Cost "savings" may often simply represent cost shifting to other parts of 
the health sector with little benefit. Hospital and drug contract discounts 
favouring HMO's may simply be recouped by suppliers charging other 
patients or individual providers more. 
The shortcomings of managed health care in achieving cost containment 
suggest therefore that ultimately costs may only be contained through 
rationing. Nevertheless, managed healthcare may still have a role in 
providing incentive structures and information which encourage doctors 
to make cost effective decisions in exercising the discretion which they 
will inevitably need, given the diversity of clinical practice even with 
rationed resources (Hillman et al 1992). 
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5.4.1.1 Administrative costs and requirement 
Managed healthcare requires significant capacity in administration and 
systems planning. Within each managed healthcare plan it is necessary to 
draft contracts, administer and monitor claims, establish risk profiles and 
thus premiums, devise incentive schemes for providers and monitor 
quality, use patterns and treatment decisions. Thus, considerable 
expertise in planning, management, administration and information and 
information systems are needed (HMO Industry Profile 1992). 
An alternative study calculated administrative costs of HMO's at 9,4 
percent for 1990, a figure comparable to that of other private health 
insurers (Himmelstein and Woolhandler 1992).20 This figure contrasted 
to that of Canada's national health programme which uses only 0,9 
percent of funds on administration. The Canadian system involves a 
single national health insurer (avoiding the need for duplication and local 
risk profile analysis), uses global budgets for hospitals rather than 
requiring the monitoring of every item used, and involves minimal need 
for billing. However, the figures quoted above for both Canada and 
private United States medical insurers, apparently exclude administrative 
costs at the level of hospitals and providers surgeries, which are 
effectively included in staff or group HMO calculations and might 
significantly influence the comparison. 
5.4.1.2 Duplication of facilities and equipment 
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Managed healthcare providers are easiest to establish in urban areas as 
the density of the population is greater and services can be more 
centralised. However competition between managed care providers in a 
given area means that they may have to duplicate services and facilities 
to be able to offer potential clients a full range of services. Just as 
expensive "non-medical" signals can be used as indicators of quality in 
non-price competition for patients, there has been a tendency to provide 
cost ineffective high technology equipment as a selling point to providers 
and consumers (Robinson 1991 ). Quam (1989) suggests that increased 
competition between managed care providers in the United States has 
indeed led to significant proliferation and duplication of not only medical 
facilities, but also administrative and actuarial systems. 
A further type of duplication may occur when employers attempt to 
minimize costs or maximize benefits by changing to a new managed 
healthcare plan for employee cover. As patients will have to change 
provider, there may be of duplication investigations and consultation 
time. The extent of this is uncertain but might be contained if plans 
voluntarily, or through regulation, have to provide patients information 
to each other when this occurs. 
5.5 QUALITY ASSURANCE 
The term "Quality Assurance" refers to a formal set of activities designed 
to review and affect the quality of services provided. Doctors have a 
valuable role to play in identifYing features which impact on quality and 
20 As nearly all insurance packages now incorporate managed health care techniques such as utilization review (lnglehart 
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will be required to participate or appoint representatives in the managed 
care plans' committee that is responsible for quality assurance 
programmes. These programmes form a crucial component of managed 
healthcare and are required to ensure that standards are maintained. 
Because of the focus on cost containment in managed healthcare there 
have been fears that quality of patient care would suffer. Federal 
legislation in the United States of America requires managed healthcare 
plans to actively monitor and maintain quality. 
Although quality assurance and utilization review is closely associated, 
there are distinct differences. If utilization management is too tight, 
quality of care may suffer (Shouldice 1991 ). The focus therefore differs: 
utilization review ensures the appropriate and controlled utilization of 
medical resources whereas the focus of quality assurance is to ensure 
that the quality of care delivered is high. In order to achieve these 
objectives, these two interrelated issues should be separated. It is vital 
for managed care plans with utilization review programmes, also to have 
quality assurance programmes in order to prevent deterioration in quality 
(Shouldice 1991 ). 
5.5.1 TREATMENTGUIDELINES 
Guidelines are written statements that have been systematically 
developed. They provide practitioners and patients with the means to 
1992), their administrative costs may be higher than traditional fcc-for-service i~surance arrangements. 
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make educated decisions regarding appropriate health care (Bernstein et 
al1993:197; Burroughs 1994:74; Applegeet 1993:587). 
The purpose of guidelines is to encourage the physician to make a 
scientific diagnosis based on valid research. The physician is then able to 
design a treatment plan based on the patient's need rather than on the 
physician's personal preference. As a result physicians will operate in a 
manner that allows for minimum deviation from the expected protocol 
(Tingley 1993 :332). 
At best, guidelines are crystallisations of the best medical information 
available (Bergman 1994:70-1). The main aim of providing guidelines is 
to educate the provider of health care in order to keep up-to-date with 
excellent health care practice (Onion & Walley 1995:3). They aim at 
improving the quality and efficacy of health care (Appelgeet 1993: 587). 
On the other hand, sceptics refer to guidelines as "cookbook medicine". 
They maintain that the individual is ignored given that the variation in 
conditions from one individual to the next is not taken into 
consideration. In addition the physician believes that his/her autonomy as 
a doctor is threatened and that medical judgement is curtailed (Bergman 
1994:73; Onion & Walley 1995:3). 
On the contrary, there are those who argue that guidelines are designed 
to support medical decision amking (Bergman 1994:74). 
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Advantages and limitations of guidelines 
Guidelines are useful with respect to the following (Onion & Walley 
1995:4; Davidoff et al 1995:442; Bernstein et al 1993:197; Tingley 
1993: 331; Meeker 1992:790-1): 
• Keeping up-to-date with the latest medical information, keeping 
at the forefront of technological advances; 
• Standardizing medical practice; 
• Minimizing variance from one health practitioner to another; 
• They form a baseline of practice from which the various doctors 
can work and at the same time standardise their practice; 
• When kept up-to-date, guidelines minimise obsolete practice; 
• Guidelines are essential for effective utilization review. 
Utilization is measured against the guidelines to establish if the 
service concerned was utilised within reason. For example, a 
patient may have a prescription for two diuretics in the treatment 
of hypertension where the guidelines recommend a second line 
medication such as an ACE inhibitor to be more effective. By 
using the guidelines the reviewer is able to make the decision that 
a less cost-effective treatment is being used than the one found in 
guidelines; 
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• Reducing the incidence of inappropriate care, with the guideline 
forming the benchmark; 
• Supporting the physician in a court of law, by supporting the 
physician's decisions; 
• Reducing the cost of health care by (I) decreasing quantity and 
variety; (2) increasing cost-effectiveness, and (3) assuring the 
appropriateness ofhealth care. 
Although guidelines appear to be advantageous given the above list, they 
do have limitations. The limitations are as follows (Onion & Walley 
1995: 4; Bernstein et al 1993:197; Tingley 1993: 333; Richardson 
1994:25-28; Meeker 1992:790): 
• Absolute conformity to a set of guidelines prevents the doctor 
from treating the patient appropriately when required treatment 
varies from the guidelines; 
• Innovation and research are inhibited m the presence of 
restrictive guidelines; 
• Clinical guidelines may threaten the autonomy of the practitioner 
the utilization reviewer may hold the doctor to a treatment 
specified in the guidelines where the doctor should be the one 
responsible for the treatment decisions; 
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• Guidelines empower the negligent doctor to abdicate for the care 
of his/her patient, especially in terms of malpractice. Using 
guidelines as an excuse for poor health care decisions; 
• Any guidelines, developed by the health insurer, are met with 
scepticism by the practitioner given the motivation for cost 
reduction; 
• There is the risk of inappropriate use of guidelines by managed 
care organisations, in zeal to reduce costs. The physician's 
medical decision may become tainted by economic consideration. 
The effectiveness of guidelines is a hotly debated issue. There appears to 
be some consensus that the guidelines are worthwhile but providers of 
health care use them inconsistently (Schevellis v Eijk, vd Lisdonk, vd 
Velden & v Weel 1994 :257). Compliance can be achieved by means of 
careful follow-up and in some cases, denial of cover for care (Lobash & 
Hammond 1994:787). 
The South African environment is able to accommodate such guidelines 
in their most benign form. Providing the physicians with continuing 
medical education incorporating guidelines is currently the level of 
enforcement of the use of these guidelines in South Africa, says Coetzer 
(1996) at a conference presentation. 
In summary, guidelines are: 
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• Recommendations of clinical treatment modalities; 
• Designed to assist the health care practitioner in providing cost-
effective health care; 
• In danger of limiting the scope of health care provision and 
threatening the autonomy of the practitioner, and, 
• Are available in a variety of forms, for example, algorithms and 
practice parameters. 
5.6 MANAGED CARE MODELS 
There are currently a wide variety of networks operating in South 
Africa. They include Independent Practitioner Associations (IPA), 
Preferred Provider Organisations (PPO), Exclusive Provider 
Organisations (EPO), Point of Service arrangement and Health 
Maintenance Organisations (HMO). 
5.6.1 INDEPENDENT PRACTITIONERS ASSOCIATIONS (IPA) 
This system is also known as an individual practice association. The 
HMO contracts with an independent practice association to provide 
health care services in return for a negotiated fee. The negotiated rate 
may include all or some of the costs of general practitioner services, 
specialist referrals, hospitalisation and ancillary services. 
The IPA in tum contract with doctors who continue in their existing 
individual or group practices. They continue to see non-HMO patients, 
and maintain their own offices, medical records and support staff. The 
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IPA may compensate participating doctors on a per capita fee schedule 
or on a fee-for-service basis (Veliotes et a11993:58). 
Generally, all doctors who meet predetermined credential criteria can 
participate in the entity. IPA's provide a broad choice of participating 
doctors and they create an organised forum for providers to negotiate as 
a group with the HMO. However, providers maintain the right to 
negotiate direct1y and contract with other managed care plans and to 
accept private patients (Managed Care Information, Definitions and 
Contract Considerations 1993:274); Sunshine & Evens 1994: 768; 
Gorey 1994:24-7). 
Independent Practitioners Associations have been the fastest growing 
type of HMO in the US over the last decade (Inglehart 1992). 
5.6.2 PREFERRED PROVIDER ORGANISATIONS (PPO) 
PPOs are another type of managed care organisation in which a network 
of preferred providers is established to provide health services 
(Ceslowitz 1993 :360). According to Ceslowitz (1993 :361) discounts are 
negotiated with the provider, for example 35 percent discount from 
pharmacists, in exchange for the channelling of clients to the network. 
The patients receive financial incentives for using the preferred provider, 
for example, a co-payment such as a levy on the cost of medicines may 
be waived. PPO are networks of doctors (and other providers) who 
provide services at low costs to managed health care schemes through, 
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for example, discounted fee-for-service or capitation rates. Members are 
offered broader and cheaper cover if they consult doctors on the 
scheme's list but are not excluded from using other providers if they so 
wish. Management monitoring of utilization and quality is used to 
promote cost effectiveness as PPO providers have little incentive to do 
this, especially where payment is on a fee-for-service basis. 
5.6.3 EXCLUSIVE PROVIDER ORGANISATIONS 
An Exclusive Provider Organisation is similar to a Preferred Provider 
Organisation just that members may only use the funders' 
predetermined network if they want the third party payer to pay the 
account for the rendered service. Should they elect to see other 
providers they are responsible for the full cost (Managed Care 
Information, Definitions and Contract Considerations 1993: 273). A 
South African example of this is the Mines Benefit Society. All 
expenses are covered as long as the member uses the network. Any care 
rendered by a non-network provider is for the patient's account. 
5.6.4 POINT OF SERVICE ARRANGEMENT 
In contrast, the Point of Service arrangement is the loosest type of 
network. The choice of provider is not limited. A third party payer 
attached to this type of arrangement frequently requires a co-payment 
from the member for services rendered. If the member uses a provider 
from the network the co-payment is reduced or even waived (Managed 
Care Information, Definitions and Contract Considerations 1993: 273). 
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5.6.5 HEALTH MAINTENANCE ORGANISATION (HMO): STAFF MODEL 
AND GROUP MODEL 
Health Maintenance Organisations (HMO) is the best-known model in 
the United States where managed health is more broadly applied (Gore 
1993:300). An HMO is an arrangement between health fund 
administrators and providers of health care for the purpose of delivering 
health services to an enrolled population for a prepaid fee (Kongstveldt 
1989). 
By definition a HMO must compnse the following (Veliotis et al 
1993:58): 
• An organised system to ensure the provision of health cares in a 
specific geographic area; 
• An agreed set ofbasic and supplemental health services; 
• Voluntary enrolment of a group of people; 
• A financial plan to underwrite the costs of the services provided; 
• A management organisation to manage the affairs of the HMO. 
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In group or staff model HMOs, a group of doctors contract to provide a 
package of services to a defined membership. A group of doctors (and 
allied medical staff) establish themselves as a legal entity and practice 
under one roof, thereby cutting overhead costs. Examples of staff model 
HMOs would include Kaiser Permenente in the United States of America 
and Vaalmed in South Africa. 
' They then contract with managed health care schemes to provide health 
services to members at a given per capita rate, for a standard retainer fee 
or negotiated fee-for-service rate. Doctors have to take costs into 
consideration in all treatment decisions because of the limits imposed by 
the payment schedules arranged with financiers, but in other respects 
have considerable freedom in medical decision making. 
5. 7 REMUNERATION SYSTEM21 
Risk is an intrinsic factor associated with the provision and financing of 
health care. The fundamental relationship between risk and 
reimbursement is that the higher the risk, the higher the compensation. 
Conversely, the lower the risk, the lower the compensation. The method 
of payment of health care providers determined the degree of risk 
assumed by them (Boland 1991 ). It is therefore important to identify the 
various payment methods that may be used by managed care 
organisations. 
21 Remuneration models prevalent in the South African Medical aid environment are explored 
in question 2.4.2. of the interview Framework 
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Managed care plans utilising remuneration methods such as capitation, 
fixed fees and withholds will effectively shift certain, or in some cases all, 
the financial risk away from the payers of health care onto the providers. 
It is important that risk should not be passed onto the patients (MASA 
1992). 
There are broadly six types of payment systems. The risk profile of each 
payment method is different and various combinations of these basic 
models may be used (Kongsveldt 1989), or combinations thereof 
(Financial Mail July 1997: 6): 
• Fee-For-Service (FFS): This is the traditional system for 
payment, which remunerates service providers for each unit of 
service provided. This is the method currently used by medical 
aid schemes in South Africa. Costs for each unit are usually 
calculated according to a fee schedule. In South Africa the fee 
schedule could be MASA fees, Scale of Benefits, or negotiated 
fee schedule (Veliotis et al 1993:39). 
Managed care companies have moved away from this system of 
payment, as it transfers none of the risks to the. providers. In 
new, or emerging markets, however, managed care companies 
might be prepared to contract with service providers on this basis 
while they gather information on the health profile of the patients 
base or the treatment patterns of the providers. 
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• Discounted fee-for-service: It is common to have discounted fee 
charged in a negotiated fee schedule. The Representative 
Association ofMedical Schemes (RAMS) recommended Scale of 
Benefits currently in operation is an example of the discounted 
fee-for-service. This is where providers agree to discount their 
services in return for guaranteed or accelerated payments. 
• Global fees: These are similar to the FFS system with the 
difference that a single fee would be paid for an entire procedure. 
For example, a single fee would be paid for a triple bypass 
operation, covering the cost of accommodation, the cost of the 
surgeon, anaesthetist, pathology work and all post-operative 
medication and care. In this case, the hospital bears the cost risk. 
As a result there is a temptation to under-service the patients. 
• Per diem rates: This is a set payment per day in hospital, 
regardless of the services rendered or actual costs incurred 
(modified in exceptional cases such as when a patient is in 
Intensive Care). The range of allowable services is included in 
contracts between the providers and funders, and generally 
excludes specialists' fees. While this system overcomes the 
incentive to under-service there is a financial incentive to increase 
the time spent by patients in hospital. For this reason per diem 
rates are not common in South Africa. 
• Diagnosis-related groups: This is where a single fee is paid to a 
hospital for all treatments related to a particular diagnosis and a 
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single episode of care, regardless of duration of stay. For 
example a fixed fee of Rl 0 000 may be paid for the entire fees of 
a patient admitted after suffering a heart attack. Specialist rates 
can also be determined for certain categories of procedure (e.g. 
coronary, artery bypass surgery, and tonsillectomy). While this 
system is effective in controlling costs in a single episode of care, 
it does not protect the funder from the costs of further care 
which may be required. 
• Capitation: Capitation fees are fixed fees paid to the provider 
per member per month, regardless of the service required by the 
patient. General practitioners may receive a fixed monthly 
payment for every plan member that they contract to see. In 
return for this payment, however, the managed care organisation 
may require that these doctors be responsible for all general 
practitioner consultations as well as for costs of medicines, 
specialist care and hospitalisation, or any combination thereof. 
When providers assume responsibility for large, uncontrollable 
costs the question of financial risk becomes a major issue and 
must be clearly understood by the doctor. 
Capitation payment methods effectively place the health care 
provider at risk for medical expenses and utilization. Caution 
should therefor be exercised before accepting capitation payment 
systems, especially if the risk for the various parties has not been 
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clearly defined. Other problems associated with capitation-based 
systems include (Veliotis et al 1993:39): 
• Since capitation is statistically based, it is not sensitive to 
small enrolments and therefore it may not be possible to 
spread risk adequately. For example, if doctors or group 
practices are responsible for the full comprehensive service 
and there are insufficient members in the risk pool, 
seriously ill cases may deplete the whole capitation fund 
and doctors may be liable for an unlimited amount that may 
be incurred in the specified time period. 
• There are often no disincentives for members to utilise 
services supplied for contracted providers. This may result 
in an excess demand for services by members. 
• There are natural incentives for doctors to reduce the 
amount of services rendered. Doctors who accept both FFS 
and prepaid patients may be inclined to differentiate 
between these two groups, and prepaid patients may 
receive sub-optimal care. 
The introduction of capitation products depends on a reliable database of 
patient histories and claims patterns. Few organistions have this type of 
information. The front runner in capita ted products has been Medimo (a 
joint venture between Afrox Health and Medi-Clinic) but actuarial 
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miscalculations resulted in Medimo assuming losses and withdrawing its 
capitation products from the market. 
The greater the risk borne by the provider, the greater the incentives to 
under-service, and extensive quality control is required to ensure this 
does not occur. Capitation fees are often risk-adjusted to reflect the 
demographics of the patient base and its expected health care utilization 
(for example, fees may be adjusted upwards for elderly patients). This is 
common in South Africa where many doctors working for mining 
companies, for example, are paid a salary. 
Research in 1994 by American based Interstudy found that 69,3 percent 
of health maintenance organisations were using capitation as a 
reimbursement method for primary health care, 30,2 percent for 
speciality care (rather than fee-for-service) and 18 percent for hospital 
care (rather than fixed cost per diem rates), (Financial Mail July 1997:8). 
Providers may be remunerated through a combination of varwus 
systems. It is common for managed care companies, which act as 
intermediaries between service providers and funders, to be remunerated 
on a capitation basis and then remunerate the providers on a discounted 
fee-for-service basis. It is also common for Independent Practitioners 
Associations to be remunerated on a capitation basis and for the 
individual doctors to be remunerated on a proportion of their actual 
billing. 
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One managed care company in the Far East remunerates doctors on a 
"wellness capitation fee". Under this system, doctors are paid a fixed fee 
per patient for each day that the patient is well. Payment is made 
monthly, based on the number of days during the month that the patient 
is well. The definition of"well" is modified in the case ofthose suffering 
from incurable illnesses (Financial Mail July 1997:4). 
Doctors therefore have a strong incentive to get it right the first time and 
shift the emphasis from curative to preventative medicine. The patient is 
deemed to be sick on any day he visits the doctors and until such time as 
he reports directly to the managed care company that he is well. 
One criticism of the Far East model is that doctors may be tempted into 
short, quick fix cures rather than long-term programmes aimed at 
addressing the patient holistically. Experience shows, however, that this 
seldom occurs - according to a report on managed care by Hollandia 
Reinsurance. Another criticism is that the system is administratively 
burdensome. 
5.8 FORMULARIES 
An important tool for cost-effective prescribing is a drug formulary. This 
is a concatenated list of essential drugs that is used to narrow the margin 
of choice when prescribing, and therefore reducing the overall cost of 
prescriptions (Mcgahan 1994: 120). The list is comprehensive and 
dynamic; it is not an unusable document that in cast is stone for 
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generations. It is aimed at promoting doctors to prescribe in a cost-
effective manner (Kongstvedt 1993: 152). 
Not only does retrospective drug utilization review provide guidelines 
and insight for prospective drug utilization review, it also assists in the 
design of drug formularies. There are four types of formularies, ranging 
from an open one to a very tightly managed one, where reimbursement is 
made only for the medicines on the list (Guiaquinta 1994 :31 ). 
The four types of formularies are ( Guiaquinta 1994 :31) : 
• Open: This is a guide to recommended medicines. 
• Closed/restricted: Compulsory use of the medicines on the list is 
the only way to be reimbursed for the cost of the medicines. An 
example of this is the Essential Drug List that has been released 
for the public health sector in South Africa. 
• Incentive-based formulary: In this case there is a free choice of 
drugs but the medicines off the list are more costly for the payer. 
Alternatively there may be co-payment for the patient on drugs 
that are not on the list. 
• Patient-driven formulary: This is a list of drugs that may be 
prescribed according to the patient's medicine benefit. In this 
way the patient presents the doctor with a list of, for example, 
medicines for epilepsy and anxiolytics that are not on the list. 
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5.9 SHORTFALLS OF MANAGED HEALTH CARE 
Managed health care has been criticised for creating incentives not only 
to avoid over-treatment but to under-treat and reduce the quality of care 
(Bergman 1994:73; Onion & Walley 1995:3). Furthermore, whereas 
patients have unlimited choice of provider under conventional medical 
aid cover, they may have limited choice of provider under managed 
health care plans. This may mean that patients cannot use the most 
geographically accessible medical service or those, which the patients 
feel provide the best quality care. 
From a patient's point of view, this is the chief concern. In the long -
term, however, if the patient is dissatisfied with all of the doctors 
available or with any particular doctor the patients could change 
managed care provider or choose not to join a managed care unit and 
continue on the medical aid system. There is therefore an incentive for 
the managed care company to improve its quality of care and provider-
patient relationships so that they recruit more members and therefore 
increase their income. Their restricted choice must also be seen against 
the restricted choice, which would arise if private care becomes 
unaffordable for the patient. 
A further criticism of managed healthcare comes from the doctors. 
Doctors have jealously guarded their clinical independence and do not 
take kindly to the thought of having health service managers who may or 
may not be medically qualified, interfering with their choices of 
!53 
treatment. However, it should be pointed out that this is not as bad as 
doctors often portray. In the public sector at present, many decisions 
that affect patient treatment are made by health service managers 
together with senior consultants for example, what drugs will be 
available in the public sector hospitals and therefore may be prescribed, 
treatment guidelines in public hospitals etc.. There are numerous 
examples from other parts of the world of how HMO managers have 
developed appropriate working relationships with the doctors they 
employ. Rather than a threat, the establishment of HMO's should be 
seen as an opportunity by health professionals to rationalise their 
provision of healthcare, to introduce peer auditing, to establish more 
cost effective health practices and to become part of a team (Price 
1992). 
5.10 EXPERIENCES IN THE UNITED STATES 
Most empirical evidence was derived from experience of the managed 
healthcare industry in the United States, where, managed healthcare has 
proved to be a feasible, if not particularly satisfactory, approach to 
private sector financial difficulties.. Over 160 million Americans are 
enrolled in a managed care of some form today (Online Forum 1998). 
Managed healthcare began in the United States in 1923 - but it only 
really started making an impact in the 1970s (Sunday Times 1998:1 ). 
Since managed healthcare became prominent in the very early 1980s, it 
has increasingly penetrated the market. The proportion of insured 
Americans covered by managed health care plans increased from 27 
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percent in 1987 to 49 percent in 1990, while 95 percent of American 
employees' health benefit plans incorporate features of managed care 
(Ingelhart 1992:742). More recent figures show that 85 percent of all 
individuals in the United States of America are covered by managed 
healthcare, without the balance of 15 percent on fee-for-service 
indemnity type products (Sunday Times Business Times 1998: 1 ). 
" A managed care "take-over" will occur between 1996 and 2000" 
(Coile RC 1995: 60). At the beginning of 1995 every state except 
Alaska and Wyoming had at least one HMO. Highlights of the dramatic 
transformation to managed health care include: 
• Two out of three insured Americans are now enrolled in HMOs and 
managed care plans, according to a study by KPMG Peat Marwick 
of companies with more than 200 employees (Veliotis et al1993) 
• Three-fourths of all physicians have contracts with HMOs and 
managed care plans, and 89 percent of physicians employed in group 
practices are working under managed care agreements (Eckholm 
1994:5). 
Further, forecasts have it that government health care programmes will 
be rapidly converted into HMOs within the next five years. Medicare 
and Medicaid will be market targets for HMO enrolment. Already HMO 
enrolment for Medicaid recipients increased by 63 percent in 1994, 
according to the United States Department of Health and Human 
Services (Coile 1995). It is interesting to note that more than 50 percent 
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of the increase in Medicaid HMO enrolment is due to state legislated 
health reform initiatives. 
Evidence derived from American experience highlight some of the major 
benefits and problems associated with managed care. However we 
should be cautious about the degree to which United States experience 
is applicable in South Africa as the nature of the economy and society 
differ in important respects. For this reason local institutions are 
"Africanising" the American concept to deal with the lack of historic 
medical data in South Africa, demographics and geographies. 
In the United States the overall measurable success of managed health 
care is proven by an increase in health costs consistently below the 
national inflation index. 
5.11 MANAGED CARE IN THE SOUTH AFRICAN CONTEXT 
The Commission of Inquiry, which was appointed by the State President 
in 1993, submitted a comprehensive report, the Melamet Report, with 
findings and recommendations to the Minister of Health during April 
1994. One of the recommendations was that medical schemes should 
report on developments regarding managed care and that the Council for 
Medical Schemes should encourage the wider application of managed 
care. 
In the Registrar of Medical Schemes' annual report ending 31 December 
1994 various schemes reported positively on results in pursuance of 
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utilization and performance profiling programmes with remarkable cost 
savings. 
It is evident from available figures that medical benefit schemes, by way 
of managing health care and the rendering of services to their members 
by means of their own facilities, contained costs effectively. 
Considerable savings have also been reported by schemes managing their 
own pharmacies. The absence of the profit motive, together with 
successful negotiations regarding prices and effective purchasing, 
contributed most to savings. 
5.11.1 COST SAVINGS 
Managed health care has shown potential to provide cost savings in 
certain situations. Comparison of a staff model type HMO and medical 
aid schemes in South Africa has shown that utilization of doctors, 
investigations and hospitalisation was markedly lower in the former 
(Broomberg and Price 1990). 
Two particular areas may yield cost savings through managed health 
care: 
Firstly, there would seem to be great scope for control of hospital costs. 
Berman (1993) reports that inpatients per 1000 members' stand at 316 
for United States HMO's, 499 for United States indemnity insurance and 
732 for South Africa private care. Furthermore actual hospital cost per 
day in HMO owned facilities stands at R373 compared to R600 - 900 in 
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the private medical aid sector. A further cause for concern is the ability 
of South Africa doctors to hold shares in hospitals to which they refer 
patients. This creates incentives, which would encourage, rather than 
decrease, use of hospitals. In the United States, ownership of shares in 
facilities, which could lead, to "self-referral" is prohibited.22 
Secondly, savmgs on pharmaceutical costs through formularies and 
rigorous generic drug substitution may be large. Drug costs accounted 
for 27 percent of medical scheme spending in 1992 as opposed to 8 
percent in the USA where insurers only pay for generic drugs, when they 
are available (Cowlon 1993). Further more, rising drug costs (29, 7 
percent for 1991 -1992) have been a major source of medical cost 
inflation (Steyn 1993). 
The type of HM:Os and provider payment mechanisms, which emerge, 
may well influence managed health care ability to control costs. Group 
and staff model HMOs, with capitation payment, seem most cost 
effective. IPAs tend to be less successful at cost control irrespective of 
whether management is mainly done by peers or insurance company 
managers, who are perhaps more focused on cost containment. This 
might be because they tend to be FFS (Enthoven and Kronik 1989) 
which makes them less capable of influencing doctors' practice patterns. 
22 Ownership of shares in hospitals by doctors would seem to be problematic only if hospitals 
are funded on a fee-for-service basis. if hospitals have fixed budgets or are paid, for example, 
on a diagnostic Related Group (DRG) basis, provider's incentives would be reversed and share 
ownership by referring doctors might improve cost effectiveness, as their profits would rise 
through reducing unnecessarily expensive treatment. 
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In South Africa, group and staff model HMOs, on the whole, faced 
greater resistance from providers and consumers. FFS .IPAs have been 
the fastest growing type in the United States in the 1980s and seem to be 
the most prevalent in South Africa. This would suggest that the scale of 
savings in South Africa will be limited. IPAs may however be the most 
feasible way to acclimatise South Africa doctors and patients to managed 
health care practices. Once this has happened more cost effective models 
of managed health care might have a better chance of acceptance, if cost 
pressures remain unresolved. In the United States for example, a trend 
away from FFS for primary physicians by the early 1990s were noted 
(Gold 1991). IPAs may also have the benefit of avoiding significant 
capital and population distribution constraints in a South African 
context. Overall, it is likely that introduction of managed health care in 
South Africa will have to be an evolutionary process, adapted to 
particular political-economic and demographic circumstances. 
5.11.2 PROBLEMS IN IMPLEMENTATION IN SOUTH AFRICA 
Evidence derived from American experience can highlight some of the 
major benefits and problems associated with managed care. However we 
should be cautious about the degree to which United States experience is 
applicable to South Africa as the nature of the economy and society 
differ in important respects. Some of the specific problems, which may 
be encountered in South Africa, will be discussed below. 
5.11.2.1 Administrative costs and capacity 
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Administrative costs ofHMOs reported in the United States (9,4 percent 
- 13 percent) seems more expensive than in current SA medical schemes 
which over the past decade, never spent more then 7,2 percent of 
subscriptions on administration. While international comparisons are 
difficult to interpret23 , whether managed health care is of net benefit will 
depend more on whether any new administrative costs can create larger 
savings in other areas. Already we have seen a 
23 In particular it should be noted that medical aid figures exclude administrative costs of 
private hospitals and doctors in, for example, billing, pursuing accounts and bad debt. These 
are generally included in managed health care administrative cost data. Direct comparisons 
between figures for US managed health care organisations and medical aids are therefore 
likely to be biased in favour of the latter. 
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Perhaps of more concern is whether the private sector in South Africa 
has access to a large enough pool of administrative capacity (managers, 
accountants, and computer systems). United States experience indicates 
that among the most common problems to be expected with managed 
health care plans are: incorrect pricing, poor budgeting, rapid expansion, 
poor financial recording and inadequate cost control. While there does 
seem to be some available private health sector expertise and computer 
facilities, if this is inadequate, not only might managed health care fail to 
control costs and maintain quality but plans may become insolvent with 
subsequent disruption of services. Furthermore, skilled personnel may be 
drawn in from other areas of the economy where they are needed. The 
situation will need to be monitored to identify and control these types of 
problems if they emerge. 
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At the level of individual practices, particularly those with high patient 
volumes, it is possible that the introduction of managed health care may 
impose significant extra administrative burdens on practitioners. This 
could occur particularly when practitioners have to contend with a large 
variety of different systems used by different funders. Managed health 
care plans will have to be sensitive to the need to limit inconvenience to 
practitioners and avoid unnecessary time consuming systems if they are 
to optimise cost effectiveness and acceptance by providers. 
There is concern that deregulation of scheme plans may lead to 
proliferation of benefit packages requiring investment in aggressive 
marketing by schemes and thus inflated costs. Diversity of plans could 
also make marketing more complex, adding to "the risk of 
disinformation and misrepresentation" (Magannis (1) 1993). However 
regulating of marketing (e.g. prohibiting use of brokers by health 
insurers and plans) may be able to contain these problems. 
The relatively small population served by private health services in South 
Africa has been argued to be a constraint on potential benefits of 
managed health care. 
Each HMO has been calculated to require a minimum membership of 
25000 in a defined geographical area (Tollman et al 1990). While there 
are indications that small United States HMOs may be less viable than 
large, in 1990 39 percent ofHMOs (including IPSs) in the US had fewer 
than 20 000 enrolled (Gold 1991). Thus although it can be argued that 
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population constraints might limit the application of some HMO models 
in South Africa, particularly in rural areas, the possibility that versions of 
IP A or PPO-type plans may be feasible is not ruled out. In addition, the 
vast majority of consumers of private medical care in South Africa live in 
urban areas, so private managed health care plans are less likely to be 
hindered by this consideration. 
5.11.2.2 Lack of competition 
Related to the issue of the size of South African markets is the question 
ofwhether it can sustain enough plans for competition between managed 
health care schemes. Competition between plans to attract more 
members through lower contribution rates is seen by many as key to the 
success of managed health care cost control and is central to the idea of 
managed competition. Even if no direct competition is possible however, 
"yardstick competition" enforced by regulators or funders might be 
feasible. "Yardstick competition" involves comparing the costs of similar 
schemes in different areas and requiring that costs be reduced to those of 
the most cost-effective performer. 
5.11.2.3 Quality control 
The medical profession has frequently voiced concerns that managed 
health care focuses on cost containment and given providers incentives 
to under-service and delay treatment, with possible reduction in service 
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quality. There is, however, no clear evidence ofthis in the United States 
(Tollman 1990). 
5.11.2.4 Curative bias 
Theory suggests that benefits of preventative care for future curative 
cost control will make managed health care plans promote preventative 
care strongly. However Tollman et al (1990) point out that the major 
thrust of managed health care practice, has been reduced to curative care 
expenses. There can be no presumption that curative care will be more 
expensive to a particular scheme then preventative care, particularly in 
the short-term. Evidence of neglect of preventative care has for example 
been seen in Brazil where HMOs have referred clients to the public 
health system for immunisation rather than providing for it themselves 
(Lewis and Welch 1987). 
This would not however seem to be an intractable problem in South 
Africa. Regulation could ensure that certain preventative services were 
included in all plans. Alternatively, in view of the limited access to 
private care in South Africa, certain public sector preventative 
programmes (e.g. immunisation) will have to be operated anyway, and it 
may be most effective to rely on them for provision. 
5.12 CONCLUSION 
Managed care has its origins in efforts to improve access to healthcare. 
In general, managed care does a better job than the traditional fee-for-
service system in ensuring that consumers get preventative care and in 
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curbing unnecessary tests and procedures. Managed care also has the 
potential to co-ordinate care, minimize conflicts between treatments or 
prescriptions authorized by a patient's various physicians. It is also 
generally acknowledged that managed care has succeeded in transferring 
risk back to the provider and in cutting healthcare costs. 
Managed care depends, for its success, on gathering data about patients' 
medical spending patterns, claims history, drug utilization and a host of 
other information which is proving invaluable in managing risk in health 
funding. At its core, it places providers at risk for the health of the 
community. 
In countering the negative issue around managed care Gradison, 
President of Health Insurance Association of America comments (Online 
98:2): "Managed care is responsible for an increasing number of health 
plans having coverage for wellness and prevention programmes. Because 
of managed care, consumers now have much more information at their 
disposal, including innovations such as 
24-hour toll-free telephone services offering information about coverage 
and advice about health care. Because of managed care, health plans are 
now beginning to provide consumers with important quality of care 
measures, thereby enabling consumers to better compare how well 
competing health plans perform when delivering care. Also, many 
consumers use their managed care coverage with a minimum of 
paperwork and with very little out-of-pocket expense. 
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In short, managed care has raised the ·quality of healthcare and has 
brought about accountability to the nation's health system. It has put 
brakes on health care cost inflation, which prior to managed care ran 
anywhere from two to three times the general inflation." 
Managed care exists in different forms, with different benefit structures, 
finance mechanisms, and provider configurations. It is still evolving and 
therefore very much a work in progress. 
The following chapter deals with regulation in health care funding in 
South Africa and what the pending new regulation might mean for the 
subject of risk management. 
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CHAPTER 6: DRAFT POLICY :REGULATIONS UNDER THE 
MEDICAL SCHEMES ACTS, 1998 (ACT NO. 131 OF 1998) 
6.0 INTRODUCTION 
The objective of the proposals are by and large to improve the 
affordability of and access to private health care through medical 
schemes yet it targets areas which impact directly on the medical 
funders' ability to manage risks. An important element of these 
reforms would be to reinforce the requirement of community rating 
within medical schemes. The core of a community rated system is such 
that people should not be discriminated against in obtaining medical 
schemes cover on the basis of their health risks. This goal in itself flies 
in the face of risk management principles and goals. There has been an 
outcry from the health insurance industry and this chapter will divulge 
more of the proposals as well as industry views. 
Many of the proposals made are set against the Department of 
Health's more general policies for the health system as a whole. These 
include attempts to maximize the effectiveness of the health system in 
the delivery of services: improve equity in the financing and delivery of 
health care and promote greater efficiency in the use of resources. 
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6.1 REVIEW OF CURRENT HEALTH ENVIRONMENT 
Private sources of funding account for nearly 62 percent of total health 
expenditure in South Africa and provides care for 23 percent of the 
population on a regular basis ( Mcintyre, Bloom, Doherty & Brijal 
1995: I). Medical schemes are the principal financial intermediaries in 
the private sector, accounting for almost two-thirds of total private 
spending on health services. The private health sector is therefore a 
significant part of the national health system in South Africa. It plays 
an essential complementary role to the public health system. However, 
the private health sector faces a number of acute problems and 
challenges to its long-term sustainability: 
• Costs in the private sector, particularly those within medical 
schemes, have increased more rapidly than the rate of inflation and 
make up an ever-increasing proportion of the average salary. In 
1980 the average contribution was approximately 7 percent of the 
average salary. By 1996 contributions had spiralled to 17,3 percent 
(Draft Policy Document 1997:4). 
• The proliferation of non-indemnity medical insurance has led to 
substantial cream skimming, and many young and healthy members 
have opted out of traditional medical aid schemes, preferring only 
to obtain catastrophic health care cover. Thus risk pools of 
medical schemes have been systematically denuded of the young 
and healthy members. The impact has been to reduce or eliminate 
cross-subsidisation within medical schemes. To avert collapse, 
schemes are forced to charge even higher premiums to those who 
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remain (especially the old and sickly) at the time when they can 
hardly afford it. Most of these inevitably fall back onto the public 
sector. 
• Many medical schemes have varying benefit packages, some of 
which provide inadequate cover. Many people with these 
unrealistically low options exhaust their medical aid cover very 
quickly and are transferred to public hospitals, a dumping 
phenomenon that is increasingly becoming common. Demand 
pressure is consequently increasing on the public hospital system at 
a time when there is not adequate capacity to provide for 
additional people. 
• Some schemes have introduced individualised medical savings 
plans. These plans might encourage people to opt out of insurance 
type medical schemes thus threatening cross subsidisation. In 
addition such savings accounts can create perverse incentives that 
discourage use of preventative health care. They can also create 
opportunities for tax avoidance. Lastly, low income persons and 
those who left employment frequently may be grossly underfunded 
under a savings accounts regime, as they would be able to save 
less and to meet fewer of their health care needs. 
Other challenges within medical schemes relate to inappropriate 
governance systems and inadequate financial administration of funds 
of schemes. One further finds that lack of adequate reserve 
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requirements on medical schemes prejudices the solvency of many 
medical schemes. 
Many medical schemes are also too small. When few people subscribe 
to a medical aid scheme, the benefits of economies of scale are lost. It 
also becomes difficult to spread the risk of illness across a larger risk 
pool. 
There have also been a number of cases of fraud reported to the 
Council for Medical Schemes during the last few years. Such 
fraudulent behaviour is a major concern and contributes to escalating 
costs because for every claim made for a non-health benefit or for a 
non-member or his/her dependent benefit contributions have to 
increase to ensure that there are sufficient funds to pay for legitimate 
health care benefits. 
6.2 COMMUNITY RATING AND OPEN ENROLMENT 
The Department of Health considers that community rating will ensure 
that cross-subsidisation takes root in medical schemes. Community 
rating will contribute towards equalising contributions for high and 
low risk members and will promote greater equity. Although this may 
involve slightly higher contributions for current younger and healthy 
members. International and local evidence suggest that overall system 
costs diminish in high risk-pooled environment (Draft Policy 
Document 1997:7). 
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The most important characteristics of the community rated system 
proposed by the Department would be : 
• "Avoidance of the individual's age, gender, claims patterns 
experienced and health risk when determining contributions; 
• Residual ability to use members' incomes and/or number of 
dependants for determination of contribution rates; 
• Membership of the scheme will define the community for the 
purposes of determining contributions; 
The characteristics of open enrolment includes: 
• Anybody must be able to enter a medical scheme if they can afford 
to pay the average contribution regardless of their health 
conditions. In this regard open schemes will be required to accept 
all applicants while employer based schemes may accept any 
applicant. This provision will however be subject to protections 
against adverse selection. 
• Anybody must be able to stay in a medical scheme, regardless of 
their health condition" (Draft Policy Document 1997: 7). 
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In this system medical schemes will rate the community of members it 
covets rather than the individual. The consequences of risk rating will 
be to protect greater cross-subsidisation from the healthy to the sickly. 
The Department accepts that adverse selection can result from open 
enrolment, especially in the case where people join schemes late in life 
for a limited period and only to obtain benefits ( Draft Policy 
Document 1997:9). Such opportunistic behaviour can also result in 
inequitable transfer from long term scheme members to those only 
joining late in life. There may therefore be strong efficiency and equity 
arguments for some form of anti-selection mechanism for persons 
joining for the first time only late in life. The Department considers 
that such protections should be based on a system of lifetime 
community rating underpinned by gradual increases in waiting periods 
to deter late and strategic entry into a medical scheme. Such an 
approach is preferred internationally 24 as the one that provides 
incentives for people to join health insurance schemes while still young 
and healthy and that also protects equity. The Department therefore 
proposes that various protections be created by limiting certain aspects 
of open enrolment and that open enrolment be conditional upon the 
following: 
• An applicant must have been a member of another medical scheme 
immediately prior to applying; 
24 Ireland, for example, varies qualifYing periods for insurance by the age of the applicant. 
Australia also relies on a system of waiting time and lifetime community rating as the most 
effective mechanism of deterring late and strategic entry to medical schemes. Draft Policy 
Document ( 1997:10) 
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• Where a current member of a scheme wishes to change to another 
scheme such transfer should not be prevented on the basis of the 
existence of a pre-existing condition; 
• If a person was not a principal or dependant member of a medical 
scheme immediately prior to applying for membership then the 
scheme would be permitted to limit that individual's access to the 
scheme through a system of waiting periods. The draft document 
released in July 1997 indicated that a maximum of 12 months 
waiting period could be imposed in this regard, with an option of 
waiving all or part of the waiting period in return for paying 
contributions, at an average rate. More recent proposals issued in 
May 1999 ( Government Gazette No. R. 599 (7)) limited the 
general waiting period to three months ''provided that an applicant 
may elect to make a payment to the scheme in lieu of the waiting 
period". Further constrains in the proposals include: 
• A medical scheme may impose a specific waiting period of no 
more than nine months for any pregnancy-related benefit that is 
not part of prescribed minimum benefits. 
• A general waiting period may not be imposed on any applicant 
if, at the date of application, he or she had been a member or a 
dependant of a member of another medical scheme for a 
continuous period of two years or more. 
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Such a system of waiting periods may well be the most effective 
interim way of containing the worst aspects of adverse selection, while 
ensuring that equity goals of government; 
• Pre-existing sickness conditions: A medical scheme may require 
an applicant to provide the scheme with a medical report on any 
condition for which medical advice, diagnosis, care or treatment 
was recommended or received within the six months period 
ending on the date on which an application was made 
(Government Gazette No. R599 (8)): 
• Where a pre-existing condition exists m an applicant, 
schemes may impose a condition-specific waiting period 
for not more than twelve months from the effective date of 
coverage: Provided that: 
• No waiting period may be applied to any 
treatment or diagnostic procedures covered 
within the prescribed minimum benefits; 
• No exclusion may be applied to any person who, 
at the time of application, had been a member or 
a dependant of a member of another medical 
scheme for a continuous period of at least two 
years, and who changes to a new scheme because 
of a change in employment and applies for 
membership within three months of the termination 
of membership from the other medical scheme. 
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• Amnesty Period prior to introduction of later joiner penalties: For 
a period of six calendar months following the effective date of 
these regulations, (i.e. from 1 January 2000 until 30 June 2000 
inclusive) medical schemes must accept persons meeting the 
definition of a late joiner and applying for cover without imposing 
any of the late joiner penalties described above. 
6.3 DEMARCATION BETWEEN BUSINESS OF MEDICAL 
SCHEMES AND COMMERCIAL INSURANCE 
A further proposal is to effect proper demarcation between the 
business of medical schemes and that of commercial insurance. This 
has arisen as a result of risk rated non-indemnity insurance products 
been able to "cherry-pick" and attract the younger and generally 
healthy members out of schemes leaving the sickly and elderly behind. 
Many medical aids have been forced either to increase their 
contribution rates or adopt similar strategic behaviour and discriminate 
between the classes of risk. The result has been that many high-risk 
individuals have lost cover. Many expert opinions 25 have argued that 
such strategic "cream-skimming" can only be effectively attenuated 
within the ambit of a single act. It has been argued that such consistent 
regulation will level the playing fields between medical schemes and 
commercial health insurance and that it will lead to the stabilisation of 
medical schemes risk pools. There has nonetheless been some 
25 Such as South African Chamber of Business comments on the draft discussion document pertaining to 
the financing of the private health industry in South Africa SA COB 1997. 
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resistance to the notion of making all health product register under a 
single Act in some submissions. While the Department remains firmly 
committed to the ultimate consolidation of all Act governing private 
health care financing, this issue cannot be resolved in the short term 
The Department therefore proposes that the integrity of the 
community rated medical schemes environment be protected through 
proper demarcation of the dividing line between medical schemes and 
commercial health insurance policies as defined within the proposed 
insurance bills 26• Such demarcation should be effected through a 
redefinition of business of a medical scheme within the Medical 
Schemes Act. Any person who operates any entity with the object of a 
medical scheme should be required to comply with the Act. 
26 Short-Term Insurance Bill and Long-Term Insurance Bill Department of Finance 1997. 
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6.3.1 PROPOSED CHANGES 
With reference to Chapter 3 and the current definition of a medical 
aid, the following change has been proposed: 
"medical scheme" means any organisation, institution, fund , plan, 
arrangement, agreement or insurance policy established with the object 
of enrolling members and making provisions for : 
(a) the obtaining by members thereof and by dependants of such 
members of any service; 
(b) the granting of assistance to members thereof in defraying 
expenditure incurred by them in connection with the rendering of any 
servtce; or 
(c) the rendering of a service to members thereof or to dependants of 
such members either by the scheme itself or by any supplier of a 
service or group of suppliers of a service in association with or in 
terms of an agreement with the scheme. 
It is proposed that the term "service" be altered to "health care 
service" with the current definition of service applied to " health care 
service". The intention is to make clear the nature of services covered. 
In addition it is proposed that forms of health cover such as Benefit 
Funds, Friendly Societies. Exempted Schemes, and other schemes that 
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engage in the business of a medical scheme should also be required to 
register in terms of the medical Schemes Act. 
The intention of these alterations is to ensure that all forms of health 
cover, which have the object of a medical scheme, are registerable in 
terms of the Act. This is based on the premise that it would be the only 
way of adequately protecting the public and of ensuring the 
establishment and maintenance of viable pools, and thereby ensuring 
that proper community rating exists with cross-subsidisation, where 
the healthy and the young help to subsidise the sick and the elderly. 
6.4 MEDICAL SAVINGS ACCOUNTS 
The Department remains ''unconvinced" about the value of savings 
accounts in containing costs in the long-run. Medical costs will begin 
to decline in a meaningful manner only through adoption of 
alternative delivery and payment mechanisms that can contain both 
unit costs and number of episodes of care. However the Department is 
willing to consider the continued interim existence of savings schemes 
under the following conditions: 
• Only a maximum of 25 percent of annual contribution income 
can be accumulated into an individualized savings account, the 
remaining 75 percent should be paid into a pooled fund; 
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• All services in the proposed prescribed minimum benefits package 
should form part of the pooled community rated portion of the 
fund; 
• Where withdrawal ofbenefits occurs, these should be subject to a 
final withholding tax as proposed by the Katz Comrnission27 • 
(Refer to Appendix 1 of Chapter 6 for more detail medical savings 
accounts). 
6.5 PRESCRIBED MINIMUM BENEFITS 
The section set out the scope, level and operation of the set of 
prescribed minimum benefits to be available to all members and 
dependants, as provided for under section 29(1)(o) and 29(1)(p) of the 
Act. The intention of the regulations in specifying a set of prescribed 
minimum benefits for hospital care is:-
• To avoid loss of cover in the event of serious illness, and 
consequent risk of unfunded use of public hospitals; and 
• To encourage efficient allocation ofprivate and public health care 
resources. 
Opposition to the concept of prescribed minimum benefits has been 
based on concerns that such a minimum will make schemes 
unaffordable and would therefore inhibit growth of private sector 
coverage. 
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It is however clear that most schemes will be providing more than the 
prescribed minimum benefits. The Department considers that the 
question of co-payment for such ancillary benefits is different from 
that of prescribed benefits as demand for such services is largely 
predictable and discretionary. Co-payments for such services would 
not therefore have adverse equity implications. Hence co-payments 
will be allowed for additional benefits. 
6.6 MULTIPLE BENEFIT OPTIONS WITHIN SCHEMES 
Many medic~l schemes currently offer a differentiated set of benefits 
and a system of options within one scheme. Such a system is 
predicated on the basis that it allows a medical scheme to develop 
niche products that some members may prefer. Although not in favour 
of a proliferation of options offered by schemes, the Department has 
accepted the need for flexibility. However, all options need to include 
at least the minimum prescribed benefits, no cross-subsidisation is 
allowed between options, each option has to have at least 2500 
members and options created solely for the purpose of hosting defined 
groups on an exclusive basis may not be registered. 
6.7 LIMIT ON TAX DEDUCTIONS 
27 Sixth Interim Report of the Commission of Inquiry into aspects of the Tax Structures of South Africa. July 1997. 
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Other proposals limit the tax deductions for medical aid only to those 
schemes registered under the Medical Schemes Act and disallow pre-
funding of post-retirement medical scheme contributions. The latter 
proposal is aimed at limiting the individualisation of accumulating 
funds and "inevitable discrimination of high risks within this 
environment". 
6.8 RESERVE REQUIREMENTS 
Many medical schemes currently operate without provtston for 
adequate reserves. The Department believes that it is financially 
prudent to keep a level or reserve because premium income may at 
times not be adequate to cover benefits - because of increases in 
medical costs and variations in claims. Presently it is merely a 
recommendation that Medical Schemes maintain accumulated funds 
equivalent to 25 percent of their annual contribution income. The 
Council for Medical Schemes has recommended that this requirement 
be made mandatory (Draft Policy Document 1997 :25). 
Sufficient reserves are critical to deal with volatility of claims, and 25 
percent represent only 3 months of average claims. The Department 
therefore proposes that new schemes should have business plans that 
make provision for the required levels of solvency margins before they 
can be registered. Existing schemes should be given three years in 
which to comply or face de-registration. 
6.9 MANAGED HEALTHCARE 
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The introduction of managed healthcare in South Africa raises a 
number of issues including the ability of managed care to contain costs 
without hurting access and quality of care, the need to ensure solvency 
of managed care plans; fairness in contracting and the needs to 
develop appropriate standards for resolution of potential disputes 
among the contracting parties (Draft Policy Document 1997:29). 
Some of the proposals made in this document will also apply to 
managed care organisations. In addition, the Department has 
established a consultative forum on managed health care in South 
Africa. Conditions for providing managed healthcare are documented 
in point 13 of the May 1999 Government Gazette No. R599 and can 
be found in Appendix 2 of Chapter 6. 
6.10 CONCLUSION 
The reforms proposed in this document have been prompted by 
concerns over rising costs of private medical cover; increasing cream-
skimming by life insurers and the resultant risk rating by medical 
schemes; and concerns that adequate access to medical schemes cover 
should be available at prices which do not exclude high risk groups. 
The Department considers that these problems can best be resolved 
through a system of lifetime community rating that relies on the 
application of longer waiting periods for people entering medical 
schemes only late in life. In addition the Department believes that a 
prescribed minimum package of benefits will afford members of 
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schemes meaningful benefits, and limit the tendency to shift costs of 
some members to the public sector. 
Clearly the proposals, if anything widen the already wide disparity in 
the practice of risk management in the medical funding industry in 
South Africa versus the theoretical benchmark. In particular, 
community rating and guaranteed access will undermine the actuarial 
determination of risk to allow for appropriate premium charges. 
In response to the criticism that guaranteed access could result in 
healthy members deferring membership until late in life, the 
department proposes a waiting period whereby new members would 
have to wait up to three months before gaining access to the scheme. 
Whether this would be sufficient to prevent adverse selection is not 
certain. 
The funding crises facing employers could worsen, should government 
legislate against screening members based on risk factors such as age, 
medical history and previous claims patterns. 
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APPENDIX 1 :GOVERNMENT GAZETTE NO. R. 599. (6). 
PROVISION 
ACCOUNTS 
OF PERSONAL MEDICAL SAVINGS 
( 1) A medical scheme shall not pay into a members' personal 
medical savings account an amount that exceed an equivalent 
of three contribution months during any calendar year. 
(2) Funds deposited into or advanced by a medical scheme into a 
member's personal medical savings account shall not be used to 
purchase or reimburse any relevant health service which forms 
part of the prescribed minimum benefits. 
(3) Funds deposited in a member's medical savings account may 
not be used to offset contributions. 
(4) The maximum allowable cumulative balance in a member's 
personal medical savings account shall not be more than three 
times the annual allowable limit that can be paid into such an 
account. 
(5) Credit balances in the member's personal medical savings 
account may be transferred to another scherr:e with a personal 
medical savings account regime when such member changes 
schemes. 
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( 6) Any balance in a members' personal medical savings account shall 
be excluded from the calculation of the mandatory nett assets of 
the medical scheme. 
(7) Every medical scheme must provide the following to the Registrar 
, with regard to members' personal medical savings accounts 
(a) Details of amounts paid into members' personal medical 
savings accounts; 
(b) details of benefits, by category, paid out of members' personal 
medical savings accounts; 
(c) details on both debit and credit balances in members' personal 
medical savings accounts; and 
(d) any other reports that the Council may specifY 
from time to time. 
185 
APPENDIX 2: GOVERNMENT GAZETTE NO. R.599. (13) 
CONDITIONS FOR PROVIDING MANAGED HEALTH CARE 
( 1) If a medical scheme provides benefits to its members by means 
of a managed health care arrangement or agreement, such 
arrangement or agreement. 
(a) must be reduced to writing; and 
(b) may not absolve a medical scheme from its responsibility 
towards its members if any person is in default to provide 
any service in terms of such arrangement or agreement. 
(2) The arrangement or agreement contemplated in sub-regulation 
(1) must specifically provide that no member or dependant of a 
member may be held liable to the participating provider for any 
sums owed by the medical scheme. 
(3) An agreement or arrangement contemplated in sub-regulation 
(1) must provide that a party to the agreement or arrangement, 
including a trustee, agent or representative of such party, may 
not institute any legal action against a member or a dependant 
of a member to collect sums owed by the medical scheme. 
(4) A provider of managed health care may not, in terms of an 
arrangement or agreement contemplated in this regulation, or 
otherwise, assume financial liability for any cover beyond the 
scope of what such provider is able to provide and such 
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-, 
liability must be clearly defined by means of the arrangement or 
agreement between the provider and the scheme. 
(5) An agreement or arrangement between a provider of managed 
healthcare and a medical scheme must require either party to 
give at least 90 days advance notice before terminating the 
agreement or arrangement. 
(6) A managed health care organisation shall not in any manner 
forbid or discourage a participating provider from informing 
patients of the care they require, including various treatment 
options, and whether in the provider's view, such care is 
consistent with medical necessity and medical appropriateness. 
(7) A provider shall not be prohibited from protesting or 
expressing disagreement with a medical decision, medical 
policy or medical practice of the managed health care 
organisation, within the constraints of the professional practice 
and ethical guidelines for the profession. 
(8) A managed health care organisation shall not terminate the 
contract with a provider because 
(a) the provider expresses disagreement with the organisation's 
decision to deny or limit benefits to a member 
(b) the provider assists the member to seek reconsideration of 
the organisation's decision; or 
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(c) a provider discusses with a member any aspect of the 
member's medical condition, any proposed treatment or 
treatment alternatives, whether covered by the managed 
health care organisation or not. 
(9) Nothing in this regulation shall be construed to prohibit a 
managed health care organisation from 
(a) requiring of a provider to refrain from making, publishing, 
aiding or disseminating, directly or indirectly, any oral or 
written statement or any pamphlet or circular that is false or 
maliciously critical of the managed health care organisation 
and is calculated to injure or prejudice such managed health 
care organisation; and 
(b) terminating a contract with a provider because such provider 
materially misrepresents the proVIsiOns, terms and 
requirements of the managed health care organisation. 
(10) A managed health care organisation that endeavours to 
procure a network of providers must 
(a) upon request, provide an application and information 
required for consideration for participation in the 
organisation's network, to any provider wishing to apply for 
participation in the organisation's network;and 
(b) make publicly available its application requirements. 
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( 11) A managed care organisation may not deny an applicant 
participation, or terminate participation on its network on the 
basis of 
(a) race, gender, age, religion, national ongm or any other 
arbitrary grounds that may constitute unfair discrimination; 
(b) the type or number of appeals filed by the provider; or 
(c) the type or number of complaints or grievances the provider 
filed or requested for review. 
(12) Where a managed health care organisation proposes to 
terminate a provider's contract, the notice of termination must 
include: 
(a) the reasons for the proposed action; 
(b) a notice that the provider has a right to request a hearing or 
review, at the provider's discretion, before an impartial panel 
appointed by the Council for Medical Schemes for that 
purpose; 
(c) a period of not less than 30 days within which a provider 
may request a hearing or review; and 
(d) a period for a hearing date which must be within 30 days of 
the date of receipt of the request for a hearing. 
( 13) The panel contemplated in sub-regulation (12)(b) must render 
a decision within three days of such hearing, and must 
communicate the decision to the provider, and the decision 
must include reinstatement of the provider, or provisional 
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reinstatement subject to conditions set forth by the panel or 
termination of the provider's contract. 
(14) A managed health care organisation may not use a financial 
incentive that directly or indirectly compensates a provider for 
ordering or providing less than medically necessary for, or less 
than appropriate care to, his or her patients. 
(15) Nothing in subregulation (14) should be deemed to prevent a 
managed health care organisation from using a payment 
arrangement which- is based on a cost per member per month 
and which is consistent with the intent of this subregulation. 
( 16) Any information pertaining to the diagnosis, treatment or 
health of any member of a medical scheme or of any dependant 
of such member must be treated as confidential. 
( 1 7) A medical scheme is entitled to access any treatment record 
held by the provider and other information pertaining to the 
diagnosis, treatment and health status of the member in terms 
of the agreement or arrangement, but such information may 
not be disclosed by the provider to any other person without 
the express consent of the member, except for purposes of 
notification as stipulated in a relevant Act or regulations. 
( 18) A managed health care organisation must annually submit to 
the Council, on application for accreditation, a written quality 
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assurance plan and a written utilization revtew plan that 
includes the following 
(a) the goals and objectives; 
(b) the staffing and contractual arrangements; 
(c) a system for communicating information regarding utilisation 
review activities to providers and schemes; 
(d) a system for communicating information regarding quality 
assurance activities to schemes, providers and members; 
(e) the scope of the quality assurance activities; 
(f) the scope and description of the utilisation review activities; 
and 
(g) a description of peer review system. 
(19) A managed health care organisation may not prohibit in its 
rules the initiation of an appropriate intervention by a provider prior 
to receiving authorisation from the managed health care organisation, 
where a person presents with any condition that requires immediate 
medical or surgical intervention. 
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CHAPTER7:METHODOLOGY 
7.0 INTRODUCTION 
To achieve the stated objectives of (a) determining the extent of risk 
management by medical aids in South Africa and (b) exploring 
alternatives to managing risk in health care funding, literature relating 
to risk management and the formulation and implementation of a 
managed health care strategy will be reviewed. This theory is translated 
into a semi-structured interview framework (a copy of which is 
attached as Appendix 7.1) in order to assess the extent of 
implementation of risk management in the medical aid industry to date. 
7.1 SAMPLE 
The research study is carried out on a random sample of the medical 
aid population. A profile of each company included in the sample is 
then compiled as a result of the interviews. 
Given that managed healthcare is a relatively new concept to South 
Africa the operations of other managed care players falling outside the 
study will also be reviewed and a company profile compiled. The 
purpose of this is to determine the benchmarks with respect to the 
outcomes of managed healthcare strategies and to better assess the 
relative performance/views/opinions of the sample study to this 
benchmark of managed care operators. 
(1) RANDOM SAMPLE SURVEY 
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In order to get an unbiased image of the whole population and to 
reproduce the characteristics of the whole population it was decided to 
use a random sample of the medical aid population. A random sample is 
a sample, which is chosen so that every member of the population is 
equally likely to be a member of the sample, independently of which 
other members of the population are chosen (Clarke and Cooke 
1983:32). This random sample will be interviewed and the results will 
be drafted under "results of study''. 
A list of names in alphabetical order can be regarded as being in 
random order with respect to the variant of interest. In these cases a 
systematic sample from an alphabetical list can be treated as if it were a 
random sample (Clarke and Cooke 1983:36). 
For the purpose of this research study an alphabetical list of medical 
schemes was granted by Medscheme28, the largest administrator in the 
country. From this list every fifth scheme was selected into the sample. 
Therefore a sample of seven companies was selected from the 
population of forty-three. 
The sample comprises: 
• Bonitas Medical Fund 
• Commercial Union Health Medical Scheme 
• Finmed Medical Schemes 
• Medical Expenses Distribution Society Medsure Medical Aid 
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• Northern Medical Society 
• SAKA V Mediese Helps Fonds 
• Southern Healthcare JV 
With exception to Medsure all sample companies participated in the 
study. 
The sample population accounts for over 1,5 million covered lives, or 
22,3 percent of the medical aid population. The type of companies 
falling into the sample are a fair representation of the industry given 
that three of the schemes are traditional schemes by definition, three are 
new generation schemes and the other offers the full range of managed 
care services. 
Graph 7.1: Representation in Sample Population 
2) REVIEW OF KNOWN MANAGED CARE IMPLEMENTORS 
28 Refer to Chapter 9 for the table on medical aids population. 
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Insight will also be drawn from a brief analysis of existing managed care 
players falling outside the ambit of the sample. This will facilitate a 
relative comparison of how far down the road all the insurance models 
i.e. traditional schemes, new generation schemes and managed health 
care schemes are in terms of risk management strategies and the 
implementation thereof 
Those with known legs of managed health care i.e. 
1. Sanlam Health, 
2. Northern Medical Aid, 
3. Southern Health Care N, 
4. Momentum 
5. Fedsure Health, 
6. Medscheme Managed Health, 
7. Galaxy Health, 
8. Healthcare Management Services, 
9. QA Care, 
10. Qual sa, 
11. Norwich Health. 
12. Medimo 
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7.2 RESEARCH DESIGN 
The research design is explorative in nature. The members of the sample 
will be interviewed and the Delphi technique applied. The Delphi 
technique, in its simplest form, eliminates committee activity among the 
experts altogether and replaces it with a carefully designed programme 
of sequential individual interrogations (usually best conducted by 
questionnaires) interspersed with information and opinion feedback. 
The principles involved in the Delphi technique include: 
Sending out a comprehensive questionnaire which can also be asked in 
an interview, 
A follow-up questionnaire 1s fed back to the respondents, with a 
summary of the distribution of these responses by stating the average 
answer. The respondent is then asked to reconsider his/her previous 
answer and revise it if/she he so desires. If his/her response is extremely 
contrary to the first answer, he/she is to be asked to state his/her reason. 
Placing the onus of justifYing relatively extreme answers on the 
respondents has the effect of causing those without strong convictions to 
move their estimates closer to the median, while those who feel that their 
argument for a "deviationist" opinion tended to retain their original 
estimate and defend it. The median of these final responses could then be 
taken as representing the nearest thing to a group consensus. 
On completion of all interviews, notes taken on the extent of risk 
management implementation in the industry are reviewed. This is to be 
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compared with the concepts referred to in the literature to see if they 
apply or whether there are other considerations. The risk management 
alternatives will be examined. The steps taken by these bodies will be 
compared with the literature to see whether the actions taken by the 
implemet:J.tors complied with the theory. 
For the purpose of this report principle number (2) in the Delphi 
technique will not be strictly adhered to given that the contact person in 
each organisation is either the Chief Executive Officer or the Managing 
Director, both of which are difficult to get appointments with. It is thus 
vital to get the most out of the one session with the individual. Further 
communication will be conducted telephonically or with other contacts 
in the organisation. 
By conducting in-depth personal interviews with the respective 
organisations one is able to determine the medical aids' strategy 
and progress on risk management and managed healthcare. 
The guidelines, in terms of the methodology used, for explorative 
research are described as follows by the 1988 Human Science 
Research Council Report: (Ferreira & Mouton 1988: 140). 
Explorative Research: 
As formulated by Selltiz, Jakoda, Deutch (1965), the objective of 
explorative research is: 
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• To gain new insights into the risk management function of 
the organisation; 
• To identify central concepts to study requmng further 
attention; 
• To determine priorities for further research studies; 
• To generate hypotheses. 
The three components of explorative research as described by 
Selltiz et al ( 1965) are: 
• A literature survey; 
• Interviews with people with practical experience. With the 
aid of a research schedule, semi-structured interviews will be 
conducted. A research schedule refers to questions or 
themes from literature used as important guidelines for 
interviews. The schedule serves as a control to ensure that 
subtopics are covered but further questions may arise during 
the interview to explore specific aspects; 
• Analyses of insights. 
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This research project includes all three components of 
explorative research. 
Qualitative Framework: 
Research of this nature is qualitative by definition. The process is 
one where (Buckley 1976:34): 
• The findings are conceptualised within a theoretical framework; 
• The theoretical frame of reference IS guided by a comprehensive 
literature survey; 
• A number of questions orientate the study but further questions can 
arise during the research interviews; 
• Semi-structured interviews in the form of extended discussions and 
organised listening are used; 
• These different methodologies are integrated by the research. 
The interviews of this research are semi- structured in order to get the 
responses of the executives on the central concepts of decision making 
theory and their application in practise, and also to give enough 
opportunity for input on new ideas and concepts that have been proven 
to work in real life situations. 
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The material gathered during the interviews is analysed. Through a 
process of analytical induction conclusions can be drawn on: Risk 
management concepts applied in the medical aid industry and top 
managements' understanding and strategic thinking on risk management. 
7.3 COMPANY OVERVIEWS 
A brief overview of each company IS given to facilitate a better 
understanding of the medical aid industry and its players. The 
overview touches on the company's history, its members, range of 
services and financial performance. Most of the financial information 
provided refers to the years 1995 and 1996 as it is the latest available 
data. 
BONITAS MEDICAL FUND 
Company Profile 
Bonitas registered as a medical scheme in 1982 and targeted black 
state employees who had previously not been accorded such benefits 
by the government. It currently caters to over 1000 individual 
organisations, municipalities and department group~, with state 
members comprising over 95 percent of the membership base. 
Range of Services 
Bonitas is a traditional medical aid still risk rating members by income 
and number of dependants. Medscheme administers the group's funds, 
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and hospital utilization management is addressed by Medchemes' 
Hospi-Serve, the new age hospital benefits management programme. 
The group recently introduced savmgs accounts but according to 
management, given the low demand, it has not been as popular with 
Bonitas target market i.e. lower income black market. 
The group pays out no-claims bonuses but it plays a relatively 
unimportant role given the size of the payouts last year i.e. R4 million 
as compared to total claims paid of Rl.1 billion. 
Financial Performance 
Bonitas has a sound balance sheet. Despite the decline in membership 
base, Bonitas has strengthened its financial position considerably and 
this is reflected in its improved solvency and financial base ratios of 33 
percent (1995:27 percent) (Duff and Phelps Credit Rating Co. 
1997:27) and 43 percent (1995:40 percent) (Duff and Phelps Credit 
Rating Co. 1997:27) respectively for the 1996 financial year. The large 
underwriting surplus and strong investment performance resulted in 
the cash flow from operating activities improving to R145m, up from 
only Rl6m in 1995. Consequently, cash flow to claims paid improved 
to 14,4 percent (1995:1,8 percent) (Duff & Phelps Credit Rating 
Company 1997:27). 
Member Base 
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Despite the scheme's membership base decreasing by 2 percent in 
1996 it still caters for 185 000 members or approximately 740 000 
beneficiaries, making it the largest open medical scheme. Bonitas has 
retained its young membership profile, with 83 percent of members 
being younger than 50 years of age. 
COMMERCIAL UNION HEALTH MEDICAL SCHEME 
Company Profile 
The recently launched fund, (April 1998) plans to enter the market as 
a new generation medical scheme, that proves affordable and equitable 
healthcare cover to both groups and individual members. 
Range of Services 
Hospitalisation and chronic illness benefits are incorporated into their 
products. The new generation fund offers savings accounts. An 
innovative inclusion of an insured benefit that covers potentially high-
cost out-of-hospital services, differentiates their products from 
competitors. Commercial Union does offer the initial and crucial 
elements of managed health care i.e. hospital utilization and 
pharmaceutical benefit management, including a chronic medication 
programme, all of which are outsourced. 
Member Base 
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As a young fund it only covers 3520 lives. 
FINMED MEDICAL SCHEME 
Company Profile 
Finmed was established in 1972 and targets the medium-sized 
corporate market. Finmed introduced a savings-linked product last 
year. Finmed operates predominantly out in Gauteng and Western 
Cape, which collectively account for 80 percent of the membership 
base. Finmed is a traditional medical scheme administered by 
Medscheme. 
Financial Peiformance 
Finmed exhibits a comparatively weak solvency position (Duff & 
Phelps Credit Rating Co 1997:33). The scheme has a retained cash 
flow to claims paid ratio of 2,8 percent (1995: 0,6 percent) and cash 
coverage ratio stands at 1 months cover, compared to 0,7 months 
cover in 1995. 
Member Base 
The scheme has lost a large number of members in recent years and 
membership reduced by a further 14 percent in 1996. The scheme now 
caters for 18 236 members, down from 24 800 in 1993. However the 
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stratification by age category evidences a relatively young age profile, 
with 75 percent of members younger than 50 years of age. 
MEDICAL EXPENSES DISTRIBUTION SOCIETY (MEDS) 
Company Profile 
MEDS was established approximately 35 years ago. The scheme is 
group based, and is administered by Southern Healthcare Medical 
Scheme Managers. 
Financial Peiformance 
MEDS ended the 1996 financial year on a positive note with an 
underwriting profit of R6m, as opposed to the poor results recorded in 
1992 and 1993 (where underwriting deficits ofR18m and R26m were 
recorded, respectively). Notwithstanding a further 5 percent decline in 
members, sounder underwriting criteria resulted in premium income 
increasing 23 percent to R64m (1995:R52m). Claims incurred for the 
period reduced to R54m (1995:R57m). 
From a solvency perspective, MEDS's solvency position improved to 
91 percent (1995:77 percent), which is the highest in the industry. 
Similarly, the retained cash flow: claims paid and cash coverage ratios 
increased to 25,4 percent and 6 months cover respectively. 
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Member Base 
Large underwriting losses were incurred by the scheme in the early 
1990's and this necessitated a substantial increase in premiums, which 
together with poor service levels resulted in large membership losses 
(since December 1993, the scheme has lost approximately 62 percent 
of its membership base) (Duff and Phelps Credit Rating Company 
1997:36). Presently the scheme caters for 5 645 members and 8 836 
dependants. 
NORTHERN MEDICAL SOCIETY 
Company Profile 
Northern Medical Society (NMS) was established in 1948 and 
targeted the corporate market. Although the scheme aggressively 
pursued membership growth prior to 1994, this led to poor 
underwriting results and the scheme had to consolidate. In 1995/1996 
the scheme implemented a number of corrective measures, which 
included amongst others, high contribution increased surcharges on 
companies with less than 20 members; and the phasing out of 
continuation of member subsidies. These initiatives continued in 1997 
with removal of direct payment facility for providers in excess of the 
national claims average; analysing doctors claiming patterns; as well as 
launching the Chronic Medication Programme and hospital pre-
notification. 
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Range of Services 
Hospital pre-authorization, case management and review, profiling of 
providers; implementation of a chronic medication plan. 
Financial Peiformance 
Certain key ratios are still below industry norms. Due to the scheme's 
contribution re-rating and greater emphasis on cost containment 
measures, particularly through the wider implementation of managed 
health care principles, the scheme was able to substantially improve its 
underwriting result to a R14m surplus (1995:R31m deficit), in spite of 
an increase in delivery costs from 7,9 percent to 8,5 percent of gross 
premium income position (Duff & Phelps Credit Rating Co 1997:47). 
NMS's solvency ratio improved to 22,6 percent in 1997 (1996:15 
percent ;1995:11 percent) (Financial Mail 1998:78), although this is 
still below industry averages. Furthermore, the scheme demonstrated 
improved liquidity, as evidenced by a retained cash inflow of R23, lm 
(1995: R19,3m outflow) and a cash coverage ratio of 1,6 months ( 
1995: 1,3 months). 
Member Base 
The scheme caters for 64 000 members and is independently 
administered by Northern Medical Administrators which was acquired 
by Healthcare Management Services, a subsidiary of South African 
Druggist, in 1997. 
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SAKAV MEDIESE HELP FONDS 
Company Profile 
SAKA V was established in 1942 to provide health care for co-
operatives in the Cape Province. The scheme expanded into other 
regions and by 1992 it had managed to capture approximately 95 
percent of the co-operative market on a national scale. SAKA V 
further expanded operations in 1993 by entering the open market. 
Range of Services 
As much as 50 percent of the member base are on a savings plan. The 
group includes a co-payment on claims, which range from 10 percent 
to 30 percent, dependants on the scheme also represented. SAKA V 
outsources its hospital utilization management to Qualsa. The group 
does not have a preferred provider network. 
The group still has a long way to go in implementing managed care; 
practitioner health care delivery is still checked retrospectively but the 
group is starting to compile practice profiling. The group has limited 
disease protocols and is still investigating drug formularies. 
Financial Peiformance 
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Despite moderate growth (of 7,5 percent) in both premium income 
and claims paid, SAKA V's incurred loss ratio declined to 100 percent, 
following a R3m transfer to reserves. Accordingly, the underwriting 
loss increased to R6m (1995:R4m loss), notwithstanding the fact that 
the scheme reflects one of the lowest delivery cost ratios, of only 4 
percent of net premium income. 
SAKA V was unable to significantly augment its members' surplus, due 
to the much lower than average contribution increases levied on 
members during the year. This resulted in a relatively static solvency 
margin and financial base ratios of 22 percent and 32 percent 
respectively. Cash flow was also hampered and the retained cash flow 
to claims paid ratio reduced to 5,4 percent (1995 :8,2 percent). Cash 
coverage sits at 2,8 months cover (Duff & Phelps 1997:50). 
Member Base 
The membership base has grown steadily over the past few years, and 
currently caters for 29 827 members and a further 47 733 dependants. 
The scheme operates predominantly in the Western Cape region. 
SOUTHERN HEALTHCARE JV 
Company Profile 
Southern HealthCare N (SHC) were the first to launch managed care 
products in January 1997. To date they have seen the largest 
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investment of all the managed care companies (Heymans 1997:27). 
The group was formed out of a venture with Anglo American, 
Southern and United Healthcare (one of the largest managed care 
providers in the United States of America) and employs 700 people. 
The association with United Healthcare provides access to expertise 
and patient information. 
SHC being the first managed care player in the South African market 
faced grievous teething problems but is now the furthermost up the 
learning curve. 
Via its association with United Healthcare, SHC has attempted to 
transplant American information systems and procedures into the local 
environment. The information systems were some of the most 
expensive in the market and required considerable adaptation. Initial 
attempts to create a network of service providers met with 
considerable resistance and relationships between SHC and the 
medical fraternity were strained. 
• SHC initially signed preferred provider agreements with a 
limited number of hospitals. After examining a number of 
issues, including pressure from Competition Board, SHC 
opened its network to all hospitals willing to sign and abide by 
the SHC terms. 
• Medical practitioners have been threatening to resign from the 
supplier network because of late payments. 
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• Service providers have experienced difficulty complying with 
lCD I 0 and CTP4 coding systems, which SHC was the first to 
introduce. 
Range of Services 
Networking: Southern Health's provider network is more than 4000 
providers - including general practitioners and specialists. It is 
negotiating with others and expects to have close on 6000 providers in 
the Southern Healthcare Network by the end of 1998. It is important 
to note that Southern expects doctors on its network to play the role 
of gatekeeper and feed it patient information timeuosly. The groups 
hospital network is wide and incorporates 198 hospitals (a large 
proportion of the private hospital industry). 
SHC uses Medicredit aligned pharmacies for its pharmacy network. 
Southern effectively manages the patient through the health care 
system and they police protocols very closely. 
Capitation: SHC underwrites the healthcare risk of a specific product 
as the quoted rate for a period of 12 months. SHC has the capabilities 
to implement capitation agreements, but have chosen not to do so at 
this stage as they focus instead on strengthening its database. It is in 
the process of analysing data captured since January 1998. 
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Financial Performance 
Southern Health is a scheme established in 1990 and administers by 
SHC. Premium income for the year ending December 1996 increased 
by 32 percent. Claims paid for the year increased by 22 percent. The 
net premium income ratio improved to 80 percent (1995:90 percent). 
Delivery costs were kept low and thus delivery costs as a percentage 
of gross premium income decreased to 7,7 percent (1995: 11,9 
percent). Key financial ratios strengthened further during 1996 as a 
result of a much improved bottom line surplus. Solvency stood at 44 
percent (1995:32 percent) and the cash coverage ratio improved to 8,7 
months cover (1995: 5,7 months). Southern Health demonstrates a 
strong cash flow position, as indicated by a retained cash flow: claims 
paid ratio of 34 percent, which is one of the strongest in the industry 
(Duff & Phelps Credit Rating Co. 1997: 54). 
Member base 
Southern have 110 000 beneficiaries on managed care at present and 
targets to double this figure in 1998. There are an additional 150 000 
lives under administration which also utilise modules of managed care. 
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OTHER MANAGED CARE OPERATORS OUTSIDE SAMPLE 
For the purpose of comparison, herewith an overview of managed 
healthcare players in the South African environment. 
SANLAM HEALTH 
Company profile 
Sanlam has invested much capital in exploring and initiating managed 
healthcare. As one of the forerunners in developing this concept in 
South Africa it emerged with what appears to be irreparable scars. The 
group typically targets the private medical aid market but has 
broadened its product range to include the lower end of the market. 
In July 1997, Sanlam and Vuna Health Care, a subsidiary of Thebe 
Investments, formed a joint venture company called South African 
Health Alliance (SARA). SARA will target the lower end of the 
market, typically those in formal employment but not on medical 
cover. 
After expenencmg a lot of resistance to its aggressive managed 
healthcare proposals, Sanlam has made a real effort to improve its 
provider relationships: 
• Sanlam Health was the first company to introduce a 
professional fee that was acceptable to the pharmacies (Rl8,33 
per item). An agreement in this regard was signed with United 
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South African Pharmacies (USAP), consisting of 1200 
pharmacies, 
• After an appeal from certain hospitals, reimbursement 
agreements for 1998 have been renegotiated on more 
favourable terms; 
• Together with the South African Managed Care coalition, 
Sanlam Health has launched a public company called African 
Health Synergies (Pty) Ltd that will operate as an independent, 
self-regulated network of service providers. Sanlam invested 
R2m in this venture and a further R1 ,2m has been supplied as 
loan capital. 
Range of Services 
Sanlam Health manages hospital and pharmaceutical utilization with 
the use of pre-authorisation, on-line case management, a nurse-line 
and claims auditing. At the last count Sanlam Health reported a 20 
percent savings on bed days per 1000 members that it manages. 
A preventative initiative was to be launched in January 1999 with a 
maternity and mammography programme for beneficiaries on the 
Sanmed scheme. 
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A fraud unit was introduced in 1997. This division has made 
significant strides in identifying fraud by providers and members 
(Sunday Times Business Times 1998:6). 
San1am's provider network includes 108 hospitals m the nine 
provinces, reimbursed on a per diem basis. 
DISCOVERY HEALTH 
Company profile 
Discovery Health was founded in 1992. The decision to launch a 
medical insurance product in 1994 has resulted in enormous growth 
for Discovery, previously called Momentum Health. Premium income 
rose from RlOm in 1994 toR331m in the financial year ending June 
1997. Although growing at such a high rate, administration systems 
coped and solvency remained intact as a result of sound underwriting 
principles. Discovery now enjoys a dominant position in the new 
generation health insurance market. 
Although Discovery Health is investigating the lower end of the 
market, its primary focus is the Upper B income group. The pricing of 
its products make this an attractive option for the young and healthy, 
although they have recently introduced a scheme to meet post-
retirement medical scheme requirements. 
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Range of Services 
Discovery's managed care activities primarily cover hospital utilization 
and have signed provider agreements with hospitals. They have 33 
full-time nurses that handle on-line case management for hospital 
admissions and management of their maternity programme. The 
distribution of acute and chronic medicines has been outsourced to 
Medicredit and Direct Medicines. Retrospective reviews of hospital 
utilization are managed in-house. 
Discovery has developed its own clinical systems to investigate 
appropriateness of treatment and facilitate data warehousing to allow 
peer review of service providers. Discovery's plans were to introduce a 
nurseling in January 1998 to support the clinical department. 
Future plans include the introduction of clinical guidelines, disease 
management programmes and dental benefit management. 
Member Base 
Discovery has 200 000 lives on its savings plan and an estimated 500 
000 lives m total. 
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FED SURE HEALTH 
Company Profile 
Fedhealth, employing 600 people, has shown exceptional growth in 
the past three years with its savings accounts offering much attraction. 
Fedhealth is making a big drive into the market with its recent 
acquisition of a 30 percent stake in South African Druggist and 
majority stake in Norwich (holding company of D&E). Further 
acquisitions in the course of 1998 could see the group's member base 
exceeding 500 000 principal lives. 
Fedhealth plans to target the emerging blue-collar market. The group 
is designing a user-friendly lower end of the market products that will 
be supported by sophisticated identification technologies. 
Range of Services 
Fedhealth has a medical savmgs scheme product in which 
hospitalisation and chronic diseases are managed. The management of 
hospital utilization has been outsourced to MX Health. This 
relationship is being revised given the groups strategy to acquire HMS 
and its component parts. 
If the aforementioned acquisition is successful we could expect the 
group to explore more comprehensive managed care products, such as 
capitation of GP services, in future. The group should then have a 
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comprehensive hospital network i.e. owns 25 percent of Netcare, and 
a comprehensive primary care network with GPNet and Medicross. 
Member Base 
Fedsure Health has close to 350 000 members (i.e. Fedhealth 110 000, 
D&E 110 000, NMA 110 000). Fedhealth's principal members are 
growing at 40 percent per annum. 
MEDSCHEME MANAGED HEALTHCARE (MMH) 
Company Profile 
Medscheme are the largest medical administrators in South Africa with 
2 million lives under administration, this is almost a third of the private 
medical aid market. MMH's strategic direction appears to be driven by 
the need to capitalize on their large patient base. 
Access to this large patient base offers significant advantages: 
• Patient information: A long track record in claims 
administration has enabled Medscheme to accumulate an 
extensive database of pharmaceutical and hospital usage 
according to diagnostic and procedure codes. This data was 
used to publish minimum quality criteria for chronic medicine 
prescribing, which was accepted by the South African 
Managed Care Coalition (SAMCC). 
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• Bargaining power: The sheer size of Medscheme allows them 
to negotiate discounts with service providers. So far, 
Medscheme has provider arrangements with 150 hospitals and 
over 300 doctors. Currently PBM is negotiating preferential 
medicine priced with dispensing doctors and pharmacists. 
• Competitive pricing of services. Increased bargaining power 
will assist Medscheme to lower its cost base and provide 
competitively priced services as it moves from discount-based 
arrangements to risk-sharing with providers. 
Range of Services 
Medscheme was historically labelled as a "traditional" medical aid, but 
it has more recently become more aggressive, offering new generation 
options such as savings account and managed healthcare alternatives. 
Medscheme believes it has the widest range of managed care products 
available, all of which utilize their integrated databases. 
Its product offering includes: 
• Hospital benefit management, supported by a contracted network 
of hospitals; 
• Clinical advisory services; 
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• A disease management programme, for addressing Aids , among 
other; 
• A dental benefit management programme; 
• An optical benefit management programme; 
• Chronic medication benefit management; 
• MedBenefit - a programme to incentivise a healthy lifestyle; 
• Member and general practitioner profiling services; 
• Two integrated managed care projects involving pnmary care 
practitioners who co-ordinate patient referrals to contracted 
hospitals. 
Their pharmaceutical utilization management capabilities, through 
PBM Pty Ltd, are of the best in the industry. PBM was the first 
company to launch a chronic medicine programme after which it 
developed a utilization management system to monitor acute 
medication. PBM provides pharmaceutical utilization services for 
1,8m lives, 70 percent of these being Medscheme members. Its 
activities include pre-authorisation, profiling of scripts, negotiating 
discounts, retrospective reviews and clinical interventions with regards 
to appropriateness and generic substitution. 
In conjunction with MMH, PBM will manage chronic diseases such as 
diabetes, asthma, peptic ulcers and coronary artery disease. They are 
in the process of launching an HIV I Aids management programme. 
MMH and PBM have successfully launched an integrated managed 
care programme for 10 000 lives. Features include risk sharing with 
219 
doctors and contracted hospitals, a drug formulary, hospital case 
management and joint clinical case management between MMH and 
PBM. This integrated programme has been kept to a small scale and is 
the start 'of MMH's move towards the underwriting of healthcare 
costs. 
The group offers hospital benefits management through Hospi-Serve. 
The programme was launched in 1996 and by the end of 1997 Hospi-
Serve had enrolled 16 medical schemes, covering more than 1, 1 
million lives. Hospi-Serve has 38 managed care staff in Johannesburg, 
Cape Town and Durban, supported by a head office team comprising 
two doctors, a project manager, a systems analyst, a coding co-
ordinator and a researcher. 
Hospital Network: Mr Reg Magennis, Managing Director of 
Medscheme's Managed Care Division, says the Hospital Network 
involved contractual relationships between his company and 152 
hospitals operated by Apex and National Hospital Network. The 
hospitals have agreed to fixed fee tariffs and discounts for members of 
schemes administered. 
"We are starting a transition from a dictatorial approach to a co-
operative approach," says Mr Magennis. " We are moving towards 
risk- sharing. We are re-engineering incentives in the market place to 
ensure that hospitals receive better services for their own 
efficiencies. "(Outcomes 1998:2). 
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Member Base 
By virtue of the 2 million strong patient base, MMH will be a strong 
contender in the managed care arena. Like other medical schemes, 
Medscheme lost beneficiaries with the emergence of the new 
generation schemes from Momentum and Fedsure Health. Defensive 
measures were taken and products and marketing strategies re-
engineered. 
Medscheme's membership levels were recently restored when 
Medscheme took on the administration of Palmed. Medscheme 
administers medical schemes from a wide range of income groups, 
including the low-end schemes like Bonitas and Sizwe Medical. 
GALAXY HEALTHCARE SOUTH AFRICA 
Company Profile 
Galaxy is a 44 percent subsidiary of the insurance group Hollard. The 
other 56 percent is held by Universal Healthcare. Galaxy Healthcare is 
a new entrant in the managed care market and started operations in 
January 1998 when it assumed management of Telkom's medical 
scheme, Telemed. The contract for the management of Telemed's 90 
000 beneficiaries was won after it was put out for tender of which 22 
contenders bid. 
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Galaxy's role is one of re-engineering the medical schemes based on 
managed care principals. Galaxy does not charge a fee for its service 
but rather shares in any savings generated as a result of its systems. 
Galaxy has aligned itself with short-term insurer Universal Health care. 
Galaxy will manage the risk that Universal assumes when msunng 
medical schemes. 
Range of Services 
Galaxy implements a full managed care software package and facilitate 
other healthcare requirements like risk insurance agreements with 
service providers. 
Member Base 
The contract started with 90 000 members and a further 50 000 lives 
was to be added during the first part of 1998. 
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HEALTHCARE MANAGEMENT SERVICES (HMS) 
Company Profile 
Health care Management Services (HMS) is 100 percent owned by 
pharmaceutical giant South African Druggist. HMS took a different 
approach to many in its entree into the medical market. It bought out 
carefully targeted businesses with substantial track records in 
complementary medical fields. The group thus avoided most of the 
teething problems. This unique approach brought into the HMS orbit 
all the components of a highly professional managed care service. 
Within the HMS stable one will find: 
• Managed Care : (a) MSO - administrator (b) Mediscor 
pharmaceutical utilization (c) Dentmate - dental programme; 
• Northern Medical Administrators 
• Medicross- 32 clinics countrywide, housing general practitioner 
serVIces, pharmacy, dentist, radiology, optometry and 
physiotherapy. 
• Service providers - (a) GPnet - network of doctors (b) Link -
pharmacy franchise (c) Ampath - pathology services. 
• Professional Services 
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HMS has a fairly extensive provider network, via their ownership of 
healthcare providers Medicross, Ampath and Link franchise. Unlike 
other managed care companies they have negotiated discounts for 
volumes. HMS has to date no agreements with hospital networks. Yet, 
co-parent Fedsure with a 30 percent stake in SA Druggist has a similar 
stake in the Netcare group of hospitals, which would render a 
relationship feasible. 
Hospital admissions are managed on a case by case basis and cost 
saving measures are being implemented. HMS has proven savings of 
20 percent on hospital costs for the Malkor medical scheme. 
Range of Services 
HMS is primarily involved with hospital utilization management, 
management of specialist referrals and procedures and dental 
utilization. Tools employed to do this include, pre-authorisation, case 
management of hospital admissions and chronic beneficiaries, peer 
review/profiling of service providers, claims auditing and clinical 
intervention with the use of in-house developed protocols. 
Case management is conducted by nurses and doctors in GPnet and 
Medicross. Disease management programmes, which are still at an 
early stage, including diabetes and hypertension. Other high cost areas 
such as maternity and radiology are also monitored. 
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.J 
HMS will assume risk. Besides a primary care capitation product 
being offered through Medicross, HMS will assume the full risk of the 
total healthcare cost of a medical aid. No agreements have yet been 
signed in this regard. 
As far as managing pharmaceutical benefits is concerned, HMS, owns 
Mediscor Pharmacy Benefits Management System (PBM). The 
retrospective nature of claims processing currently utilised by Clearing 
houses in South Africa were not designed to cope with the increasing 
demands for sophistication required to introduce managed care 
principles. 
Limitations of the current prescription claims processing systems are: 
• Increased financial risk at the service provider levels due to 
exceeded benefits and rejections; 
• Regression of service provider payment periods; 
• Inability at administrator level to effectively implement managed 
care tools; 
• Loss of potential medicine rebate income at medical scheme level; 
• Inability to implement formularies and conduct concurrent 
utilization reviews; 
• Lack of. ability to customise and accurately budget medicine 
benefits; 
• Escalation of paper mountains. 
As a result of the aforementioned limitations Mediscor is introducing a 
fully integrated on-line transaction processing point of sale pharmacy 
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benefit system i.e. PBM. The new fourth generation Mediscor PBM 
acquired from a United States supplier will become operational during 
the third quarter of 1998. 
The role of a PBM is to offer a range of organisation activities 
designed to influence the behaviour of physicians, pharmacists, and 
patients, in order to facilitate the best quality of pharmaceutical 
utilization and care, at the lowest possible cost. 
PBM's benefits to medical schemes: 
• Centralized control of medicines benefit utilization 
• Effective control of medicine costs 
• Appropriate medicine benefit design 
• On-line claims adjudication and drug utilization review 
• Prior authorisation for chronic conditions 
• Cost-effective drug formulary management 
• Deductible, co-payment or co-insurance levy management 
• Financial, utilization and management reporting 
• Accurate medicine benefit budgeting 
Member Base 
The acquisition of NMA in November 1996 gave HMS access to a 
patient base of 500 000 lives. This base has remained constant since 
but a cautionary announcement put out by both parent companies i.e. 
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SA Druggist and Fedsure allows one to speculate that a fundamental 
change is lurking. 
Through Mediscor, HMS has access to 1,2 million lives i.e. nearly 20 
percent of the covered population. The management of drug utilization 
of about 420 000 ofthese lives will commence in 1998. D&E is one of 
Mediscor's largest clients for claims processing. 
QA CARE- HOSPITAL UTILIZATION MANAGEMENT 
Company Profile 
Hospital utilization Management Company QA Care focuses 
exclusively on the hospital related aspect of managed healthcare. 
With a staff of 60 people - including qualified medicaVnursing 
personnel supported by sophisticated computer systems - QA Care 
authorises admissions and manages at least 250 hospital admissions a 
day through its offices in Randburg, Cape Town, Port Elizabeth, 
Durban and Pretoria. Between them, these offices support a national 
network of case managers who cover every hospital. 
QA Care says due to hospital cost reductions, without sacrificing 
quality, one of its medical scheme clients had its latest member annual 
subscription increased to 12 percent compared with a national average 
of 25 percent to 30 percent. 
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Range of Services 
The overall objectives of QA Care are attained as follows: 
• Continuously gathers and interprets data in order to improve on 
the services offered to members and their medical schemes; 
• Applies clinical protocols to assess necessity and appropriateness 
of care/hospitalisation which have been developed in collaboration 
with specialist bodies; 
• Conducts concurrent reviews in order to formulate and implement 
a case management plan; 
• Negotiates with service providers m order to determine 
appropriate facilities; 
• Conducts prospective reviews, m order to ascertain which 
members require education on their condition and assistance with 
discharge planning; 
• Conducts retrospective reVIews m order to compare the 
authorisation and case management notes with the amount billed; 
• Source- and- promote the use of out of hospital services; 
• Utilises and promotes the use of resources within the community; 
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• Provides comprehensive reports on utilization, costs and clinical 
effectiveness of tertiary medical services. 
Member base 
The scheme covers over 100 000 members, with D&E as the largest 
client. 
QUALSA 
Company Profile 
The group is 70 percent owned by management and 30 percent 
owned by Hollandia Re-insurance Group. Qualsa has positioned itself 
as a hospital utilization management company servicing the needs of 
the private medical aid industry. It charges a fixed fee per member per 
month and has not entered into any risk taking or sharing agreements 
with funders or providers. Yet in a short period of time Qualsa has 
demonstrated significant savings for the scherries they manage. 
Qualsa plans to remain a specialist hospital utilization management 
company and does not foresee any changes to its strategy in the very 
near future (Heymans 1997: 24). 
Range of Services 
229 
Not dissimilar to QA Care, Qualsa conducts pre-authorisation, on-site 
and telephonic case management, concurrent review and claims 
auditing. It also covers the management of the following diseases: 
diabetes, hypertension, asthma and rheumatic illnesses. They also offer 
a case management service to psychiatric, transplant patients and 
stereotactic surgery (an expensive out-of-hospital procedure) patients. 
Qualsa employs in-house guidelines but does not intervene with the 
clinical judgement of the physician. 
After 16 months of operation, Qualsa has demonstrated the following 
cost savings: 7 percent on admission management; 20 percent to 40 
percent on medical and surgical case management; 35 percent on peri-
natal management; 30 percent on mental health management and 30 
percent on claims auditing. 
Member Base 
Qualsa has shown rapid growth since its launch in October 1996 and 
presently conducts hospital utilization for 400 000 lives. 
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NORWICH HEALTH 
Company Profile 
The recent entry ofNorwich into the managed care arena was a logical 
move for Norwich Holdings which owns the second largest medical 
aid administrator, Davinson & Ewing (D&E). Norwich Health's late 
entry into the market leaves them with some catching up to do, but has 
probably allowed them to learn from some of the expensive mistakes 
made by their competitors. 
Range of Services 
Hospital and pharmaceutical utilization management will be 
outsourced initially, the former currently sits with QA Care. They plan 
to bring these functions in-house relatively soon especially with 
Fedsure Holdings recent acquisitions ofNorwich Holdings. 
Norwich has signed provider agreements with a number of IPS' and 
has approximately 4000 doctors in its network. Hospital agreements 
have been signed with National Hospital Network and Netcare. 
Member Base 
Norwich Health has access to D&E's 450 000 patient base. They will 
start operations with approximately 40 000 lives under management. 
They target to have 100 000 lives on managed care plans by February 
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1999. Norwich is likely to establish itself as a dominant player in 
specific geographic areas where D&E has a strong presence. The 
Eastern Cape is a traditional stronghold. 
MEDIMO 
Medimo is no longer in practice but deserves a mention, given its early 
foray into the offering of capitation products, for the purpose of 
illustration. 
Company Profile 
Medimo was a joint venture established by Afrox Health and Medi-
Clinic. After six years of operation, Medimo had been slow in 
generating returns and its markets are being threatened by new 
entrants. This lead to the holding companies closing down the 
operation in 1998. 
Medimo's approach to managed care was VIa the primary care 
physician network. Medimo monitored costs and quality by facilitating 
peer reviews regulated by the doctors themselves. The approach was 
well received by the doctors and they had signed agreements with 80 
percent of all practising GP's in South Africa. 
Recently Medimo ran into trouble and incurred substantial losses when 
assuming risk on a capitation product for the Mines Benefit Society. 
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Range of Services 
Medimo offered hospital benefit management via a pre-authorisation 
and claims auditing process. Other services offered by Medimo 
included the management of radiology, pathology utilization and high-
cost chronic disease including asthma, cholesterol, diabetes, 
addictions, rheumatic and cardiovascular diseases. They also group 
offered capitation products. 
Information systems 
All software and systems were home-grown and were able to 
accommodate a wide range of managed care servic~s and the general 
coding categories but claims processing systems appeared to be less 
than adequate. 
Member Base 
Although one of the first to enter the managed care arena six years 
ago, Medimo's patient base remained relatively small. It had a base of 
140 000 lives from 17 medical aids, the larger of these being Esmed 
with 60 000 beneficiaries. The base was too small to be economically 
viable. 
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APPENDIX 1 
MEDICAL AIDS POPULATION, 1997 
Allacare Medical Aid PO Box 2650 011-807-1490 
Scheme Rivonia 
2128 
Alliance Medical Benefit PO Box 2004 011-329-0500 
Society Rand burg 
2125 
Beland Medical Aid Box 974 011-490-2400 
South dale 
2135 
Bestmed Medical PO Box 2297 012-326-9111 
Fund Pretoria 
0001 
Bonitas Medical Fund PO Box 2020 011-329-0500 
Rand burg 
2125 
Caremed PO Box 90 021-509-9111 
Howard Place 
7450 
Cape Medical Plan PO Box 966 021-937-8300 
Parow 
7499 
Commercial & PO Box 82540 011-490-2400 
Industrial Medical Southdale 
Aid Society 2135 
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(CIMAS) 
Compcare Medical Scheme Pr Bag X42 011-807-4610 
Rivonia 
2128 
CU Health Medical Scheme PO Box 75405 011-453-8910 
Garden View 
2047 
Docmed Medical Scheme PO Box 16332 0 12-664-1648 
Lyttleton 
0157 
East Coast Medical Plan PO Box 12052 041-551-873 
Centrahil 
6006 
Fedsure Health (FEDMED) PO Box 2916 011-239-8000 
Rand burg 
2125 
Ferrromed PO Box 40599 012-421-2000 
Arcadia 
0007 
Finmed Medical Scheme PO Box 2006 011-329-0300 
Rand burg 
2125 
Hosmed Medical Aid PO Box 4709 011-335-7335 
Scheme Johannesburg 
2000 
Lifemed Medical Scheme PO Box 1411 011-807-4610 
235 
Rivonia 
2128 
Malesela Medical Scheme PO Box45 021-947-9111 
Sanlamhof 
7532 
Meddent Medical Scheme PO Box 9153 021-407-3800 
Johannesburg 
2000 
Medical Expenses PO Box 10178 011-335-3555 
Distribution Society Johannesburg 
(MEDS) 2000 
Medical Service Plan Pr Bag X3011 011-329-0500 
Rand burg 
2125 
Medicover 2000 Pr Bag X20 011-622-6111 
Garden view 
Medihelp PO Box 26004 012-334-2000 
Arcadia 
0007 
Medimed Mediese Skema PO Box45 021-947-9111 
Sanlarnhof 
7532 
Medsure Medical Aid Pr Bag Xll 021-410-1488 
Roggebaai 
8012 
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Medshield Medical Scheme PO Box 9471 011-407-3800 
Johannesburg 
2000 
National Medical Plan PO Box 2388 031-366-5500 
Durban 
4000 
NBC Medical Aid Society PO Box 47125 011-880-1447 
Park:lands 
2121 
National Independent PO Box 1790 031-301-2791 
Medical Aid Society Durban 
(NIMAS) 4000 
Northern Medical Soeiety PrBagx6 011-497-8411 
Ex com 
2023 
Premier Medical Plan POBox 95 0431-21227 
East London 
5200 
Pretmed PO Box 3497 012-326-5673 
Pretoria 
0001 
Protea Medical Aid Society PO Box 6112 021-590-5398 
Roggebaai 
8012 
Regional Medial Aid PO Box 9308 011-332-7400 
Scheme Johannesburg 
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2000 
SAKAV Mediese Help PO Box 33 021-872-1437 
Fonds Hoofstraat 
7622 
Sanitas Medical Scheme PO Box 2825 031-304-2621 
Qual bert 
4078 
Selfined Mediese Skema PO Box45 021-947-8250 
Sanlarnhof 
7532 
Stability Medical Aid PO Box 5703 011-486-1702 
Society Johannesburg 2000 
Southern Health PO Box 10296 011-335-3260 
Johannesburg 2000 
Tafelberg Medical Aid PO Box 6175 021-592-4820 
Roggebaai 8012 
Topmed Mediese Skema PO Box45 021-94 7-8006 
Sanlarnhof7532 
Vaalmed Pr Bag 016-9330-001 
X020 
Vanderbijlpark 1900 
Visimed PO Box 567 051-409-0111 
Bloemfontein 9300 
Source: Medscheme 
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APPENDIX2 
INTERVIEW FRAMEWORK 
l.OGENERAL 
1.1 GENERAL INFORMATION ON THE COMPANY 
• Name of company? 
• Title of interviewee? 
• Number of members and beneficiaries on the scheme? 
1.2 BROAD RISK MANAGEMENT PRINCIPLES AND ISSUES PLAGUING 
THE HEALTH CARE INDUSTRY 
• Do you practice risk management? [;Nj 
• What type of professional would sit on the risk management committee? 
• Do you have set resources dedicates to risk management? [ I Nj 
2.2 RISK IDENTIFICATION 
• How do you identify risks? 
• How are risks pooled? 
[;Nj 
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•!• Income bracket; [Y I Nj 
•!• Gender; Health status; [Y I Nj 
•!• Geographies; IY IN) 
•!• Other 
• How do you assess future risks? 
2.3 RISK EVALUATION 
• Which tools are used? 
• To what use do you put collated data? 
2.4 RISK TREATMENT 
2.4. 1 Risk Control 
2.4.1.1 Do you apply the risk control technique of avoidance? I Y I ij 
2.4.1.2 Do you apply risk reduction through claims management? IY I ij 
2.4.2 Risk Financing 
2.4.2.1 Which remuneration system do you use? : 
•!• Fee-for-service; 
•!• Discounted fee-for-service; IY I N) 
•!• Global fee; IY I Nj 
·:· Per diem rates; IY I Nj 
•!• Diagnosed-related groups; ty I N) 
•!• Capitation; lY I Nj 
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2.4.1.2 Do you envisage a change in the remuneration system in future? 
[IN] 
2.4.1.3 How do you provide for costs: 
• Retention ~ INj 
• Reinsurance ~ I Nj 
• If risk retention is applied, do you: 
• Treat losses as a current expense ~ I Nj 
• Create reserves for loss liabilities ~ I Nj 
• Borrow the funds at the time of the loss ~ I Nj 
3.0 HEALTH CARE OPTIONS 
3.1 Co-payment plans 
3 .1.1 Have you implemented/explored co-payment plans? 
• Do you believe that co-payment: 
Reduces moral hazard 
[IN] 
[IN] (a) 
(b) Increases the consumer's sensitivity to the true cost of the care? [ I Nj 
3.2 Bonus and/or rebates options 
• Do you implement bonus or rebate options? [IN] 
• Do you payout a fixed rebate for no claims made during any one year ? 
[IN] 
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3.3 Savings Accounts 
• Do you offer the option of medical savings accounts? [IN] 
• What would you consider to be the positives or negatives to this structure? 
3.4 Case- management/utilization management? 
• Do you pursue case management? [IN] 
• Is this done I Internally I or I out sourced I ? 
• What is your definition of case management ? 
•:• Is each claim reviewed? [INj 
•:• Who reviews the claims? (list profession of the individual conducting 
the claims management) 
•:• Are the information technology systems sufficient to capture claims 
patterns and communicate with doctors and monitor provision of care? 
[INj 
•:• Are these claims patterns used to assess future risks? 
•:• Do you have protocols for each disease? 
•:• Do you work off a drug formulary? 
~ I Nj 
~ I Nj 
IY I Nj 
3.5 Do you currently implement or intend on implementing managed health care 
principles ? 
• What active steps towards managed health care has the organisation already 
taken example: 
•:• Pre-authorization ofhospitalisation, 
•:• Case management; 
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•!• Drug review 
•!• Quality of health delivery control; 
IY I Nl 
ty;Nj 
•!• Preferred provider status with any specific hospital network or doctor 
organisation? ty;Nj 
• What are the barriers to implementation of managed health care? 
Availability and reliability of data 
•!• Doctor participation as gatekeeper 
•!• Information systems across the entire health continuum 
• If you were to rank the five alternatives above in terms of the better risk 
management strategy, how would they rank? 
•!• Co- Insurance , ____________________________________ _ 
•!• Bonus & rebates 
-----------------------------------
•!• Claims management _____________________ _ 
•!• Savings Accounts:__ _______________ _ 
•!• Managed health care, _____________________ _ 
• Do you have any data on the outcome of implemented programmes? 
4. 0 Draft policy on financing of health care in South Africa 
• How will the pending legislation, with respect to community rating, impact 
the industry at large, and its ability to manage risk? 
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CHAPTER 8: RESULTS AND DISCUSSION OF RESULTS 
This chapter covers the exploratory work, more specifically the 
results of the study on the sample population. The results of the 
study are then briefly compared to the views held by the managed 
care population and a conclusion is drawn on each result. 
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I 
2 
3 
4 
5 
6 
7 
8.1 RESULTS 
8.1.1 GENERAL INFORMATION ON THE COMPANY 
"Name of company?; Title of interviewee? Number of members and 
beneficiaries on the scheme?" 29 
(a) Schemes contacted as part of sample survey 
Table 8.1.1 :General information on each medical scheme 
COMPANY INTER VIE WE TITLE MEMBERS BENEFICIARIE 
E 1998 s 1998 
Bonitas Medical Bafana Nkosi Managing 185 000 740 000 
Fund Director 
Commercial Union Steve Navis Managing I 600 3 520 
Director 
FinMed Medical Eric Wilson MD Medscheme 18 236 40 119 
Schemes Managed Care 
Medical Expenses Rob Leonardi Chief Operating 5 645 8 836 
Distribution Society Officer 
Northern Medical JeffSloame Managing 64 000 110 000 
Society Director 
SAKAV Mediese Leon Laubsher Managing 29 827 77 560 
Fonds Director 
Southern Health Graham Chief Executive 50 000 110 000 
Anderson Officer 
TOTAL 354 308 I 090 035 
As Table 8.1.1 illustrates the sample population, including both 
members as well as beneficiaries) accounts for 1,5 million, or 
29 Summary of the questions in Appendix 7 .I 
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22,3 percent, ofthe 6,7 million covered lives in the country. The 
individuals interviewed all held senior positions i.e. five 
managing directors and two chief executive officers. It is a fair 
assumption that individuals holding such senior positions within 
a firm would play a pivotal role in the organisations strategy on 
risk management. 
(b) Managed health care participants 
Table 8.1.2: Number of covered lives under each medical 
h "th d sc erne WI a manage care programme 
COMPANY LIVES/BENEFICIARIES 
Sanlam Health 600 000 
Momentum Health 200 000 
Fedsure Health 110 000 
Medscheme Managed Healthcare 1 100 0000 
Galaxy Healthcare 200 000 
Healthcare Management Services 500 000 
QA Care 100 000 
Qual sa 400 000 
Norwich 40 000 
TOTAL 3 250 000 
All of the managed care players featured in the table above 
are medical funders with exception of QA Care and Qualsa 
who manage third party hospital utilization. 
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The sum of the two groups i.e. sample population plus 
managed care population, even though there are some 
overlays for example with Bonitas and Medscheme, 
essentially dominate the medical aid population in South 
Africa, and are hence clearly representative of the 
population. 
8.2.2 BROAD RISK MANAGEMENT PRINCIPLES 
• "Do you practice risk management? 
• What type of professional would sit on the risk management committee? 
• Do you have set resources dedicated to risk management?" 
(a) Schemes contacted as part of sample survey 
All of the schemes responded positively to the first 
question of practising risk management in so far as risk 
identification, evaluation and risk financing is concerned. 
On the question of who sits on the risk committee, 2 out 
of the 7 sample companies had health professional on their 
committee and only these two recalled setting aside 
resources for risk management. The other 5 did not have 
health care representatives on their risk committees. 
(b) Managed Healthcare participants 
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The essence of managed care is one of a broader 
application of risk management techniques. Managed care 
players differentiate themselves from the sample 
population in their broader application of risk treatment 
techniques. 
On the issue of risk management committees, it appears 
that the managed care players have a plethora of nursing 
skills but only a minority have general practitioners or 
specialist on-board. Many, however, state that they can tap 
into such resource when necessary. 
(c) Additional views emanating from interviewees30 
1. Rob Leonardi, chief operating officer of Southern 
Healthcare expresses the fact that medical aids in this 
country have differed from classic insurers as a direct 
result of the Medical Schemes Act of 1967, whose 
underlying assumptions and restriction inhibited the 
interventionist role of Medical Schemes. There were, 
however, certain fundamental principles that underpinned 
this Act: 
• The Act assumed that the number incoming younger 
members would equate to outgoing older members; 
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• The conventional insurers would not be allowed to 
compete in medical funding, which has not been the 
case since the amendments to the Act in 1989 and 
1993 and with the resulting advent of new generation 
schemes. 
• That utilization rates would remain constant. Yet due 
to advancing technology, changing practitioner 
profiles and changed consumer expectations, this is 
no longer the case. 
(d) Discussion ofresults 
Even though the interviewees answered positively io implementing risk 
management, it was clear that the extent of risk management practised 
was questionable. It was apparent that most peoples' views on the 
definition of risk management encompassed only risk identification and 
risk financing. Risk evaluation and risk treatment were often sorely 
lacking. This difference of definition distorts the view given when 
1 00% of interviews affirm they practice risk management. 
Barring in mind that the legislative environment, with its guaranteed 
payments and prescribed minimum benefits, often denied the industry 
the opportunity to apply risk management in its more comprehensive 
form as explored in Chapter 3. 
30 Any additional views expressed by the interviewee will be elaborated under this heading. 
Where views are considered controversial the speaker will not be identified but different 
speakers will be distinguished from one another by the comment numberings. 
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8.1.3 RISK IDENTIFICATION 
• "How do you identifY risks? 
• How are risks pooled? 
• How do you assess future risks?" 
(a) Schemes contacted as part of sample survey 
Six out of the seven sample companies still identify risks 
based on what is termed "conventional income tables", 
where individuals are risk rated based on their respective 
income brackets. A medical scheme would they then apply 
the practice of risk pooling. After forming risk pools, 86% 
of the sample population, community rate based on the 
outcomes of a checklise 1, with claims history identified as 
playing an important role in risk identification by all 
sampled members. 
Four of the seven sampled msurers have started 
identifying risk based on age tables and number of 
dependants as opposed to the conventional income tables. 
Only one of the schemes have started using tools such as 
disease management and preventative care programmes 
as a means of assessing future risks. This particular 
31 Refer to Chapter 2, paragraph 2.3.2.1 for more detail on "checklists". 
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scheme has also invested heavily on information 
technology systems and is mining data to identify trends 
that could result in future risks. 
(b) Managed Healthcare participants 
The tools used to identify risks were not dissimilar to that 
expanded on by the sample population. However 
increasingly more emphasis is being placed on the ability to 
collate material data with the aid of information technology 
in order to apply tools to better assess future risks. 
(c) Additional views emanating from interviews 
1) Savings accounts cherry picked the better risks, as a 
result of this, younger healthier people have opted out 
of traditional schemes, in favour of the cheaper 
savings accounts, eroding cross-subsidisation within 
traditional schemes which has arguably lead to the 
financial demise of certain medical aids. 
2) Adrian Gore (Discovery Health): Gore's view is that it 
will become increasingly difficult to marry the 
legislative requirements of community ratings and 
open enrollment with risk management. Yet it is only 
with more refined risk management tools that medical 
schemes can ensure their survival in future. 
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(d) Discussion of results 
The conventional method of risk pooling based on income 
tables, followed by a community rating founded primarily 
on claims history, can barely be termed "risk identification. 
An individual's income bracket is not reflective of the 
underlying risk. Yet as much as 86 percent of the sample 
still rate this method as their primary risk identification tool. 
One could go so far as to say that historically medical 
schemes have not identified risks. Risk pooling is merely a 
form of diversification to ensure a more predictable 
outcome. Having said that 57 percent of the sample did say 
that the medical scheme the represented had or were in the 
process of launching products that identifying risks based 
on age tables and number of dependants, referring more 
specifically to medical savings accounts. 
On the question of assessing future risks, the medical aid 
industry in South Africa still has a long road ahead. 
8.1.4 RISK EVALUATION 
• "Which tools are used to evaluate risks? 
• To what use do you put collated data?" 
(a) Schemes contacted as part of sample survey 
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After pooling risk groups, the community rating is based on 
(a) the groups size and (b) historic claim experience. 
Medical funders would then underwrite the risk. It has only 
been in the past few years that the new generation schemes 
i.e. 4 out ofthe 7, have started to assimilate claims patterns 
data. 
Graph 8.1 : Data Collation and Analysis 
C Collated data used to 
evaluate risks (14%) 
• Collated Data still not 
actively used (86%) 
As reflected in graph 8.1, only 14% of interviewees 
responded positively to actively using claims pattern data to 
evaluate future risks. 
(b) Managed Healthcare participants 
The managed care population is investing significantly in 
information technology. Examples of investment in IT by 
medical funders include: 
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• Healthcare Management Services has, together with 
IBM, implemented a general benefit management 
system. They have invested in state of the art equipment 
and improved pharmaceutical utilization management 
software. Some of the key features include on-line 
adjudication of prescription, connection to doctors and 
paperless processing. 
• Medscheme has traditionally run old, unsophisticated 
claims processing systems. The transformation process 
has been expensive and challenging. The group has 
made significant investment in IT systems, it is now at a 
stage where the systems are able to support a fully 
integrated managed healthcare service. The claims 
administration, pharmaceuticaVhospital utilization and 
disease management operations are all linked and able 
to communicate. 
• Norwich has sourced IT both locally and internationally 
at an estimated budget of R20 million (Heymans 
1997:22). 
• Sanlam spent substantial amounts on local and 
international software but then struggled to integrate all 
the components of the system. The claims processing 
also proved to be inadequate and are being upgraded to 
cope with the workload. 
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These investments in information technology will result in 
the gathering of vital medical data which the industry needs 
to understand and evaluate future risk and manage the 
health delivery process. 
(c) Additional views emanating from interviews 
1. Graham Anderson, chief executive officer of Southern 
Health says: "Managing healthcare costs is all about 
information and we have diagnostic and procedural 
information which is telling a story. With this 
information, I believe we are going to be able to 
significantly influence the cost trends downwards over 
the next couple of years. We've analysed our 
information and are busy pinpointing areas of high cost 
utilization, such as low back pain, the caesarean 
section rate and the high cost of treating pneumonia. 
We are also getting information on disease, which is 
enabling us to implement our disease-management 
tools. We are also staring to collate invaluable 
information about the provider groups - and 
disseminating it to our provider groups so they can see 
how profiles compare to their peers. In addition, 
increased information about patients is enabling us to 
identify those patients that need closer management, so 
that we can implement these disease management tools 
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in treating patients who are incurring high costs as a 
result of mismanagement of their chronic situation". 
2. Reg Magennis, managmg director of Medscheme's 
Managed Care division says: "Our company makes a 
positive contribution towards enhancing the quality of 
care by monitoring care against best practice clinical 
norm developed from claims data." He believes that 
data and information are a critical success factor for 
managed care world-wide. Medscheme's data 
warehouse is South Africa's most extensive repository 
ofhealth-care claims and information 
(d) Discussion of results 
The information technology infrastructure across the 
health channels in South Africa is still inadequate to enable 
broader risk management strategies, as reflected in graph 
8.1.4 where only 14 percent ofthe sample population were 
actively using collate data to evaluate risks. A case in point 
is that of processing pharmaceutical prescription claims: 
South African clearing-houses are still using the very 
limiting retrospective claims processing. Mediscore 
Pharmaceutical Benefit Managers (a wholly owned 
subsidiary of SA Druggist) is in the process of introducing 
South Africa's first fully integrated on-line transaction 
processing point-of-sale pharmacy benefit system. Only 
once the system is fully operational will pharmacists and 
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medical aids be able to implement formularies and conduct 
concurrent utilization reviews. 
The study concluded that medical schemes in South Africa 
do not sufficiently evaluate risks. 
Medical aids are increasingly investing in IT systems, 
empowering them to better capture and then analyse 
occurrence data. These tools will enable medical schemes 
to better evaluate risks, empowering them to put in place 
the necessary risk control measures to ensure future 
viability. 
A significant differentiator between the managed 
healthcare population and the sample population is that the 
former has invested significantly m Information 
Technology (IT) in the recent years. The fruits of which 
will come from the collating and analysing of data with 
data warehousing tools. Information will empower the 
funders to understand, identify, analyse and control risks 
better. 
8.1.5 RISK TREATMENT 
8.1.5.1 Risk Control 
"Do you apply the risk control technique of avoidance? 
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Do you practice risk reduction through claims management?" 
(a) Schemes contacted as part of sample survey 
Historically medical aids have been loath to turn down 
applicants and would take on both the sick as well as the 
healthy and price premiums accordingly. The sample 
survey confirms this with not one scheme saying it 
practices risk avoidance. 
All of the sample schemes implemented cost control 
measures by way of claims management. Only 14 percent 
monitored quality too, the balance, 86%, did not give clear 
intention to follow a more comprehensive embrace of 
health care to the extent of actively monitoring quality of 
serVIce. 
(b) Managed Healthcare participants 
Similar to the sample this population too has not practiced 
risk avoidance. 
Each managed care player has progressed beyond the 
passive roll of retrospective claims management. Pre-
authorisation and increasingly clinical intervention i.e. case 
management or utilization management is helping the 
managed care players to control risks. 
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(c) Additional comments emanating from interviews 
The following comments emanate from one of the 
interviews: 
The Medical Scheme Act of 1967 inhibited cost controls 
historically by disallowing managed health and 
guaranteeing payments. Amendments to the Medical 
Schemes Act in 1989 and 1993 removed many legal 
obstacles to the development of managed health care in 
the private sector. In particular the guarantee of payments 
to providers has been removed, allowing schemes to refuse 
to pay for treatment deemed unnecessary. In addition, the 
amended Act gives freedom to medical scheme and 
insurers to create "limited" medical cover packages, 
replacing legislation which specified which benefits must 
be included. At the same time the South African Medical 
and Dental Council has removed previous prohibitions on 
collaboration between providers and insurers, thereby 
allowing the formation of managed health care schemes. 
(d) Discussion of results 
Claims management is the most common form of risk 
control. Given that claims management is retrospective in 
nature it very rarely empowered the medical aid to monitor 
or intervene m the hea1thcare delivery process. 
Retrospective reviews i.e. claims management, are no 
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longer sufficient in controlling risks. In order to identify 
potential future risks and control current risks better it is 
imperative that medical schemes become more proactive 
and invest more resources on how data capturing and 
mining. It is only with information that medical schemes 
can employ active pre-authorisation and case management. 
8.1.5.2 Risk Financing 
• "Which remuneration system do you use? 
• Do you envisage a change in the remuneration system in 
future? 
• How do you provide for costs: retention or reinsurance?" 
(a) Schemes contacted as part of sample survey 
Graph 8.2 : Modes of remuneration across the sample 
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recommended by the Registrar of Medical Schemes and 43 
percent of the sampled population took out reinsurance. 
(b) Managed Healthcare participants 
• These schemes should, by definition, make a more 
aggressive move towards risk sharing with health care 
providers, yet the spread of remuneration methods, 
from fee-for-service to capitation, is similar to that of 
the sample population. At the extreme of the spectrum 
would be capitation but this is still far off, even for 
managed care implementers, with perhaps the 
exception ofMedimo,32 the consequence ofwhich was 
liquidation. 
• As with the sample population, costs are 
predominantly addressed on a pay as you go basis out 
of reserves. 
c) Discussion of results 
It is becoming clear to the decision makers in the industry that applying 
fee-for-service as the main remuneration method does very little to aid 
the medical aid industry to manage risks. With fee-for-service all the 
claims are reviewed in retrospect with little scope for retribution. 
32 Refer to Chapter 7, company profile for more detail. 
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• As reflected in graph 8.2 fee-for-service, historically the 
more prevalent remuneration mode, still dominates with 
every scheme still catering for it. However all the 
interviewees envisaged a stronger move towards risk 
sharing with providers in future via either global fees, 
per diem rates (where 43% of the sample had started 
implementing these tools) or even capitation at the 
extreme (as reflected by the 14% penetration). 
On the question of providing for costs, the funding of risk 
seems quite similar across the board. Costs have been 
predominantly addressed on a pay-as-you go basis, out of 
reserves. Each medical aid having set reserves as 
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Increasingly schemes will look at more sophisticated modes of 
remuneration, which enable the medical aid to play a more value added 
role in health care delivery and will make service providers share more 
risk and become more accountable for the level of care they are 
delivering. 
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8.2 HEALTH CARE OPTIONS 
8.2.1 CO-INSURANCE PLANS? 
"Have you implemented/explored co-payment plans? 
Do you believe that co-payment: reduces moral hazard, 
increases the consumer's sensitivity to the true cost of the 
care?'' 
(a) Schemes contacted as part of sample survey 
Co-insurance schemes did not prove popular. Only one 
scheme included a 30 percent co-insurance on all products 
and another added a I 0 percent co-payment if the member 
used an out-of-network provider. 
100 percent ofthe schemes interviewed were ofthe opinion 
that co-insurance make the consumer more sensitive to 
health care costs but it was not ideally effective due to the 
fact that co-insurance is not paid at the point of service but 
rather billed at the end of the month. 
(b) Managed Healthcare participants 
Managed care players do not view co-insurance plans as 
vital in managing the health care process, which is about 
more than just cost savings. Yet one scheme, Southern 
Health, enforces a surcharge if members on the managed 
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care program do not refrain from drugs outside the 
formulary. 
(c) Additional views emanating from interviews 
Three of the interviewees expressed that co-msurance 
achieved, more than anything else, the goal of short-term 
cost savings. 
(d) Discussion of results 
Co-insurance is viewed as a short term, cost saving scheme. 
It does little in the way of controlling or managing risk. 
8.2.2 BONUS AND/OR REBATE OPTIONS 
"Do you implement bonus or rebate options?" 
(a) Schemes contacted as part of sample survey. 
Only one scheme interviewed offered a no-claim bonus. Yet 
the relative size of the bonus i.e. 0.4 percent of total claims 
paid rendered the bonus meaningless. 
(b) Managed Healthcare participants 
Bonus and rebates are uncommon in managed care. 
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(c) Additional views emanating from interviews 
1. Bafana Nkosi from Bonitas highlights that pending 
legislation will render this alternative null and void. As a 
result bonus options will in future play an even smaller role 
in the risk management process. 
(d) Discussion of results 
As with co-payment plans, bonus options were not viewed 
as vital in monitoring the appropriateness of long-term 
health care delivery. It is viewed as a short term, cost 
saving scheme. 
8.2.3 MEDICAL SAVINGS ACCOUNTS 
• "Do you offer the option of medical savings accounts? 
• What would you consider to be the positives or negatives to 
this structure?" 
(a) Schemes contacted as part of sample survey 
Of the population surveyed 71 percent offered medical 
savings accounts. The market for new generation funds, 
offering medical savings accounts, is estimated to be as 
large as the life assurance market, and growing at more 
than 25 percent per annum. 
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The second question on pros and cons IS addressed 
comprehensively under point (c): additional views 
emanating from the interviews. 
(b) Managed Healthcare participants 
The managed care population still view saving accounts as 
important in managing risks. A majority of this populations 
business still emanates from this model. 
Only one scheme concurred with literature33 m 
downplaying the significance of savings accounts ability to 
manage long term appropriateness of care i.e. future risks. 
(c) Additional views emanating from interviews 
1. Bafana Nkosi of Bonitas highlighted that m 
Medschemes experience, savings accounts have not 
been very popular with the lower income black 
markets. 
Medical savings accounts have been purely understood 
by the lower income groups. Aas a result insurance 
companies are now starting to introduce ''Nurseline" 
33 A report by Hollandia Reinsurance on managed care says the proponents of 
managed care and medical savings account schemes appear to be 
diametrically opposed. 
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to assist medical savings scheme members with their 
healthcare decision. 
2. Another interviewee believed that savings accounts 
certainly provided an incentive to abstain from 
unnecessary out-of-hospital care as the consumer has 
to pay the bill once a certain threshold has been 
breached. This invariably has its downfalls such as the 
longer-term health consequence of not using 
preventative as opposed to curative measures. 
3. Dave Avnit, Executive Chairman of Fedsure Health 
believes that MSA were perhaps the medical aids first 
attempt at properly addressing risk management. 
"Proof of the viability of savings accounts, given the 
risk management tools implemented, is the fact that 
major new generation funds such as Fedhealth and 
Momentum were able to grow exponentially and yet 
remain profitable. Unlike traditional schemes who after 
a period of enormous growth ran into losses, 
necessitating consolidation". 
Health insurers have been accused of cherry picking 
the young and healthy and the cause of further 
deterioration of the financial position of medical 
schemes. The government has, however, 
acknowledged that these schemes have a role to play 
268 
m the primary healthcare environment, but the tax 
benefits associated with these schemes are likely to 
change. Contributions to the schemes will probably 
remains tax deductible, but the interest earned on the 
savings will be taxable. 
Avnit goes on to say that companies focused purely on 
MSA might find their profits plataueing soon if the 
government regulates the industry further as envisaged 
by the white paper. 
4. Dan Pienaar of Liberty Health says that the use of risk-
management principles in insurance-based products is 
an effective way of containing contribution increases. 
Given that new generation products are based on 
effective risk management principles, the risk of the 
young and healthy members carrying a disproportionate 
contribution is avoided. 
(d) Discussion of results 
Medical savings accounts are conceptually sound in that 
they are designed to encourage members to be more 
accountable for everyday care. With medical savings 
accounts contributions are based on age and gender, which 
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are better indicators of risk than salary. Having said this, 
literature does question the ability of savings accounts to 
manage long-term appropriateness of care34• 
8.2 DOES YOUR ORGANISATION PURSUE 
MANAGEMENT/ UTILIZATION MANAGEMENT? 
• "Is each claim reviewed? 
• Who reviews the claims? 
CASE-
• Are the information technology systems sufficient to capture claims 
patterns and communicate with doctors and monitor provision of 
care? 
• Are these claims patterns used to assess future risks? 
• Do you have protocols for each disease? 
• Do you work off a drug formulary?" 
(a) Schemes contacted as part of sample survey 
• All of the sample population funds pursue some form of 
case management to assure objective considerations of 
appropriateness of admission, length of stay and 
timeliness of professional and ancillary services. 
34 A report by Hollandia Reinsurance on managed care says the proponents of 
managed care and medical savings account schemes appear to be diametrically 
opposed 
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However only 14 percent manage all cases from a 
general practitioner level through to hospital care. 
Graph 8.3: Utilization Management 
Management of Utilisation 
0 Internal 57% 
•outsourced 43% 
As reflected in Graph 8.3 , 43 percent of funds outsource 
utilization/case management and receive statistics on a monthly 
or quarterly basis. 
• In all the cases the case managers comprised nurses or 
sister with the added consultation of a doctor or 
specialist where required. 
• All the sample candidates considered IT systems in the 
industry as sufficient to capture claims patterns and 
communicate with doctors and monitor provision of 
care. 
• Only 14 percent of the sample population actively mine 
data to identify potential future risks. 
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• It is clear from Graph 8.4 (below) that the industry has 
embraced the concept of formularies with as much as 
nearly 30 percent of the sample population making use 
of formularies. Disease protocols, on the other hand, 
have not been sufficiently addressed with only 14 
percent of the sample responding positively to the 
question. 
Graph 8.4: Formulary and disease protocols 
iciA~;·, ............................ . 
(b) Managed Healthcare participants 
• Managed care players apply case management with internal 
resources as appossed to outsourcing this task. But even with 
the managed care population reviews are confined to reviews 
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of hospitals and or abnormal claims as opposed to monitoring 
the whole health delivery chain. 
• Managed care players place more importance on formularies 
and disease protocols. Formularies are now a de facto 
standard and much effort is currently being placed on 
developing disease protocols. 
d) Discussion of results 
• Even though all of the sample population say they do 
pursue case management, further discussion lead to the 
conclusion that majority use the terms case management 
and claims management interchangeably, which is not 
correct. 
• It is also important to note that only 14 percent manage 
all cases from a general practitioner through to hospital 
care. Therefore not all cases are managed. 
• The fact that no one considered their investment in 
information technology as insufficient should be treated 
with circumspect given that it is only in 1998 that a 
funder, for the first time, can trail drug treatment by any 
one patient by a multitude of health care providers with 
the aid of Mediscor's Pharmaceutical Benefit 
Management. 
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This view is also in contradiction to the result as shown in 
8.4.1 where only 15 percent of the sample were collating 
data to use in evaluating risks. Information technology is a 
necessity in collating data. 
8.4 MANAGED CARE 
"What active steps towards managed health care has the organisation 
already taken example: 
• Pre-authorization of hospitalisation, 
• Case management; 
• Drug review 
• Quality of health delivery control; 
• Preferred provider status with any specific hospital network or 
doctor organisation?" 
(a) Schemes contacted as part of sample survey 
Graph 8.5 : Managed Health Care steps implemented by Medical 
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As shown in graph 8.5 , pre-authorisation of hospital care 
and case management at hospital level are now conducted 
across the sample population. It is only in the areas of case 
management at the general practitioner level and quality 
control (both scoring 14 percent compliance) that the 
sample group is sorely lacking. 
Preferred provider networks are increasingly becoming the 
norm with 57 percent of the sample having appointed such 
networks. 
Even though only 30 percent of the sample were actively 
using formularies, as much as 71 percent had taken steps 
towards putting formularies in place. 
(b) Managed healthcare participants 
Each of the funders in this population currently pre-
authorise hospital care, case manage at the hospital level 
and work off drug formularies. Selecting preferred provider 
networks have become standard practice. Even managed 
care players have not mastered case management at the GP 
level, with exception to one fund. The control of quality of 
delivered health care is still not an achievable goal. 
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(c) Additional comments emanating from interviews 
(1) The managed care players such as Southern and 
Sanlam, who signed preferred hospital provider 
contracts faced much pressure from doctor groups, 
hospital groups and the Competition Board until they 
opened their network to all hospitals willing to abide 
by their terms. The lesson learnt by all the medical aid 
players is that health care providers still carry much 
weight in this country unlike the scenario in the United 
States where the level of provider over-capacity 
rendered the funder in a stronger position. As a result 
managed health disciplines will be more difficult to 
enforce on providers in South Africa. 
(2) Graham Anderson of Southern Health says on 
provider networks: "This is important because our 
provider network is the source of our information. If 
we don't know that a patient is accessing the system, 
that he or she is seeing a specialist, being admitted into 
hospital or undergoing major surgery until such time 
as the account lands on our desk, we haven't a hope in 
effectively managing that cost". 
276 
(3) Service providers have experienced difficulty in 
complying with ICD1035 and CTP4 coding systems, 
which Southern Health was the first to introduce. 
(d) Discussion of results 
From the outcomes of the sample survey it is clear that 
medical aids are making inroads towards managed care by 
implementing the first phases i.e. pre-authorisation of 
hospital care and case management at the hospital level. 
Only 14 percent of the sample, however, believe as theory 
imparts, that management of health care is a long- term 
process which necessitates an understanding of the 
continuum of health care services, and that the consumer 
needs to be monitored and managed throughout this 
continuum. 
Despite a unanimous acceptance from the interviewees of 
managed care in principle, its introduction is proceeding 
slower than anticipated, with many testing the water first 
with certain managed care tools. Given that hospitalisation 
and drug costs comprise by far the biggest component of 
the national health bill i.e. 75,4 percent (Registrar of 
Medical Schemes 1994: 11 ), it is these elements that are 
receiving the greatest scrutiny. 
35 These codes refer to procedures and diagnosis which providers must supply to be inputed into the 
database 
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8.4.1 BARRIERS TO IMPLEMENTATION OF 
MANAGED CARE 
"What are the barriers to implementation of managed health 
care 
• Availability and reliability of data 
• Doctor participation as gatekeeper 
• Information systems across the entire health 
continuum" 
(a) Schemes contacted as part of sample 
The sample schemes were asked to rate what they 
considered to be the barriers to implementation of 
managed care in South Africa. The outcomes are depicted 
in graph 8.6. on the following page. 
278 
Graph 8.6: Barriers to Implementation 
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All of the Medical Aids in the sample voted that collecting data 
was a problem as was the role of the general practitioner in the 
whole process. Only 28% considered the information systems m 
the industry as sufficient to handle the process of managed care. 
(b) Managed healthcare participants 
Other problems to implementation sited by those that have 
attempted to implement managed care where: 
• Resistance from servtce providers and medical aid 
members. Providers have not been sufficiently educated on 
what the role of gatekeeper encompasses. 
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• Non-compliance by beneficiaries with the general rules and 
regulations set by the managed care companies; 
• A lack of formal representatives of service providers 
(especially specialists) with whom managed care companies 
can negotiate; 
• A service provider system that is unable to cope with new 
reimbursement methods such as per diem fees; global fees 
and capitation. 
{c) Additional comments emanating from interviews 
Adrian Gore of Discovery Health sights the largest difference 
between the United States' health system and South Africa's is the 
formers oversupply of doctors. 
Specialisation USA - Patients South Africa -
per Doctor Patients per doctor 
Surgeons 1000 23000 
Paedi tri ti ons 8000 33000 
Gynaecologists 15000 8000 
Psychiatrists 32000 6000 
Orthopaedic 20000 16000 
Surgeons 
Source : Discovery Health 
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Gore is of the beliefthat managed healthcare relies on an oversupply 
on doctors. Given the laws of supply and demand, medical schemes 
are then in a better position to negotiate discounts. 
He envisages a more South Africa centric managed healthcare model 
termed integrated care, which entails a move away from traditional 
fee-for-service to a more PPP, savings accounts model. 
He goes on to say that South Africans, in general, tend to use health 
care services more liberally and do not take well to being told which 
doctor to visit i.e. in terms of preferred provider networks. 
(d) Discussion ofresults 
The medical industry in South Africa, very clearly have some stumbling 
blocks to address before the implementation of broader managed care 
principles is made possible. This includes educating both the health care 
fraternity as well as members of the population about the issues 
involved. The gatekeeper role is vital as it is the point of first entry in the 
health service chain. Yet doctors need to be better educated on the 
significance of the role and consequences of their actions. 
The industry further reqmres a significant investment in information 
technology in order to collate data, to facilitate service provider reviews 
and to cope with the various reimbursement methods. One could very 
well envisage a more "South African centric" model. The bottom line 
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though is that any move towards a more managed/co-ordinated health 
care industry is a move in the right direction. 
8.5 ALTERNATIVE SCHEMES 
"Rate which alternative your schemes considers superior in 
addressing risk management in health care funding " 
(a) Schemes contacted as part of the sample 
Graph 8.7: Superior Tools for Risk Management 
As reflectd on graph 8. 7, 71 percent of the sample population rated 
managed care as the superior risk management tool in funding health 
care. This was followed by close of 30 percent that felt medical 
savings accounts were still the better toll in managing risks 
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(b) Managed healthcare participants 
The managed care population are protagonists of the managed health 
care models to better manage risks. 
(c) Discussion of results 
This question attempted to gage, which systems each funder 
considered to be the better in terms of dealing with risk. Even 
though more schemes in South Africa are currently employing 
medical savings accounts versus comprehensive managed care 
porgrammes, the desired balance appears to be reversed, with the 
majority siting managed care at the better tool. Going forward one 
,, would expect the industry to increasingly move towards a managed 
care model. 
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8.6 RESULTS OF IMPLEMENTED PROGRAMMES THUS 
FAR: 
None of the sampled schemes were able (willing) to divulge results 
of managed care modules to date. For the purpose of illustrating 
the short term benefits of managed care, this section will review 
data provided by four managed care players i.e. QA Care, Qua/sa, 
San/am, and Medcheme. 
8.7.1 QA Care 
QA Care36 is responsible for the management of eight 
medical schemes' utilization management. It has posted 
some impressive improvements in health care costs in the 
past year. QA Care imparted with data outcomes for one 
scheme, scheme A. 
Table 8.6.1: Results of Hospital Utilization Management of Medical Scheme 
A 
1997 1998 o;o 
Cost per Case R4031 R3360 (16) 
Length of Stay 2.6 days 2.2 days (15) 
Cost per hospital day R1513 Rl654 8 
36 QA Care is a hospital utilization management company, responsible for the management of 
hospital costs for medical schemes. QA Care has been active in utlisation management since 
April 1995. It has been in existence for 4 years, employs 50 sister and a total staff compliment 
of 65. It also has a team of consultants paid on a retainer basis. QA Care has I 00 000 
beneficiaries. 
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As depicted in table 8.6.1 this utilization management 
company, QA Care, was successful in managing this 
particular scheme's cost per case down by 16%. One 
would expect this to be a function of the length of stay, 
which in this case was reduced by 15%. Yet the cost per 
hospital day increased by 8%, which could be a reflection 
of the types of cases being administered or the severity of 
the treatment given in the shorter stays. 
The number of cases that were disallowed by QA Care 
''I across five schemes is presented in table 8.6.2. 
Table 8.6.2: Cases disallowed by QA Care across five schemes 
STATISTICS ON NOT AUTHORISED CASES DISALLOWED PER SCHEME. 
Scheme Period Principal members Estimated 
where cases were amount saved 
disallowed hospitalisation 
Scheme A Jan 1998 2485 R 200,000 
May 1998 
Scheme I Jan 1997 -2284 R 325,250 
May 1998 
Scheme C Jan - Dec 22653 R 1,884,650 
1997 
SchemeS Jan - Dec 1711 R 165,650 
1997 
Scheme P March 1997 - 1111 R 193,600 
May 1998 
Source: QA Care 
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I 
Rand 
on 
The above cases were not authorised mainly due to 
inappropriate facility i.e. a dental procedure that can be 
done at the dentists rooms rather than in hospital. The 
above rand amount IS the estimated cost for 
hospitalisation only and excludes associated costs I.e. 
pathology and radiology. The amounts reflected 
accounted for approximately a 40 percent total saving to 
the scheme, which would have gone undetected had it not 
been for case management. 
8.6.2 QUALSA 
After 16 months of operation, Qualsa has demonstrated the 
following cost savings: 
• 7 percent on admission management; 
• 20 - 40 percent on medical and surgical case management; 
• 35 percent on pre-natal management; 
• 30 percent on mental health management and 
• 30 percent on claims auditing. 
8.6.3 SANLAM 
Since introducing managed care in July 1996, Sanlam Health 
Care reported a 30 percent drop in magnetic resource imaging 
scans, saving R1,2 million annually which has been given back 
to the 1 million covered by its managed care scheme. The 
average length of hospital stays dropped from 2,9 to 2,4 days 
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i.e. 17 percent. Hospital admission rates dropped from 27 5 per 
thousand members to 240, and bed days from 840 to below 750 
per thousand. The average length of hospital stay for births 
dropped from 3,5 to 2,9 days and for caesarean section from 
4,7 to 4,6 days. 
Sanlam Health rejected authorisation for more than 700 
operations, which it deemed, were unnecessary : "This was 
done after proper medical evaluation, and no emergency cases 
were affected." 
"Since we introduced managed health care the result has been 
more cost-effective health care for all our members, with no 
sacrifice in quality. This then translates into lower premium 
increases and better access to quality care for more South 
Africans" says Dr Hofinan of Sanlam Health. 
Sanlam's medical advice line received 1 500 calls in its first 
month, 557 of whom decided against visiting their general 
parctitioner after receiving phone advice. 
8.6.4 MEDSCHEME 
Dr Rothberg, MD of Hospi-Serve the utilization management 
division of Medscheme, says that its introduction saw a radical 
shift from the old reliance on retrospective review of 
hospitalisation (account audit/claims management) to 
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concurrent review (case management) and prospective review 
(pre-authorisation). In the early stages of hospital benefit 
management service, proven savings of between 4 percent and 
10 percent was reported. Hospital days have been managed 
from 3,2 days to 2,6 days. Medscheme believes that after 
contracting with hospitals it can now achieve better savings due 
to improved communication, pre-notification, discounts and a 
lower cost per case. 
Other services include an on-line member and doctor profiling 
facility for the medical aids. High claiming patterns are 
counselled by nurses, who in turn contact or visit the respective 
physicians. The group will go so far as to ask for a 
reimbursement by the doctor. The provision of these services 
has resulted in a saving of more than R40m during 1997. 
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8. 7 Views on Draft Policy on Financing of Health Care 
Policy in South Africa 
"How will the pending legislation, with respect to community 
rating, impact the industry at large and its ability to manage risk?" 
(a) Schemes contacted as part of sample 
All sample members agree that the introduction of community 
rating37 will hamper risk identification and evaluation. It ,will 
further impact those schemes offering medical savings account 
given their reliance an more member specific information to 
rate individual risk, as opposed to the cross-subsidised model 
applied in community rating. 
(b) Managed Healthcare participants 
The VIew from a prominent chief executive officer at a 
managed healthcare organisation is that the introduction of 
community rating, open enrolment and minimum benefits 
effectively removes the power of pricing. His view is that one 
will not be able to simply link price with risk as was the case 
historically hence the risk management techniques must become 
more refined. 
37 The concept of community rating as intended by the bill (but not properly worded as 
such) is that medical scheme contributions may only be raised on the basis of family 
size and income. 
289 
(c) Additional comments emanating from interviews 
1. There are three concepts that give rise to the greatest 
problems (Dr Brian Brink, senior medical consultant at Anglo 
American): 
1.1 The inclusion of all immediate family members 
living in the same household as ordinary dependants 
will significantly increase the costs of the scheme 
without an appropriate and corresponding increase in 
contributions to be paid by the member concerned. 
1.2 The bill does not allow for differentiation between 
adult and child dependants in the determination of 
contribution, or differentiation on the basis of age. 
High cost individuals such as females of child-bearing 
age and grandparents will be entitled to membership at 
the same rate as all other dependants - normally 
children. 
The average cost of dependant membership will 
increase dramatically for all members. The winners 
will be those with extended families, the losers with 
small families will presumably leave the medical 
scheme when they realise that the cross-subsidy they 
are required to pay is too onerous. In time, the 
winners will also become losers. 
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1.3 The bill provides that no limitation will apply to 
the payment of any relevant health service obtained by 
a member from a public hospital. This in effect 
legislates guaranteed payment for any service rendered 
by a public hospital at whatever prices the state 
chooses to charge. It can be expected that public 
hospitals will exploit this provision to raise additional 
revenue outside of their normal budgetary constraints. 
2. The likely outcome of the regulation is that young members 
will withdraw from medical schemes because of the high 
costs and only rejoin when they anticipate high medical 
expenditure, knowing that they must be accepted. While 
there may be some protection in measures designed to 
reduce anti-selection, such as waiting periods, these are 
unlikely to contain the inevitable rise in costs to the 
remaining membership. 
The cost spiral so created will drive more low claiming 
members out of medical schemes, thus defeating the object 
of expanding access to private health care cover for more 
people. 
3. A further concern is that enforced community rating will 
aggravate the situation with regard to unfunded post-
retirement liabilities. New accounting standards require 
employers to declare these unfunded liabilities on their 
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balance sheets. The amounts of money involved are 
staggering. Any employer that has promised to pay a 
proportion of the medical scheme contribution will be 
exposed to increased and unmanageable cross-subsidy liability 
for post-retirement medical costs as a result of enforced 
community rating. 
The proVIsiOn for mmtmum benefits being not less than 
benefits provided for by public hospitals will undoubtedly 
increase costs for many schemes serving low-income earners. 
Low-cost schemes will typically have to remove any limits 
they might have on hospital benefits. Then they will no longer 
be low cost schemes. 
d) Discussion of results 
The combination of the three factors referred in point 1 above, is 
bound to raise the cost of medical scheme membership beyond 
affordable levels for employers and for average employees. The 
inevitable result will be that employers will change their basis of 
funding healthcare from a defined benefit promise towards a 
defined contribution, which will only escalate at the rate of salary 
mcreases. 
Hence employees, including the millions of trade union members, 
will bear the major brunt of the increased costs. 
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The funding system will rely on a large cross-subsidy from young 
to old. The concept can only work if it is underpinned by a 
constant influx of young members, who are prepared to 
contribute substantially more than they claim. 
Such community rating usually requires a compulsory 
membership environment to ensure that there IS an adequate 
supply of young members. However, the bill specifically 
provides for voluntary membership (open enrolment) coupled 
with guaranteed access, regardless of state of health, for all 
individuals applying to join a medical scheme. 
Adrian Gore (Discovery Health) probably summarized it best by 
highlighting his views on health care funding trends which are 
(Presentation to University of the Witwatersrand Alumni July 
1999): 
(1) Size and risk management capabilities will be more 
important. 
(2) A move away from traditional managed care towards 
integrated care. 
(3) A move from paying for sickness to incentivising wellness. 
(4) Increased expenditure on information technology. 
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( 5) The increased importance of intermediaries as agents of 
change. 
8.8 SUMMARY 
Even though the sample population unanimously affirmed that they 
implemented risk management tools it was clear from the more 
specific questions that medical schemes in South Africa have 
implemented the most rudimentary of risk management strategies. The 
analysis revealed that the medical schemes did not identify, nor did 
they evaluate or control risks. 
The information technology infrastructure across the health channel in 
South Africa is still inadequate to allow for broader risk management 
strategies. Only 14 percent of the sample collated and mined 
diagnostic data to identify and evaluate risks. 
Claims management is the standard when it comes to risk control yet 
claims management is in retrospect and offers limited recourse. The 
same logic applies to the most common form of remmuneration 
technique i.e. fee-for-service. Increasingly, however, schemes will look 
to more sophisticated remuneration methods where healthcare service 
providers become more accountable for the quality of health care they 
deliver. 
Of the alternative healthcare options, both co-insurance and bonuses 
proved unpopular but medical savings accounts was ranked the 
highest in terms of schemes that had implemented new generation 
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products and ranked second, after managed health, as the better tool 
for managing risks. 
Even though managed healthcare ranked first as the best strategy for 
an all encompassing risk management programme in healthcare it was 
clear that medical aids are still making inroads towards managed care 
by implementing the first phases i.e. pre-authorisation of hospital care 
and case management at the hospital level. Only 14 percent of the 
sample, however, believe as theory imparts, that management ofhealth 
care is a long- term process which necessitates an understanding of the 
continuum of health care services, and that the consumer needs to be 
monitored and managed throughout this continuum. 
The new legislation on community rating and open enrolment will 
lead to less short-term risk identification and evaluation abilities but 
will necessitate more acute longer-term risk identification , evaluation 
and risk financing methodologies. 
CHAPTER 9: CONCLUSION AND RECOMMENDATIONS 
9.0 INTRODUCTION 
As a consequence of the consistently spiralling health care costs in South 
Africa, healthcare has become increasingly unaffordable. Due to the very 
nature of the medical insurance industry in South Africa, the success of a 
medical scheme is largely determined by the measure to which the 
increasing number of high risk categories (aged and infirmed) are 
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subsidized by an increasing number of young and healthy. Yet the cost 
pressures have placed restraints on a medical aid's ability to obtain new 
membership and has resulted in losses for many schemes. This has called 
into question the role of risk management in the medical aid industry 
historically and its role going forward. 
The primary objective of this research was to determine to what extent 
risk management has been implemented in the South African medical aid 
industry. 
The secondary objective was to evaluate alternative health care risk 
management strategies with the purpose of identifying the most 
appropriate strategy. 
9.1 RISK MANAGEMENT 
Through the disciplines of risk management an organisation is able to 
predict and control the effect of future events on its operations. Risk 
management is concerned with identifying, evaluation, controlling and 
financing risks. 
Medical schemes face a number of challenges to secure their future role 
and long-term sustainability. They are under pressure to curb the 
continued cost spiral which is inter alias ascribed to an uncontrolled fee-
for-service reimbursement method and lack of suitable methods to 
address unacceptable claims and practice profiles. 
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The findings of the study was that that the South African medical aid 
industry has not adhered to the broader definition of risk management as 
theory prescribes. The results of the study revealed that medical schemes 
in South Africa have applied the most rudimentary risk management 
strategies. 
The full extent of risk management was one of risk pooling and risk 
financing. Yet risk pooling is a diversification process as apposed to a 
risk control tool, where cross subsidisation helps to ensure a predictable 
outcome. 
A mere 29 percent of the sample dedicate set resources to risk 
management and have comprehensive risk committees with 
representation from the health fraternity. 
Risk identification in medical schemes is still constrained to risk pooling 
but steps have been taken to better identifying risks by risk rating based 
· on age and number of dependants as opposed to conventional income 
tables. By and large the conclusion that can be drawn is that medical 
aids in South Africa rely heavily on their actuary department to 
appropriately price risk into premiums. After identifying . risks a 
community rating was historically applied based merely on the group 
size and historic claims experience. 
In future, if some of the pending legislation is promulgated, even the 
power of risk pricing will come into question. 
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The full extent of risk control measures in the industry includes 
retrospective claims reviews. Managed care players have progressed 
beyond the passive roll of retrospective review with an increasing 
number of such schemes offering clinical intervention tools such as 
hospital utilization management. 
Even though most medical schemes ·have made inroads into some form 
of clinical intervention such as hospital case management it is was 
interesting to note that 43 percent of scheme administrators outsource 
these tasks. With administrators outsourcing the task of managing 
utilization it is apparent that the party that assumes risk often does not 
manage that risk. 
The information technology infrastructure across the health channel is 
still inadequate to allow for broader risk management strategies. 
Managed health care players have started making significant investments 
in technology that will in future empower schemes to mine historic data 
to identify trends that could lead to identifying and evaluating future 
risks. 
Financing is primarily based on a fee-for-service remuneration method 
with alternate methods of remuneration, with an increasing amount of 
risk sharing, becoming increasingly more common. Costs are addressed 
on a pay-as-you-go basis, out of reserves. 
It is clear that the industry is changing. The focus has changed from 
claims processing to proactive interaction with medical providers and 
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members in order to better manage the risk. The companies with the 
greatest chance for survival are those that provide a comprehensive 
managed care service, have access to large patient volumes, have good 
information technology and a capital base that allows them to assume 
risk. 
9.2 EVALUATION OF ALTERNATE HEALTHCARE 
STRATEGIES. 
Of the alternative healthcare options, both co-msurance and bonus 
options proved unpopular but medical savings accounts ranked the most 
popular in terms of the number of schemes that implemented new 
generation products. Medical savings accounts however ranked second 
to managed healthcare as the better strategy for managing healthcare 
risks. 
These new options i.e. co-insurance, rebates etc. created an incentive for 
the insured to forego medical care in the advent of illness. "Bonus 
hunger" could conceivably induce insureds to defer or even forgo 
necessary medical treatment, jeopardising their health. The negative 
consequences of "bonus hunger" would leave its traces in the patterns of 
outlay on medical care over time. Specifically, early savings would tend 
to be wiped out in the later periods. 
A crucial issue when managing health care risks is the adjustment of 
bahaviour, which results in a reduced consumption of services. This 
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should, however, occur in a "managed" manner where medical 
professionals, as opposed to the consumer, drive the process. 
Medical savmgs accounts are conceptually sound in that they are 
designed to encourage members to be more accountable for everyday 
care. With medical savings accounts contributions are based on age and 
gender, which are better indicators of risk than salary. Having said this, 
literature does question the ability of savings accounts to manage long-
. f 38 term appropnateness o care . 
Of the alternative risk management strategies managed health care seems 
the more appropriate in fulfilling the criteria of risk management. 
Medical aids in South Africa have not been active in trying to reduce the 
frequency of loss in the longer term through active involvement in the 
delivery and quality of health care service. Managed health care provides 
the tools to address such issues. 
Managed healthcare by definition addresses many of the risk 
management principles as highlighted in this research. It not only deals 
with identifying and analysing future risks more thoroughly, it also deals 
with the treatment of risk by looking at healthcare in a holistic manner 
and exerting control through the full continuum of health care services, 
from the gatekeeper (general practitioner) level to post-hospital care and 
claims management. 
38 A report by Hollandia Reinsurance on managed care says the 
proponents of managed care and medical savings account schemes 
appear to be diametrically opposed. 
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By networking and tying in preferred providers managed healthcare also 
co-ordinates and rationalises services, hence controlling risks. In a 
managed care environment it is also easier to research the efficiency and 
quality of services as provider practices will have to conform with 
predetermined protocols and utilization of patients services is easier to 
track. 
The research shows that there exists no perfect system for healthcare. Of 
the options explored in this research, managed healthcare was the only 
~ption that fully embraced the concept of risk management. It is only 
through a more integrated approach that one can build the necessary 
databases on which to identify and evaluate risks. It is only with clinical 
intervention that one can monitor and control risks. However finding the 
more suitable "South African centric" managed care model is the 
challenge. The medical schemes that attain this milestone face the 
strongest chance of success. 
Bill Gradison, president of Health Insurance Association of America 
says (Online Forum 1998): "There's no best system. But we believe that 
the current systems (managed health care), with its faults, operates 
pretty well." 
9.3 AREAS FOR FURTHER RESEARCH 
Certain barriers to implementation of managed healthcare have been 
highlighted, some of which provide interesting topics for further 
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research. In order to attain risk management one needs comprehensive 
data. South Africa lacks comprehensive medical databases. This impacts 
risk identification, risk evaluation and risk treatment. The technological 
infrastructure in the industry is also inadequate to handle this daunting 
task; e.g. service provider systems are unable to cope with new 
reimbursement methods, general practitioner desk-top software must 
integrate with on-line electronic data exchanges. 
Therefore a look into the role of technology in risk management is a 
plausible topic for further research. 
BIBLIOGRAPHY 
• Abrams R. 1988. The pnmar:y care physician and 
utilization management. Group Health Institute. June p 
27-38); 
• African National Congress. 1994. A National Health 
Plan for South Africa. Published by the African National 
Congress Johannesburg, South Africa. 
• American Medical Association. 1992. Using Practices 
Parameters in Quality Assessment. Quality Assurance 
and Quality Improvement Programs. Office of Quality 
Assurance. Chicago, IL. 
• Applegeet, C.D. 1993.The differences between clinical 
practice guidelines, recommended practices. AORN 
Journal. 58(3):587-8. 
302 
• Baird , Thomas. 1990. Cases, problems and materials on 
bankruptcy. Boston: Little, Brown. Second edition. 
• Bannister, J. 1989. Managing Risk. London: Insurance 
and Reinsurance Research Group. 
• Bergman, R. 1994. Getting the goods on guidelines. 
Hospitals and Health Networks. 68(20): 70- 4. 
• Berman, C. 1993. Overserved populations. Conference 
paper delivered at "The medical profession in a changing 
South Africa". May 
• Bernstein, I.l., Blessing-Moore, J., Fineman, S., Gutman, 
A.A., Lee, R.E, Nicklas, R.A., Peralman, D.S. and 
Spector, S. 1993. Establishing practice parameters: 
parameters for the diagnosing and treatment of asthma. 
Annals of Allergy. 71(3): 197-9. 
• Boland P. 1991. Making managed health care work: A 
practical guide to strategies and solutions. McGraw-Hill, 
Inc/Health Professions Division. 
• Born, C.M. CPA. Marino, D. 1995. Improving materials 
management through re-engineering.. Healthcare 
Financial Management. September, p. 31 -37. 
• Broomberg, J. & De Beer, C. & Price, M.R. 1990. The 
private health care sector in South Africa -current trends 
and future developments. South African Medical 
Journal. Volume 78, p. 139-43. 
• Broom berg, J. & Price, M.R. 1990. The impact of fee for 
service reimbursement system on the utilization of 
medical services. Part II: Comparison of utilization 
303 
patterns in medical aid schemes and a local HMO. South 
African Medical Journal. Volume 78, p. 133-6. 
• Burroughs, C.E. 1994. The use of practice guidelines in 
Wisconsin for liability protection. Wisconsin Medical 
Journal. 93(2): -75. 
• Cerne, F. 1995. Cash Kings. Hospitals & Health 
Networks. April 5, p51-54. 
• Ceslowtz, S. B. 1993. Managed care: controlling costs 
and changing practice. Medsurg Nursing: Official Journal 
of the Academy of Medical-Surgical Nurses. 2(5): 359-
66. 
• Clark, B.W. 1995. Negotiating successful managed care 
contracts. Healthcare Financial Management. August, p. 
27-30. 
• Clark, C. 1995. Managed Care - Planning along the 
continuum of care. Healthcare Financial Management. 
August, p 20-21. 
• Clarke, G.M and Cooke, D. 1983. A basic course in 
statistics. Second edition. An Edward Arnold 
Publication. London. 
• Coetzer, H. 1996. Balancing the needs of the managed 
care patient with the demands of cost control and quality 
assurance. Conference Proceedings: Health Care 
Structure. 
• Coile, R.C. 1995. Assessing healthcare market trends and 
capital needs: 1996 -2000. Hea1thcare Financial 
Management. August, p60 - 62. 
304 
• Cowlin, J. 1992. Primary Health Care - Private sector 
perspective: privatisation possibilities. Primary Health 
Care Conference, Johannesburg, Glaxo/ Adcock Ingram 
July. 
• Cowlin, J. 1993. The structure and problems of the 
present health care system. Address to the Financial Mail 
Corporate Health Care Conference, Johannesburg. 
• Da Costa M, 1996. Managed Health Care in South 
Africa. Investec Securities. Unpublished report. 
• Davidson, S. 1976. PSRO utilization and audit in patient 
care. The C. V. Mosby Company. 
• De Clerk, P. 1993. What managed care will be offering. 
Address to the Financial Mail Corporate Health Care 
Conference, Johannesburg. 
• Dickey, D. 1995. Clinical engineering helps reduce 
equipment costs. Healthcare Financial Management. 
September, p 50 -53. 
• Duff and Phelps Credit Rating Co. of Southern Africa. 
1997. Semi-Annual Medical Schemes Bulletin. 
September. 
• Duncan W.J, Ginter P.M, Swayne L.E. 1988. Strategic 
management of health care organisations. Second 
Edition. Blackwell Business. 
• Eastaugh, S.R. 1995. Nationwide EDI system can trim 
administrative costs. Healthcare Financial Management. 
September, p 45-47. 
305 
• Eckholm, E. 1994. While Congress remains silent, health 
care transforms itself New York Times. December 18, 
p. Al,22. 
• Enthoven, A.C. & Kronick, A. 1989. A consumer-choice 
health plan for the 1990s: universal health insurance in a 
system designed to promote quality and economy. N 
Eng. J Med. Volume 320: 29-37. 
• Erb, J.C. 1992. Health care benefits survey: managed 
care plans. Report 2. Princeton NJ. A Foster Higgins. 
• Financial Mail. Special report: NMA Medical Fund 
Managers. March 20 1998: 70. 
• Giaquinta, D. 1994. Session II: Drug formularies 0 Good 
or Evil A view from a managed care providor,. 
Cardiology. 85(Suppl 1): 30-35. 
• Gold, M.R. 1991. HMO and managed care. - Health 
Affairs 1, Winter, p 188-206. 
• Gore, A. 1993. The Search for successful health 
principles in a changing South African health care 
environment. Transactions of the Actuarial Society of 
South Africa. 9 (Part 3). 
• Gorey, T. 1994. Heading in a new direction. Iowa 
Medicine. 84(681): 24-7. 
• Government Gazette Statkoerant. May 1999. Republic of 
South Africa. Volume 407. Regulation Gazette No. 6530. 
• Helmer, 0. 1967. Analysis of the future: The Delphi 
Method. March. The RAND Corporation, Santa Monica, 
California. 
306 
• Heymans M. 1997. An overview managed healthcare in 
South Africa. December. First National 
Equities. Unpublished Reports. 
• Hindelong, J.F. & Purvis, K.A. & Halper, S.P. & Nincic, 
D. & Shah, S. 1995. Healthcare Hotline. Donaldson, 
Lufkin & Jenerette Securities Corporation NY. 
• Horowitz, J.L. 1995. Using Strategic planning to address 
managed care growth. Healthcare Financial Management. 
April, p 23 -24. 
• Ingelhart, J.K. 1992. The American Health Care system : 
Managed Care. N Eng. J Med. September, Volume 327, 
no. 10, p 742-747. 
• King, D. & Nel, C .& Edun, W. & Young, S. 1995. 
Medical Scheme Ratings - medical bulletin. Republic 
Ratings. Johannesburg. 
• Kolb, D.S. & Horowits, J.L. 1995. Managing the 
transition to capitation. Healthcare Financial 
Management. February, p 64- 70. 
• Kongstvedt P. 1989. The managed health care handbook. · 
Rockville, MD: Aspen Publishers Inc; 
• Korpiel, M. R 1995. Issues relating to clinical pathways: 
managed care implementation and liability. Journal of 
Burn Care & Rehabilitation. 16(2 Pt 2): 191-5. 
• Lewis, M.A. & Welch, P. 1990. The private sector and 
health care delivery in developing countries. Resources 
for child health project, John Snow Inc. Quoted in 
Tollman et al. 
307 
• Lobach, D.F. and Hammond, W.E 1994. Development 
and evaluation of a computer-assisted management 
protocol: Improved compliance with care guidelines for 
diabetes mellitus. Proceedings from Symposium on 
Computer Application in Medical Care. 787-91. 
• Managed Care Information, Definitions and Contract 
Considerations. 1993. Journal of Arkansas Medical 
Society. 90(6):271-5. 
• Mandell B.B. 1986. Minutes of a meeting of the Federal 
Council of the Medical Association of South Africa. 
Supplement to South African Medical Journal. Volume 
70, number 7, September pp2-l 0. 
• Masobe, P. 1992. Trends in the private/public sectoral 
mix of health care providers. Centre for Health Policy 
Paper 26. 
• McDermott, R.E. & Ogden, J.P. 1995. What CPA's can 
do about health care costs. Journal of Accountancy. 
June, p 56 -60. 
• McGahan, A.M. 1994. Industry structure and 
competitive advantage. Harvard Business Review. 115-
124 
• Mcintyre, D.E. 1993. Health sector financing and 
expenditure in South Africa. Working Paper No 4. 
Health Economic Unit, University of Cape Town. 
• Micheletti, J.A. & Shlala, T.J. 1995. Case management 
can reduce costs and protect revenues. Healthcare 
Financial Management. April, p 64- 70. 
308 
• Micheletti, J.A. & Mervert, S. & Shlala, T.J. 1995. 
Using case management to improve claims payment. 
Healthcare Financial Management. May, p 38 - 45. 
• Miller, T. & Ryan, B. 1995. Analyzing cost variance in 
capitated contracts. Healthcare Financial Management. 
February, p 22. 
• Monagle, J.F. Risk management - a guide for health care 
professionals. An Aspen Publication. 
• Onion, C.W.R and Walley, T. 1995. Clinical guidelines: 
development, implementation, and effectiveness. 
Postgraduate Medical Journal. 71(831): 309. 
• Online Forum. 9 July 1998. A discussion on managed 
care health plans. Online News Hour. 
http://www.pbs.org/newshour/forum/july98/hmo.html 
• Outcomes. February 1998. Hospi-Serve proves its 
mettle. Medscheme Managed Care Division. 
• Pearce II, J. & Robinson,R 1991. Formulation, 
implementation and control of competitive strategy. 4th 
edition. Homewood: Irwin. 
• Price, M.R & Broomberg, J.1989. What is wrong with 
medical aid schemes? The Centre for the Study of Health 
Policy. 
• Price, M.R & Broomberg, J. 1990. The impact of fee-
for-service reimbursement on the utilization of health 
services. Part III. A comparison of cesarean section rates 
in white nilliparous women in the private and public 
sectors. South African Medical Journal. p 78:136. 
309 
• Price, M.R. 1992. Health Maintenance Organisations. 
Nursing RSA Verpleging Vol. 7, no.6, p 21 - 23. 
• Price, M.R. 1994. The impact of political transformation 
in South Africa on Policy Debates regarding the public-
private mix in Health Care. Health Policy and Planning . 
March, Volume 9, no. 1, p 50-63. 
• Registrar of Medical Schemes. 1994. Annual report of 
the Registrar of medical Schemes. 
• Report of Registrar of Medical Schemes .1995. Annual 
report of the Registrar of medical Schemes. 
• Report of Registrar of Medical Schemes. 1996. Annual 
report of the Registrar of medical Schemes. 
• Report of the Committee of Inquiry into a National 
Health Insurance system. 1995 Restructuring the 
National Health System for Universal Primary Health 
Care. 
• Richards E.P, Rathbun K.C. 1983. Medical risk 
management: preventative legal strategies for health care 
providers. Rockville, MD: Aspen Systems Corporation. 
• Schevellis, F.G., v Eijk, JJ.Th.M., vd Lisdonk, E.H., vd 
Velden, J.J. and v Weel, C. 1994. Implementing 
guidelines in general practice. Evaluation of process and 
outcome of care in chronic disease. International Journal 
of Quality ofHealth Care. 6(3): 257-266. 
• Shouldice R.G. 1991. Introduction to Managed Care: 
Health Maintenance Organisations and Competitive 
310 
Medical Plans. Arlington, VA: Information Resources 
Press. 
• Schultz, R & Johnson, A.C. 1990. Management of 
Hospital and health Services. Strategic Issues and 
Performance. St Louis: Mosby. 
• Sunshine, J.H. and Evens, R.G. 1994. The challenge of 
managed care and managed competition. American 
Journal ofRoentgenology. 162 (4): 767-71. 
• Steyn, H. 1993. The government's vision of a future 
health care structure. International Executive 
Communications, Johannesburg. 
• Tingley, W. 1993. The use of guidelines to reduce costs 
and improve quality: A perspective from insurers. Journal 
on Quality Improvement. 19 (8): 330-334. 
• The Medical Association of South Africa. 1992. Doctors 
and managed health care. Health Care Policy Division. 
• Vaughan E.J.l997. Risk Management . John Wiley & 
Sons, Inc. 
• Veliotis G.P 1991. Strategic options for the medical aid 
industry. Unpublished research report submitted in partial 
fulfilment of the requirements for the MBA degree. 
University of the Witwatersrand: Business School. 
• Veliotis, G. & Magennis, R. & Brown, M. 1993. 
Introduction to managed health care in South Africa - in 
conjunction with MASA. Medical Association of SA. 
311 
• Vincenzino, J.V. 1994. Development in health care costs~ 
Statistical Bulletin/Metropolitan Insurance Companies. 
75(1): 30-5. 
• Walters, L. 1991. The rational use of medicines in 
primary health acre. Nursing RSA Verpleging. 6(8):33-
37. 
• Williams, L. 1995 Structuring managed care joint 
ventures. Healthcare Financial Management. August, p 
32- 36. 
• Williams C.A., Smith M.L., Young P.C. 1995. Risk 
Management and Insurance. Seventh Edition. McGraw-
Hill International Editions 
• Willett A.H. 1951. The Economic Theory of Risk and 
Insurance. Philadelphia: University of Pennsylvania 
Press. 
• Zweifel 1992. Bonus options in health insurance. Boston: 
Kluwer Academic. 
• Zweifel 1996 
312 
